{
 "cells": [
  {
   "cell_type": "code",
   "execution_count": 2,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Collecting sentence-transformers==2.2.2\n",
      "  Downloading sentence-transformers-2.2.2.tar.gz (85 kB)\n",
      "\u001b[K     |████████████████████████████████| 85 kB 8.2 MB/s  eta 0:00:01\n",
      "\u001b[?25hCollecting huggingface-hub>=0.4.0\n",
      "  Downloading huggingface_hub-0.20.3-py3-none-any.whl (330 kB)\n",
      "\u001b[K     |████████████████████████████████| 330 kB 66.5 MB/s eta 0:00:01\n",
      "\u001b[?25hRequirement already satisfied: nltk in /home/ubuntu/venv/lib/python3.8/site-packages (from sentence-transformers==2.2.2) (3.8.1)\n",
      "Requirement already satisfied: numpy in /home/ubuntu/venv/lib/python3.8/site-packages (from sentence-transformers==2.2.2) (1.24.4)\n",
      "Collecting scikit-learn\n",
      "  Downloading scikit_learn-1.3.2-cp38-cp38-manylinux_2_17_x86_64.manylinux2014_x86_64.whl (11.1 MB)\n",
      "\u001b[K     |████████████████████████████████| 11.1 MB 116.2 MB/s eta 0:00:01\n",
      "\u001b[?25hCollecting scipy\n",
      "  Downloading scipy-1.10.1-cp38-cp38-manylinux_2_17_x86_64.manylinux2014_x86_64.whl (34.5 MB)\n",
      "\u001b[K     |████████████████████████████████| 34.5 MB 100.9 MB/s eta 0:00:01\n",
      "\u001b[?25hCollecting sentencepiece\n",
      "  Downloading sentencepiece-0.1.99-cp38-cp38-manylinux_2_17_x86_64.manylinux2014_x86_64.whl (1.3 MB)\n",
      "\u001b[K     |████████████████████████████████| 1.3 MB 92.0 MB/s eta 0:00:01\n",
      "\u001b[?25hCollecting torch>=1.6.0\n",
      "  Downloading torch-2.1.2-cp38-cp38-manylinux1_x86_64.whl (670.2 MB)\n",
      "\u001b[K     |████████████████████████████████| 670.2 MB 34 kB/s s eta 0:00:011     |█████████████████▍              | 364.6 MB 120.6 MB/s eta 0:00:03\n",
      "\u001b[?25hCollecting torchvision\n",
      "  Downloading torchvision-0.16.2-cp38-cp38-manylinux1_x86_64.whl (6.8 MB)\n",
      "\u001b[K     |████████████████████████████████| 6.8 MB 96.7 MB/s eta 0:00:01\n",
      "\u001b[?25hRequirement already satisfied: tqdm in /home/ubuntu/venv/lib/python3.8/site-packages (from sentence-transformers==2.2.2) (4.66.1)\n",
      "Collecting transformers<5.0.0,>=4.6.0\n",
      "  Downloading transformers-4.37.0-py3-none-any.whl (8.4 MB)\n",
      "\u001b[K     |████████████████████████████████| 8.4 MB 57.5 MB/s eta 0:00:01\n",
      "\u001b[?25hRequirement already satisfied: requests in /home/ubuntu/venv/lib/python3.8/site-packages (from huggingface-hub>=0.4.0->sentence-transformers==2.2.2) (2.31.0)\n",
      "Requirement already satisfied: typing-extensions>=3.7.4.3 in /home/ubuntu/venv/lib/python3.8/site-packages (from huggingface-hub>=0.4.0->sentence-transformers==2.2.2) (4.9.0)\n",
      "Collecting filelock\n",
      "  Downloading filelock-3.13.1-py3-none-any.whl (11 kB)\n",
      "Requirement already satisfied: pyyaml>=5.1 in /home/ubuntu/venv/lib/python3.8/site-packages (from huggingface-hub>=0.4.0->sentence-transformers==2.2.2) (6.0.1)\n",
      "Requirement already satisfied: fsspec>=2023.5.0 in /home/ubuntu/venv/lib/python3.8/site-packages (from huggingface-hub>=0.4.0->sentence-transformers==2.2.2) (2023.12.2)\n",
      "Requirement already satisfied: packaging>=20.9 in /home/ubuntu/venv/lib/python3.8/site-packages (from huggingface-hub>=0.4.0->sentence-transformers==2.2.2) (23.2)\n",
      "Requirement already satisfied: regex>=2021.8.3 in /home/ubuntu/venv/lib/python3.8/site-packages (from nltk->sentence-transformers==2.2.2) (2023.12.25)\n",
      "Requirement already satisfied: click in /home/ubuntu/venv/lib/python3.8/site-packages (from nltk->sentence-transformers==2.2.2) (8.1.7)\n",
      "Requirement already satisfied: joblib in /home/ubuntu/venv/lib/python3.8/site-packages (from nltk->sentence-transformers==2.2.2) (1.3.2)\n",
      "Collecting threadpoolctl>=2.0.0\n",
      "  Downloading threadpoolctl-3.2.0-py3-none-any.whl (15 kB)\n",
      "Collecting nvidia-cuda-nvrtc-cu12==12.1.105; platform_system == \"Linux\" and platform_machine == \"x86_64\"\n",
      "  Downloading nvidia_cuda_nvrtc_cu12-12.1.105-py3-none-manylinux1_x86_64.whl (23.7 MB)\n",
      "\u001b[K     |████████████████████████████████| 23.7 MB 37.8 MB/s eta 0:00:01\n",
      "\u001b[?25hCollecting nvidia-cufft-cu12==11.0.2.54; platform_system == \"Linux\" and platform_machine == \"x86_64\"\n",
      "  Downloading nvidia_cufft_cu12-11.0.2.54-py3-none-manylinux1_x86_64.whl (121.6 MB)\n",
      "\u001b[K     |████████████████████████████████| 121.6 MB 110.5 MB/s eta 0:00:01\n",
      "\u001b[?25hCollecting nvidia-nvtx-cu12==12.1.105; platform_system == \"Linux\" and platform_machine == \"x86_64\"\n",
      "  Downloading nvidia_nvtx_cu12-12.1.105-py3-none-manylinux1_x86_64.whl (99 kB)\n",
      "\u001b[K     |████████████████████████████████| 99 kB 16.3 MB/s  eta 0:00:01\n",
      "\u001b[?25hRequirement already satisfied: jinja2 in /home/ubuntu/venv/lib/python3.8/site-packages (from torch>=1.6.0->sentence-transformers==2.2.2) (3.1.2)\n",
      "Requirement already satisfied: networkx in /home/ubuntu/venv/lib/python3.8/site-packages (from torch>=1.6.0->sentence-transformers==2.2.2) (3.1)\n",
      "Collecting nvidia-cuda-runtime-cu12==12.1.105; platform_system == \"Linux\" and platform_machine == \"x86_64\"\n",
      "  Downloading nvidia_cuda_runtime_cu12-12.1.105-py3-none-manylinux1_x86_64.whl (823 kB)\n",
      "\u001b[K     |████████████████████████████████| 823 kB 100.2 MB/s eta 0:00:01\n",
      "\u001b[?25hCollecting nvidia-cusparse-cu12==12.1.0.106; platform_system == \"Linux\" and platform_machine == \"x86_64\"\n",
      "  Downloading nvidia_cusparse_cu12-12.1.0.106-py3-none-manylinux1_x86_64.whl (196.0 MB)\n",
      "\u001b[K     |████████████████████████████████| 196.0 MB 43 kB/s /s eta 0:00:01\n",
      "\u001b[?25hCollecting sympy\n",
      "  Downloading sympy-1.12-py3-none-any.whl (5.7 MB)\n",
      "\u001b[K     |████████████████████████████████| 5.7 MB 79.5 MB/s eta 0:00:01\n",
      "\u001b[?25hCollecting nvidia-nccl-cu12==2.18.1; platform_system == \"Linux\" and platform_machine == \"x86_64\"\n",
      "  Downloading nvidia_nccl_cu12-2.18.1-py3-none-manylinux1_x86_64.whl (209.8 MB)\n",
      "\u001b[K     |████████████████████████████████| 209.8 MB 121.9 MB/s eta 0:00:01\n",
      "\u001b[?25hCollecting nvidia-cuda-cupti-cu12==12.1.105; platform_system == \"Linux\" and platform_machine == \"x86_64\"\n",
      "  Downloading nvidia_cuda_cupti_cu12-12.1.105-py3-none-manylinux1_x86_64.whl (14.1 MB)\n",
      "\u001b[K     |████████████████████████████████| 14.1 MB 96.2 MB/s eta 0:00:01\n",
      "\u001b[?25hCollecting nvidia-cublas-cu12==12.1.3.1; platform_system == \"Linux\" and platform_machine == \"x86_64\"\n",
      "  Downloading nvidia_cublas_cu12-12.1.3.1-py3-none-manylinux1_x86_64.whl (410.6 MB)\n",
      "\u001b[K     |████████████████████████████████| 410.6 MB 5.8 kB/s  eta 0:00:01     |████████████████████            | 257.6 MB 54.5 MB/s eta 0:00:03\n",
      "\u001b[?25hCollecting nvidia-curand-cu12==10.3.2.106; platform_system == \"Linux\" and platform_machine == \"x86_64\"\n",
      "  Downloading nvidia_curand_cu12-10.3.2.106-py3-none-manylinux1_x86_64.whl (56.5 MB)\n",
      "\u001b[K     |████████████████████████████████| 56.5 MB 79.3 MB/s eta 0:00:01     |██████████████████████████▍     | 46.6 MB 79.3 MB/s eta 0:00:01\n",
      "\u001b[?25hCollecting nvidia-cusolver-cu12==11.4.5.107; platform_system == \"Linux\" and platform_machine == \"x86_64\"\n",
      "  Downloading nvidia_cusolver_cu12-11.4.5.107-py3-none-manylinux1_x86_64.whl (124.2 MB)\n",
      "\u001b[K     |████████████████████████████████| 124.2 MB 116.8 MB/s eta 0:00:01\n",
      "\u001b[?25hCollecting triton==2.1.0; platform_system == \"Linux\" and platform_machine == \"x86_64\"\n",
      "  Downloading triton-2.1.0-0-cp38-cp38-manylinux2014_x86_64.manylinux_2_17_x86_64.whl (89.2 MB)\n",
      "\u001b[K     |████████████████████████████████| 89.2 MB 39 kB/s s eta 0:00:01\n",
      "\u001b[?25hCollecting nvidia-cudnn-cu12==8.9.2.26; platform_system == \"Linux\" and platform_machine == \"x86_64\"\n",
      "  Downloading nvidia_cudnn_cu12-8.9.2.26-py3-none-manylinux1_x86_64.whl (731.7 MB)\n",
      "\u001b[K     |████████████████████████████████| 731.7 MB 22 kB/s /s eta 0:00:01████████████████████████▉     | 614.3 MB 95.3 MB/s eta 0:00:02\n",
      "\u001b[?25hCollecting pillow!=8.3.*,>=5.3.0\n",
      "  Downloading pillow-10.2.0-cp38-cp38-manylinux_2_17_x86_64.manylinux2014_x86_64.whl (4.4 MB)\n",
      "\u001b[K     |████████████████████████████████| 4.4 MB 74.9 MB/s eta 0:00:01\n",
      "\u001b[?25hCollecting tokenizers<0.19,>=0.14\n",
      "  Downloading tokenizers-0.15.1-cp38-cp38-manylinux_2_17_x86_64.manylinux2014_x86_64.whl (3.6 MB)\n",
      "\u001b[K     |████████████████████████████████| 3.6 MB 60.0 MB/s eta 0:00:01\n",
      "\u001b[?25hCollecting safetensors>=0.3.1\n",
      "  Downloading safetensors-0.4.2-cp38-cp38-manylinux_2_17_x86_64.manylinux2014_x86_64.whl (1.3 MB)\n",
      "\u001b[K     |████████████████████████████████| 1.3 MB 85.6 MB/s eta 0:00:01\n",
      "\u001b[?25hRequirement already satisfied: idna<4,>=2.5 in /home/ubuntu/venv/lib/python3.8/site-packages (from requests->huggingface-hub>=0.4.0->sentence-transformers==2.2.2) (3.6)\n",
      "Requirement already satisfied: certifi>=2017.4.17 in /home/ubuntu/venv/lib/python3.8/site-packages (from requests->huggingface-hub>=0.4.0->sentence-transformers==2.2.2) (2023.11.17)\n",
      "Requirement already satisfied: urllib3<3,>=1.21.1 in /home/ubuntu/venv/lib/python3.8/site-packages (from requests->huggingface-hub>=0.4.0->sentence-transformers==2.2.2) (2.1.0)\n",
      "Requirement already satisfied: charset-normalizer<4,>=2 in /home/ubuntu/venv/lib/python3.8/site-packages (from requests->huggingface-hub>=0.4.0->sentence-transformers==2.2.2) (3.3.2)\n",
      "Requirement already satisfied: MarkupSafe>=2.0 in /home/ubuntu/venv/lib/python3.8/site-packages (from jinja2->torch>=1.6.0->sentence-transformers==2.2.2) (2.1.3)\n",
      "Collecting nvidia-nvjitlink-cu12\n",
      "  Downloading nvidia_nvjitlink_cu12-12.3.101-py3-none-manylinux1_x86_64.whl (20.5 MB)\n",
      "\u001b[K     |████████████████████████████████| 20.5 MB 91.0 MB/s eta 0:00:01\n",
      "\u001b[?25hCollecting mpmath>=0.19\n",
      "  Downloading mpmath-1.3.0-py3-none-any.whl (536 kB)\n",
      "\u001b[K     |████████████████████████████████| 536 kB 75.6 MB/s eta 0:00:01\n",
      "\u001b[?25hBuilding wheels for collected packages: sentence-transformers\n",
      "  Building wheel for sentence-transformers (setup.py) ... \u001b[?25lerror\n",
      "\u001b[31m  ERROR: Command errored out with exit status 1:\n",
      "   command: /home/ubuntu/venv/bin/python3 -u -c 'import sys, setuptools, tokenize; sys.argv[0] = '\"'\"'/tmp/pip-install-jixsjzjy/sentence-transformers/setup.py'\"'\"'; __file__='\"'\"'/tmp/pip-install-jixsjzjy/sentence-transformers/setup.py'\"'\"';f=getattr(tokenize, '\"'\"'open'\"'\"', open)(__file__);code=f.read().replace('\"'\"'\\r\\n'\"'\"', '\"'\"'\\n'\"'\"');f.close();exec(compile(code, __file__, '\"'\"'exec'\"'\"'))' bdist_wheel -d /tmp/pip-wheel-ift51xz6\n",
      "       cwd: /tmp/pip-install-jixsjzjy/sentence-transformers/\n",
      "  Complete output (6 lines):\n",
      "  usage: setup.py [global_opts] cmd1 [cmd1_opts] [cmd2 [cmd2_opts] ...]\n",
      "     or: setup.py --help [cmd1 cmd2 ...]\n",
      "     or: setup.py --help-commands\n",
      "     or: setup.py cmd --help\n",
      "  \n",
      "  error: invalid command 'bdist_wheel'\n",
      "  ----------------------------------------\u001b[0m\n",
      "\u001b[31m  ERROR: Failed building wheel for sentence-transformers\u001b[0m\n",
      "\u001b[?25h  Running setup.py clean for sentence-transformers\n",
      "Failed to build sentence-transformers\n",
      "Installing collected packages: filelock, huggingface-hub, scipy, threadpoolctl, scikit-learn, sentencepiece, nvidia-cuda-nvrtc-cu12, nvidia-cufft-cu12, nvidia-nvtx-cu12, nvidia-cuda-runtime-cu12, nvidia-nvjitlink-cu12, nvidia-cusparse-cu12, mpmath, sympy, nvidia-nccl-cu12, nvidia-cuda-cupti-cu12, nvidia-cublas-cu12, nvidia-curand-cu12, nvidia-cusolver-cu12, triton, nvidia-cudnn-cu12, torch, pillow, torchvision, tokenizers, safetensors, transformers, sentence-transformers\n",
      "    Running setup.py install for sentence-transformers ... \u001b[?25ldone\n",
      "\u001b[?25hSuccessfully installed filelock-3.13.1 huggingface-hub-0.20.3 mpmath-1.3.0 nvidia-cublas-cu12-12.1.3.1 nvidia-cuda-cupti-cu12-12.1.105 nvidia-cuda-nvrtc-cu12-12.1.105 nvidia-cuda-runtime-cu12-12.1.105 nvidia-cudnn-cu12-8.9.2.26 nvidia-cufft-cu12-11.0.2.54 nvidia-curand-cu12-10.3.2.106 nvidia-cusolver-cu12-11.4.5.107 nvidia-cusparse-cu12-12.1.0.106 nvidia-nccl-cu12-2.18.1 nvidia-nvjitlink-cu12-12.3.101 nvidia-nvtx-cu12-12.1.105 pillow-10.2.0 safetensors-0.4.2 scikit-learn-1.3.2 scipy-1.10.1 sentence-transformers-2.2.2 sentencepiece-0.1.99 sympy-1.12 threadpoolctl-3.2.0 tokenizers-0.15.1 torch-2.1.2 torchvision-0.16.2 transformers-4.37.0 triton-2.1.0\n",
      "Collecting transformers==4.35.2\n",
      "  Downloading transformers-4.35.2-py3-none-any.whl (7.9 MB)\n",
      "\u001b[K     |████████████████████████████████| 7.9 MB 25.4 MB/s eta 0:00:01\n",
      "\u001b[?25hRequirement already satisfied: numpy>=1.17 in /home/ubuntu/venv/lib/python3.8/site-packages (from transformers==4.35.2) (1.24.4)\n",
      "Requirement already satisfied: filelock in /home/ubuntu/venv/lib/python3.8/site-packages (from transformers==4.35.2) (3.13.1)\n",
      "Requirement already satisfied: requests in /home/ubuntu/venv/lib/python3.8/site-packages (from transformers==4.35.2) (2.31.0)\n",
      "Requirement already satisfied: safetensors>=0.3.1 in /home/ubuntu/venv/lib/python3.8/site-packages (from transformers==4.35.2) (0.4.2)\n",
      "Requirement already satisfied: tqdm>=4.27 in /home/ubuntu/venv/lib/python3.8/site-packages (from transformers==4.35.2) (4.66.1)\n",
      "Requirement already satisfied: huggingface-hub<1.0,>=0.16.4 in /home/ubuntu/venv/lib/python3.8/site-packages (from transformers==4.35.2) (0.20.3)\n",
      "Requirement already satisfied: pyyaml>=5.1 in /home/ubuntu/venv/lib/python3.8/site-packages (from transformers==4.35.2) (6.0.1)\n",
      "Requirement already satisfied: regex!=2019.12.17 in /home/ubuntu/venv/lib/python3.8/site-packages (from transformers==4.35.2) (2023.12.25)\n",
      "Requirement already satisfied: tokenizers<0.19,>=0.14 in /home/ubuntu/venv/lib/python3.8/site-packages (from transformers==4.35.2) (0.15.1)\n",
      "Requirement already satisfied: packaging>=20.0 in /home/ubuntu/venv/lib/python3.8/site-packages (from transformers==4.35.2) (23.2)\n",
      "Requirement already satisfied: idna<4,>=2.5 in /home/ubuntu/venv/lib/python3.8/site-packages (from requests->transformers==4.35.2) (3.6)\n",
      "Requirement already satisfied: charset-normalizer<4,>=2 in /home/ubuntu/venv/lib/python3.8/site-packages (from requests->transformers==4.35.2) (3.3.2)\n",
      "Requirement already satisfied: certifi>=2017.4.17 in /home/ubuntu/venv/lib/python3.8/site-packages (from requests->transformers==4.35.2) (2023.11.17)\n",
      "Requirement already satisfied: urllib3<3,>=1.21.1 in /home/ubuntu/venv/lib/python3.8/site-packages (from requests->transformers==4.35.2) (2.1.0)\n",
      "Requirement already satisfied: fsspec>=2023.5.0 in /home/ubuntu/venv/lib/python3.8/site-packages (from huggingface-hub<1.0,>=0.16.4->transformers==4.35.2) (2023.12.2)\n",
      "Requirement already satisfied: typing-extensions>=3.7.4.3 in /home/ubuntu/venv/lib/python3.8/site-packages (from huggingface-hub<1.0,>=0.16.4->transformers==4.35.2) (4.9.0)\n",
      "Installing collected packages: transformers\n",
      "  Attempting uninstall: transformers\n",
      "    Found existing installation: transformers 4.37.0\n",
      "    Uninstalling transformers-4.37.0:\n",
      "      Successfully uninstalled transformers-4.37.0\n",
      "Successfully installed transformers-4.35.2\n",
      "Collecting optimum==1.15.0\n",
      "  Downloading optimum-1.15.0-py3-none-any.whl (400 kB)\n",
      "\u001b[K     |████████████████████████████████| 400 kB 28.0 MB/s eta 0:00:01\n",
      "\u001b[?25hRequirement already satisfied: sympy in /home/ubuntu/venv/lib/python3.8/site-packages (from optimum==1.15.0) (1.12)\n",
      "Collecting datasets\n",
      "  Downloading datasets-2.16.1-py3-none-any.whl (507 kB)\n",
      "\u001b[K     |████████████████████████████████| 507 kB 99.2 MB/s eta 0:00:01\n",
      "\u001b[?25hRequirement already satisfied: numpy in /home/ubuntu/venv/lib/python3.8/site-packages (from optimum==1.15.0) (1.24.4)\n",
      "Requirement already satisfied: huggingface-hub>=0.8.0 in /home/ubuntu/venv/lib/python3.8/site-packages (from optimum==1.15.0) (0.20.3)\n",
      "Requirement already satisfied: transformers[sentencepiece]>=4.26.0 in /home/ubuntu/venv/lib/python3.8/site-packages (from optimum==1.15.0) (4.35.2)\n",
      "Requirement already satisfied: packaging in /home/ubuntu/venv/lib/python3.8/site-packages (from optimum==1.15.0) (23.2)\n",
      "Requirement already satisfied: torch>=1.9 in /home/ubuntu/venv/lib/python3.8/site-packages (from optimum==1.15.0) (2.1.2)\n",
      "Collecting coloredlogs\n",
      "  Downloading coloredlogs-15.0.1-py2.py3-none-any.whl (46 kB)\n",
      "\u001b[K     |████████████████████████████████| 46 kB 8.4 MB/s s eta 0:00:01\n",
      "\u001b[?25hRequirement already satisfied: mpmath>=0.19 in /home/ubuntu/venv/lib/python3.8/site-packages (from sympy->optimum==1.15.0) (1.3.0)\n",
      "Collecting dill<0.3.8,>=0.3.0\n",
      "  Downloading dill-0.3.7-py3-none-any.whl (115 kB)\n",
      "\u001b[K     |████████████████████████████████| 115 kB 108.3 MB/s eta 0:00:01\n",
      "\u001b[?25hRequirement already satisfied: aiohttp in /home/ubuntu/venv/lib/python3.8/site-packages (from datasets->optimum==1.15.0) (3.9.1)\n",
      "Collecting fsspec[http]<=2023.10.0,>=2023.1.0\n",
      "  Downloading fsspec-2023.10.0-py3-none-any.whl (166 kB)\n",
      "\u001b[K     |████████████████████████████████| 166 kB 109.3 MB/s eta 0:00:01\n",
      "\u001b[?25hCollecting pyarrow-hotfix\n",
      "  Downloading pyarrow_hotfix-0.6-py3-none-any.whl (7.9 kB)\n",
      "Requirement already satisfied: pandas in /home/ubuntu/venv/lib/python3.8/site-packages (from datasets->optimum==1.15.0) (2.0.3)\n",
      "Requirement already satisfied: tqdm>=4.62.1 in /home/ubuntu/venv/lib/python3.8/site-packages (from datasets->optimum==1.15.0) (4.66.1)\n",
      "Collecting xxhash\n",
      "  Downloading xxhash-3.4.1-cp38-cp38-manylinux_2_17_x86_64.manylinux2014_x86_64.whl (194 kB)\n",
      "\u001b[K     |████████████████████████████████| 194 kB 128.2 MB/s eta 0:00:01\n",
      "\u001b[?25hRequirement already satisfied: requests>=2.19.0 in /home/ubuntu/venv/lib/python3.8/site-packages (from datasets->optimum==1.15.0) (2.31.0)\n",
      "Collecting pyarrow>=8.0.0\n",
      "  Downloading pyarrow-15.0.0-cp38-cp38-manylinux_2_17_x86_64.manylinux2014_x86_64.whl (38.5 MB)\n",
      "\u001b[K     |████████████████████████████████| 38.5 MB 117.6 MB/s eta 0:00:01\n",
      "\u001b[?25hCollecting multiprocess\n",
      "  Downloading multiprocess-0.70.15-py38-none-any.whl (132 kB)\n",
      "\u001b[K     |████████████████████████████████| 132 kB 102.9 MB/s eta 0:00:01\n",
      "\u001b[?25hRequirement already satisfied: filelock in /home/ubuntu/venv/lib/python3.8/site-packages (from datasets->optimum==1.15.0) (3.13.1)\n",
      "Requirement already satisfied: pyyaml>=5.1 in /home/ubuntu/venv/lib/python3.8/site-packages (from datasets->optimum==1.15.0) (6.0.1)\n",
      "Requirement already satisfied: typing-extensions>=3.7.4.3 in /home/ubuntu/venv/lib/python3.8/site-packages (from huggingface-hub>=0.8.0->optimum==1.15.0) (4.9.0)\n",
      "Requirement already satisfied: regex!=2019.12.17 in /home/ubuntu/venv/lib/python3.8/site-packages (from transformers[sentencepiece]>=4.26.0->optimum==1.15.0) (2023.12.25)\n",
      "Requirement already satisfied: tokenizers<0.19,>=0.14 in /home/ubuntu/venv/lib/python3.8/site-packages (from transformers[sentencepiece]>=4.26.0->optimum==1.15.0) (0.15.1)\n",
      "Requirement already satisfied: safetensors>=0.3.1 in /home/ubuntu/venv/lib/python3.8/site-packages (from transformers[sentencepiece]>=4.26.0->optimum==1.15.0) (0.4.2)\n",
      "Requirement already satisfied: sentencepiece!=0.1.92,>=0.1.91; extra == \"sentencepiece\" in /home/ubuntu/venv/lib/python3.8/site-packages (from transformers[sentencepiece]>=4.26.0->optimum==1.15.0) (0.1.99)\n",
      "Collecting protobuf; extra == \"sentencepiece\"\n",
      "  Downloading protobuf-4.25.2-cp37-abi3-manylinux2014_x86_64.whl (294 kB)\n",
      "\u001b[K     |████████████████████████████████| 294 kB 94.7 MB/s eta 0:00:01\n",
      "\u001b[?25hRequirement already satisfied: nvidia-nvtx-cu12==12.1.105; platform_system == \"Linux\" and platform_machine == \"x86_64\" in /home/ubuntu/venv/lib/python3.8/site-packages (from torch>=1.9->optimum==1.15.0) (12.1.105)\n",
      "Requirement already satisfied: nvidia-cublas-cu12==12.1.3.1; platform_system == \"Linux\" and platform_machine == \"x86_64\" in /home/ubuntu/venv/lib/python3.8/site-packages (from torch>=1.9->optimum==1.15.0) (12.1.3.1)\n",
      "Requirement already satisfied: nvidia-cuda-cupti-cu12==12.1.105; platform_system == \"Linux\" and platform_machine == \"x86_64\" in /home/ubuntu/venv/lib/python3.8/site-packages (from torch>=1.9->optimum==1.15.0) (12.1.105)\n",
      "Requirement already satisfied: nvidia-curand-cu12==10.3.2.106; platform_system == \"Linux\" and platform_machine == \"x86_64\" in /home/ubuntu/venv/lib/python3.8/site-packages (from torch>=1.9->optimum==1.15.0) (10.3.2.106)\n",
      "Requirement already satisfied: nvidia-cusolver-cu12==11.4.5.107; platform_system == \"Linux\" and platform_machine == \"x86_64\" in /home/ubuntu/venv/lib/python3.8/site-packages (from torch>=1.9->optimum==1.15.0) (11.4.5.107)\n",
      "Requirement already satisfied: nvidia-cufft-cu12==11.0.2.54; platform_system == \"Linux\" and platform_machine == \"x86_64\" in /home/ubuntu/venv/lib/python3.8/site-packages (from torch>=1.9->optimum==1.15.0) (11.0.2.54)\n",
      "Requirement already satisfied: networkx in /home/ubuntu/venv/lib/python3.8/site-packages (from torch>=1.9->optimum==1.15.0) (3.1)\n",
      "Requirement already satisfied: nvidia-cuda-nvrtc-cu12==12.1.105; platform_system == \"Linux\" and platform_machine == \"x86_64\" in /home/ubuntu/venv/lib/python3.8/site-packages (from torch>=1.9->optimum==1.15.0) (12.1.105)\n",
      "Requirement already satisfied: nvidia-cuda-runtime-cu12==12.1.105; platform_system == \"Linux\" and platform_machine == \"x86_64\" in /home/ubuntu/venv/lib/python3.8/site-packages (from torch>=1.9->optimum==1.15.0) (12.1.105)\n",
      "Requirement already satisfied: nvidia-cudnn-cu12==8.9.2.26; platform_system == \"Linux\" and platform_machine == \"x86_64\" in /home/ubuntu/venv/lib/python3.8/site-packages (from torch>=1.9->optimum==1.15.0) (8.9.2.26)\n",
      "Requirement already satisfied: jinja2 in /home/ubuntu/venv/lib/python3.8/site-packages (from torch>=1.9->optimum==1.15.0) (3.1.2)\n",
      "Requirement already satisfied: nvidia-nccl-cu12==2.18.1; platform_system == \"Linux\" and platform_machine == \"x86_64\" in /home/ubuntu/venv/lib/python3.8/site-packages (from torch>=1.9->optimum==1.15.0) (2.18.1)\n",
      "Requirement already satisfied: nvidia-cusparse-cu12==12.1.0.106; platform_system == \"Linux\" and platform_machine == \"x86_64\" in /home/ubuntu/venv/lib/python3.8/site-packages (from torch>=1.9->optimum==1.15.0) (12.1.0.106)\n",
      "Requirement already satisfied: triton==2.1.0; platform_system == \"Linux\" and platform_machine == \"x86_64\" in /home/ubuntu/venv/lib/python3.8/site-packages (from torch>=1.9->optimum==1.15.0) (2.1.0)\n",
      "Collecting humanfriendly>=9.1\n",
      "  Downloading humanfriendly-10.0-py2.py3-none-any.whl (86 kB)\n",
      "\u001b[K     |████████████████████████████████| 86 kB 11.8 MB/s eta 0:00:01\n",
      "\u001b[?25hRequirement already satisfied: attrs>=17.3.0 in /home/ubuntu/venv/lib/python3.8/site-packages (from aiohttp->datasets->optimum==1.15.0) (23.1.0)\n",
      "Requirement already satisfied: frozenlist>=1.1.1 in /home/ubuntu/venv/lib/python3.8/site-packages (from aiohttp->datasets->optimum==1.15.0) (1.4.1)\n",
      "Requirement already satisfied: multidict<7.0,>=4.5 in /home/ubuntu/venv/lib/python3.8/site-packages (from aiohttp->datasets->optimum==1.15.0) (6.0.4)\n",
      "Requirement already satisfied: async-timeout<5.0,>=4.0; python_version < \"3.11\" in /home/ubuntu/venv/lib/python3.8/site-packages (from aiohttp->datasets->optimum==1.15.0) (4.0.3)\n",
      "Requirement already satisfied: aiosignal>=1.1.2 in /home/ubuntu/venv/lib/python3.8/site-packages (from aiohttp->datasets->optimum==1.15.0) (1.3.1)\n",
      "Requirement already satisfied: yarl<2.0,>=1.0 in /home/ubuntu/venv/lib/python3.8/site-packages (from aiohttp->datasets->optimum==1.15.0) (1.9.4)\n",
      "Requirement already satisfied: pytz>=2020.1 in /home/ubuntu/venv/lib/python3.8/site-packages (from pandas->datasets->optimum==1.15.0) (2023.3.post1)\n",
      "Requirement already satisfied: tzdata>=2022.1 in /home/ubuntu/venv/lib/python3.8/site-packages (from pandas->datasets->optimum==1.15.0) (2023.3)\n",
      "Requirement already satisfied: python-dateutil>=2.8.2 in /home/ubuntu/venv/lib/python3.8/site-packages (from pandas->datasets->optimum==1.15.0) (2.8.2)\n",
      "Requirement already satisfied: idna<4,>=2.5 in /home/ubuntu/venv/lib/python3.8/site-packages (from requests>=2.19.0->datasets->optimum==1.15.0) (3.6)\n",
      "Requirement already satisfied: charset-normalizer<4,>=2 in /home/ubuntu/venv/lib/python3.8/site-packages (from requests>=2.19.0->datasets->optimum==1.15.0) (3.3.2)\n",
      "Requirement already satisfied: urllib3<3,>=1.21.1 in /home/ubuntu/venv/lib/python3.8/site-packages (from requests>=2.19.0->datasets->optimum==1.15.0) (2.1.0)\n",
      "Requirement already satisfied: certifi>=2017.4.17 in /home/ubuntu/venv/lib/python3.8/site-packages (from requests>=2.19.0->datasets->optimum==1.15.0) (2023.11.17)\n",
      "Requirement already satisfied: nvidia-nvjitlink-cu12 in /home/ubuntu/venv/lib/python3.8/site-packages (from nvidia-cusolver-cu12==11.4.5.107; platform_system == \"Linux\" and platform_machine == \"x86_64\"->torch>=1.9->optimum==1.15.0) (12.3.101)\n",
      "Requirement already satisfied: MarkupSafe>=2.0 in /home/ubuntu/venv/lib/python3.8/site-packages (from jinja2->torch>=1.9->optimum==1.15.0) (2.1.3)\n",
      "Requirement already satisfied: six>=1.5 in /home/ubuntu/venv/lib/python3.8/site-packages (from python-dateutil>=2.8.2->pandas->datasets->optimum==1.15.0) (1.16.0)\n",
      "Installing collected packages: dill, fsspec, pyarrow-hotfix, xxhash, pyarrow, multiprocess, datasets, humanfriendly, coloredlogs, optimum, protobuf\n",
      "  Attempting uninstall: fsspec\n",
      "    Found existing installation: fsspec 2023.12.2\n",
      "    Uninstalling fsspec-2023.12.2:\n",
      "      Successfully uninstalled fsspec-2023.12.2\n",
      "Successfully installed coloredlogs-15.0.1 datasets-2.16.1 dill-0.3.7 fsspec-2023.10.0 humanfriendly-10.0 multiprocess-0.70.15 optimum-1.15.0 protobuf-4.25.2 pyarrow-15.0.0 pyarrow-hotfix-0.6 xxhash-3.4.1\n",
      "Collecting accelerate==0.25.0\n",
      "  Downloading accelerate-0.25.0-py3-none-any.whl (265 kB)\n",
      "\u001b[K     |████████████████████████████████| 265 kB 31.9 MB/s eta 0:00:01\n",
      "\u001b[?25hRequirement already satisfied: packaging>=20.0 in /home/ubuntu/venv/lib/python3.8/site-packages (from accelerate==0.25.0) (23.2)\n",
      "Requirement already satisfied: huggingface-hub in /home/ubuntu/venv/lib/python3.8/site-packages (from accelerate==0.25.0) (0.20.3)\n",
      "Requirement already satisfied: numpy>=1.17 in /home/ubuntu/venv/lib/python3.8/site-packages (from accelerate==0.25.0) (1.24.4)\n",
      "Requirement already satisfied: torch>=1.10.0 in /home/ubuntu/venv/lib/python3.8/site-packages (from accelerate==0.25.0) (2.1.2)\n",
      "Requirement already satisfied: safetensors>=0.3.1 in /home/ubuntu/venv/lib/python3.8/site-packages (from accelerate==0.25.0) (0.4.2)\n",
      "Requirement already satisfied: pyyaml in /home/ubuntu/venv/lib/python3.8/site-packages (from accelerate==0.25.0) (6.0.1)\n",
      "Requirement already satisfied: psutil in /home/ubuntu/venv/lib/python3.8/site-packages (from accelerate==0.25.0) (5.9.7)\n",
      "Requirement already satisfied: tqdm>=4.42.1 in /home/ubuntu/venv/lib/python3.8/site-packages (from huggingface-hub->accelerate==0.25.0) (4.66.1)\n",
      "Requirement already satisfied: typing-extensions>=3.7.4.3 in /home/ubuntu/venv/lib/python3.8/site-packages (from huggingface-hub->accelerate==0.25.0) (4.9.0)\n",
      "Requirement already satisfied: requests in /home/ubuntu/venv/lib/python3.8/site-packages (from huggingface-hub->accelerate==0.25.0) (2.31.0)\n",
      "Requirement already satisfied: fsspec>=2023.5.0 in /home/ubuntu/venv/lib/python3.8/site-packages (from huggingface-hub->accelerate==0.25.0) (2023.10.0)\n",
      "Requirement already satisfied: filelock in /home/ubuntu/venv/lib/python3.8/site-packages (from huggingface-hub->accelerate==0.25.0) (3.13.1)\n",
      "Requirement already satisfied: nvidia-nccl-cu12==2.18.1; platform_system == \"Linux\" and platform_machine == \"x86_64\" in /home/ubuntu/venv/lib/python3.8/site-packages (from torch>=1.10.0->accelerate==0.25.0) (2.18.1)\n",
      "Requirement already satisfied: nvidia-cufft-cu12==11.0.2.54; platform_system == \"Linux\" and platform_machine == \"x86_64\" in /home/ubuntu/venv/lib/python3.8/site-packages (from torch>=1.10.0->accelerate==0.25.0) (11.0.2.54)\n",
      "Requirement already satisfied: triton==2.1.0; platform_system == \"Linux\" and platform_machine == \"x86_64\" in /home/ubuntu/venv/lib/python3.8/site-packages (from torch>=1.10.0->accelerate==0.25.0) (2.1.0)\n",
      "Requirement already satisfied: nvidia-cuda-nvrtc-cu12==12.1.105; platform_system == \"Linux\" and platform_machine == \"x86_64\" in /home/ubuntu/venv/lib/python3.8/site-packages (from torch>=1.10.0->accelerate==0.25.0) (12.1.105)\n",
      "Requirement already satisfied: nvidia-nvtx-cu12==12.1.105; platform_system == \"Linux\" and platform_machine == \"x86_64\" in /home/ubuntu/venv/lib/python3.8/site-packages (from torch>=1.10.0->accelerate==0.25.0) (12.1.105)\n",
      "Requirement already satisfied: sympy in /home/ubuntu/venv/lib/python3.8/site-packages (from torch>=1.10.0->accelerate==0.25.0) (1.12)\n",
      "Requirement already satisfied: nvidia-cuda-runtime-cu12==12.1.105; platform_system == \"Linux\" and platform_machine == \"x86_64\" in /home/ubuntu/venv/lib/python3.8/site-packages (from torch>=1.10.0->accelerate==0.25.0) (12.1.105)\n",
      "Requirement already satisfied: jinja2 in /home/ubuntu/venv/lib/python3.8/site-packages (from torch>=1.10.0->accelerate==0.25.0) (3.1.2)\n",
      "Requirement already satisfied: nvidia-cudnn-cu12==8.9.2.26; platform_system == \"Linux\" and platform_machine == \"x86_64\" in /home/ubuntu/venv/lib/python3.8/site-packages (from torch>=1.10.0->accelerate==0.25.0) (8.9.2.26)\n",
      "Requirement already satisfied: nvidia-cublas-cu12==12.1.3.1; platform_system == \"Linux\" and platform_machine == \"x86_64\" in /home/ubuntu/venv/lib/python3.8/site-packages (from torch>=1.10.0->accelerate==0.25.0) (12.1.3.1)\n",
      "Requirement already satisfied: nvidia-cusolver-cu12==11.4.5.107; platform_system == \"Linux\" and platform_machine == \"x86_64\" in /home/ubuntu/venv/lib/python3.8/site-packages (from torch>=1.10.0->accelerate==0.25.0) (11.4.5.107)\n",
      "Requirement already satisfied: nvidia-cusparse-cu12==12.1.0.106; platform_system == \"Linux\" and platform_machine == \"x86_64\" in /home/ubuntu/venv/lib/python3.8/site-packages (from torch>=1.10.0->accelerate==0.25.0) (12.1.0.106)\n",
      "Requirement already satisfied: networkx in /home/ubuntu/venv/lib/python3.8/site-packages (from torch>=1.10.0->accelerate==0.25.0) (3.1)\n",
      "Requirement already satisfied: nvidia-cuda-cupti-cu12==12.1.105; platform_system == \"Linux\" and platform_machine == \"x86_64\" in /home/ubuntu/venv/lib/python3.8/site-packages (from torch>=1.10.0->accelerate==0.25.0) (12.1.105)\n",
      "Requirement already satisfied: nvidia-curand-cu12==10.3.2.106; platform_system == \"Linux\" and platform_machine == \"x86_64\" in /home/ubuntu/venv/lib/python3.8/site-packages (from torch>=1.10.0->accelerate==0.25.0) (10.3.2.106)\n",
      "Requirement already satisfied: idna<4,>=2.5 in /home/ubuntu/venv/lib/python3.8/site-packages (from requests->huggingface-hub->accelerate==0.25.0) (3.6)\n",
      "Requirement already satisfied: urllib3<3,>=1.21.1 in /home/ubuntu/venv/lib/python3.8/site-packages (from requests->huggingface-hub->accelerate==0.25.0) (2.1.0)\n",
      "Requirement already satisfied: charset-normalizer<4,>=2 in /home/ubuntu/venv/lib/python3.8/site-packages (from requests->huggingface-hub->accelerate==0.25.0) (3.3.2)\n",
      "Requirement already satisfied: certifi>=2017.4.17 in /home/ubuntu/venv/lib/python3.8/site-packages (from requests->huggingface-hub->accelerate==0.25.0) (2023.11.17)\n",
      "Requirement already satisfied: mpmath>=0.19 in /home/ubuntu/venv/lib/python3.8/site-packages (from sympy->torch>=1.10.0->accelerate==0.25.0) (1.3.0)\n",
      "Requirement already satisfied: MarkupSafe>=2.0 in /home/ubuntu/venv/lib/python3.8/site-packages (from jinja2->torch>=1.10.0->accelerate==0.25.0) (2.1.3)\n",
      "Requirement already satisfied: nvidia-nvjitlink-cu12 in /home/ubuntu/venv/lib/python3.8/site-packages (from nvidia-cusolver-cu12==11.4.5.107; platform_system == \"Linux\" and platform_machine == \"x86_64\"->torch>=1.10.0->accelerate==0.25.0) (12.3.101)\n",
      "Installing collected packages: accelerate\n",
      "Successfully installed accelerate-0.25.0\n",
      "Looking in indexes: https://pypi.org/simple, https://huggingface.github.io/autogptq-index/whl/cu118/\n",
      "Collecting auto-gptq\n",
      "  Downloading https://huggingface.github.io/autogptq-index/whl/cu118/auto-gptq/auto_gptq-0.6.0%2Bcu118-cp38-cp38-manylinux_2_17_x86_64.manylinux2014_x86_64.whl (5.0 MB)\n",
      "\u001b[K     |████████████████████████████████| 5.0 MB 28.1 MB/s eta 0:00:01\n",
      "\u001b[?25hRequirement already satisfied: numpy in /home/ubuntu/venv/lib/python3.8/site-packages (from auto-gptq) (1.24.4)\n",
      "Requirement already satisfied: torch>=1.13.0 in /home/ubuntu/venv/lib/python3.8/site-packages (from auto-gptq) (2.1.2)\n",
      "Requirement already satisfied: accelerate>=0.22.0 in /home/ubuntu/venv/lib/python3.8/site-packages (from auto-gptq) (0.25.0)\n",
      "Collecting rouge\n",
      "  Downloading rouge-1.0.1-py3-none-any.whl (13 kB)\n",
      "Requirement already satisfied: transformers>=4.31.0 in /home/ubuntu/venv/lib/python3.8/site-packages (from auto-gptq) (4.35.2)\n",
      "Requirement already satisfied: tqdm in /home/ubuntu/venv/lib/python3.8/site-packages (from auto-gptq) (4.66.1)\n",
      "Collecting peft>=0.5.0\n",
      "  Downloading peft-0.7.1-py3-none-any.whl (168 kB)\n",
      "\u001b[K     |████████████████████████████████| 168 kB 33.3 MB/s eta 0:00:01\n",
      "\u001b[?25hCollecting gekko\n",
      "  Downloading gekko-1.0.6-py3-none-any.whl (12.2 MB)\n",
      "\u001b[K     |████████████████████████████████| 12.2 MB 125.2 MB/s eta 0:00:01\n",
      "\u001b[?25hRequirement already satisfied: datasets in /home/ubuntu/venv/lib/python3.8/site-packages (from auto-gptq) (2.16.1)\n",
      "Requirement already satisfied: sentencepiece in /home/ubuntu/venv/lib/python3.8/site-packages (from auto-gptq) (0.1.99)\n",
      "Requirement already satisfied: safetensors in /home/ubuntu/venv/lib/python3.8/site-packages (from auto-gptq) (0.4.2)\n",
      "Requirement already satisfied: nvidia-nccl-cu12==2.18.1; platform_system == \"Linux\" and platform_machine == \"x86_64\" in /home/ubuntu/venv/lib/python3.8/site-packages (from torch>=1.13.0->auto-gptq) (2.18.1)\n",
      "Requirement already satisfied: filelock in /home/ubuntu/venv/lib/python3.8/site-packages (from torch>=1.13.0->auto-gptq) (3.13.1)\n",
      "Requirement already satisfied: jinja2 in /home/ubuntu/venv/lib/python3.8/site-packages (from torch>=1.13.0->auto-gptq) (3.1.2)\n",
      "Requirement already satisfied: typing-extensions in /home/ubuntu/venv/lib/python3.8/site-packages (from torch>=1.13.0->auto-gptq) (4.9.0)\n",
      "Requirement already satisfied: networkx in /home/ubuntu/venv/lib/python3.8/site-packages (from torch>=1.13.0->auto-gptq) (3.1)\n",
      "Requirement already satisfied: sympy in /home/ubuntu/venv/lib/python3.8/site-packages (from torch>=1.13.0->auto-gptq) (1.12)\n",
      "Requirement already satisfied: nvidia-cuda-runtime-cu12==12.1.105; platform_system == \"Linux\" and platform_machine == \"x86_64\" in /home/ubuntu/venv/lib/python3.8/site-packages (from torch>=1.13.0->auto-gptq) (12.1.105)\n",
      "Requirement already satisfied: nvidia-cudnn-cu12==8.9.2.26; platform_system == \"Linux\" and platform_machine == \"x86_64\" in /home/ubuntu/venv/lib/python3.8/site-packages (from torch>=1.13.0->auto-gptq) (8.9.2.26)\n",
      "Requirement already satisfied: nvidia-nvtx-cu12==12.1.105; platform_system == \"Linux\" and platform_machine == \"x86_64\" in /home/ubuntu/venv/lib/python3.8/site-packages (from torch>=1.13.0->auto-gptq) (12.1.105)\n",
      "Requirement already satisfied: fsspec in /home/ubuntu/venv/lib/python3.8/site-packages (from torch>=1.13.0->auto-gptq) (2023.10.0)\n",
      "Requirement already satisfied: nvidia-cusparse-cu12==12.1.0.106; platform_system == \"Linux\" and platform_machine == \"x86_64\" in /home/ubuntu/venv/lib/python3.8/site-packages (from torch>=1.13.0->auto-gptq) (12.1.0.106)\n",
      "Requirement already satisfied: nvidia-cufft-cu12==11.0.2.54; platform_system == \"Linux\" and platform_machine == \"x86_64\" in /home/ubuntu/venv/lib/python3.8/site-packages (from torch>=1.13.0->auto-gptq) (11.0.2.54)\n",
      "Requirement already satisfied: nvidia-cublas-cu12==12.1.3.1; platform_system == \"Linux\" and platform_machine == \"x86_64\" in /home/ubuntu/venv/lib/python3.8/site-packages (from torch>=1.13.0->auto-gptq) (12.1.3.1)\n",
      "Requirement already satisfied: nvidia-cuda-cupti-cu12==12.1.105; platform_system == \"Linux\" and platform_machine == \"x86_64\" in /home/ubuntu/venv/lib/python3.8/site-packages (from torch>=1.13.0->auto-gptq) (12.1.105)\n",
      "Requirement already satisfied: nvidia-curand-cu12==10.3.2.106; platform_system == \"Linux\" and platform_machine == \"x86_64\" in /home/ubuntu/venv/lib/python3.8/site-packages (from torch>=1.13.0->auto-gptq) (10.3.2.106)\n",
      "Requirement already satisfied: nvidia-cusolver-cu12==11.4.5.107; platform_system == \"Linux\" and platform_machine == \"x86_64\" in /home/ubuntu/venv/lib/python3.8/site-packages (from torch>=1.13.0->auto-gptq) (11.4.5.107)\n",
      "Requirement already satisfied: triton==2.1.0; platform_system == \"Linux\" and platform_machine == \"x86_64\" in /home/ubuntu/venv/lib/python3.8/site-packages (from torch>=1.13.0->auto-gptq) (2.1.0)\n",
      "Requirement already satisfied: nvidia-cuda-nvrtc-cu12==12.1.105; platform_system == \"Linux\" and platform_machine == \"x86_64\" in /home/ubuntu/venv/lib/python3.8/site-packages (from torch>=1.13.0->auto-gptq) (12.1.105)\n",
      "Requirement already satisfied: pyyaml in /home/ubuntu/venv/lib/python3.8/site-packages (from accelerate>=0.22.0->auto-gptq) (6.0.1)\n",
      "Requirement already satisfied: psutil in /home/ubuntu/venv/lib/python3.8/site-packages (from accelerate>=0.22.0->auto-gptq) (5.9.7)\n",
      "Requirement already satisfied: packaging>=20.0 in /home/ubuntu/venv/lib/python3.8/site-packages (from accelerate>=0.22.0->auto-gptq) (23.2)\n",
      "Requirement already satisfied: huggingface-hub in /home/ubuntu/venv/lib/python3.8/site-packages (from accelerate>=0.22.0->auto-gptq) (0.20.3)\n",
      "Requirement already satisfied: six in /home/ubuntu/venv/lib/python3.8/site-packages (from rouge->auto-gptq) (1.16.0)\n",
      "Requirement already satisfied: tokenizers<0.19,>=0.14 in /home/ubuntu/venv/lib/python3.8/site-packages (from transformers>=4.31.0->auto-gptq) (0.15.1)\n",
      "Requirement already satisfied: requests in /home/ubuntu/venv/lib/python3.8/site-packages (from transformers>=4.31.0->auto-gptq) (2.31.0)\n",
      "Requirement already satisfied: regex!=2019.12.17 in /home/ubuntu/venv/lib/python3.8/site-packages (from transformers>=4.31.0->auto-gptq) (2023.12.25)\n",
      "Requirement already satisfied: xxhash in /home/ubuntu/venv/lib/python3.8/site-packages (from datasets->auto-gptq) (3.4.1)\n",
      "Requirement already satisfied: multiprocess in /home/ubuntu/venv/lib/python3.8/site-packages (from datasets->auto-gptq) (0.70.15)\n",
      "Requirement already satisfied: dill<0.3.8,>=0.3.0 in /home/ubuntu/venv/lib/python3.8/site-packages (from datasets->auto-gptq) (0.3.7)\n",
      "Requirement already satisfied: pyarrow-hotfix in /home/ubuntu/venv/lib/python3.8/site-packages (from datasets->auto-gptq) (0.6)\n",
      "Requirement already satisfied: pandas in /home/ubuntu/venv/lib/python3.8/site-packages (from datasets->auto-gptq) (2.0.3)\n",
      "Requirement already satisfied: aiohttp in /home/ubuntu/venv/lib/python3.8/site-packages (from datasets->auto-gptq) (3.9.1)\n",
      "Requirement already satisfied: pyarrow>=8.0.0 in /home/ubuntu/venv/lib/python3.8/site-packages (from datasets->auto-gptq) (15.0.0)\n",
      "Requirement already satisfied: MarkupSafe>=2.0 in /home/ubuntu/venv/lib/python3.8/site-packages (from jinja2->torch>=1.13.0->auto-gptq) (2.1.3)\n",
      "Requirement already satisfied: mpmath>=0.19 in /home/ubuntu/venv/lib/python3.8/site-packages (from sympy->torch>=1.13.0->auto-gptq) (1.3.0)\n",
      "Requirement already satisfied: nvidia-nvjitlink-cu12 in /home/ubuntu/venv/lib/python3.8/site-packages (from nvidia-cusparse-cu12==12.1.0.106; platform_system == \"Linux\" and platform_machine == \"x86_64\"->torch>=1.13.0->auto-gptq) (12.3.101)\n",
      "Requirement already satisfied: charset-normalizer<4,>=2 in /home/ubuntu/venv/lib/python3.8/site-packages (from requests->transformers>=4.31.0->auto-gptq) (3.3.2)\n",
      "Requirement already satisfied: certifi>=2017.4.17 in /home/ubuntu/venv/lib/python3.8/site-packages (from requests->transformers>=4.31.0->auto-gptq) (2023.11.17)\n",
      "Requirement already satisfied: idna<4,>=2.5 in /home/ubuntu/venv/lib/python3.8/site-packages (from requests->transformers>=4.31.0->auto-gptq) (3.6)\n",
      "Requirement already satisfied: urllib3<3,>=1.21.1 in /home/ubuntu/venv/lib/python3.8/site-packages (from requests->transformers>=4.31.0->auto-gptq) (2.1.0)\n",
      "Requirement already satisfied: python-dateutil>=2.8.2 in /home/ubuntu/venv/lib/python3.8/site-packages (from pandas->datasets->auto-gptq) (2.8.2)\n",
      "Requirement already satisfied: tzdata>=2022.1 in /home/ubuntu/venv/lib/python3.8/site-packages (from pandas->datasets->auto-gptq) (2023.3)\n",
      "Requirement already satisfied: pytz>=2020.1 in /home/ubuntu/venv/lib/python3.8/site-packages (from pandas->datasets->auto-gptq) (2023.3.post1)\n",
      "Requirement already satisfied: attrs>=17.3.0 in /home/ubuntu/venv/lib/python3.8/site-packages (from aiohttp->datasets->auto-gptq) (23.1.0)\n",
      "Requirement already satisfied: multidict<7.0,>=4.5 in /home/ubuntu/venv/lib/python3.8/site-packages (from aiohttp->datasets->auto-gptq) (6.0.4)\n",
      "Requirement already satisfied: aiosignal>=1.1.2 in /home/ubuntu/venv/lib/python3.8/site-packages (from aiohttp->datasets->auto-gptq) (1.3.1)\n",
      "Requirement already satisfied: frozenlist>=1.1.1 in /home/ubuntu/venv/lib/python3.8/site-packages (from aiohttp->datasets->auto-gptq) (1.4.1)\n",
      "Requirement already satisfied: async-timeout<5.0,>=4.0; python_version < \"3.11\" in /home/ubuntu/venv/lib/python3.8/site-packages (from aiohttp->datasets->auto-gptq) (4.0.3)\n",
      "Requirement already satisfied: yarl<2.0,>=1.0 in /home/ubuntu/venv/lib/python3.8/site-packages (from aiohttp->datasets->auto-gptq) (1.9.4)\n",
      "Installing collected packages: rouge, peft, gekko, auto-gptq\n",
      "Successfully installed auto-gptq-0.6.0+cu118 gekko-1.0.6 peft-0.7.1 rouge-1.0.1\n"
     ]
    }
   ],
   "source": [
    "! pip install sentence-transformers==2.2.2\n",
    "! pip install transformers==4.35.2\n",
    "! pip install optimum==1.15.0\n",
    "! pip install accelerate==0.25.0\n",
    "! pip install auto-gptq --extra-index-url https://huggingface.github.io/autogptq-index/whl/cu118/"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 1,
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "/home/ubuntu/venv/lib/python3.8/site-packages/tqdm/auto.py:21: TqdmWarning: IProgress not found. Please update jupyter and ipywidgets. See https://ipywidgets.readthedocs.io/en/stable/user_install.html\n",
      "  from .autonotebook import tqdm as notebook_tqdm\n"
     ]
    }
   ],
   "source": [
    "import torch\n",
    "from auto_gptq import exllama_set_max_input_length\n",
    "from llama_index.llms.huggingface import HuggingFaceLLM\n",
    "from transformers import AutoModelForCausalLM, AutoTokenizer, pipeline\n",
    "\n",
    "torch.cuda.empty_cache()\n",
    "\n",
    "model_name_or_path = \"TheBloke/neural-chat-7B-v3-2-GPTQ\"\n",
    "revision = \"gptq-4bit-32g-actorder_True\"\n",
    "# To use a different branch, change revision\n",
    "# For example: revision=\"gptq-4bit-32g-actorder_True\"\n",
    "\n",
    "model = AutoModelForCausalLM.from_pretrained(\n",
    "    model_name_or_path, device_map=\"auto\", revision=revision\n",
    ")\n",
    "\n",
    "model = exllama_set_max_input_length(model, max_input_length=5120)\n",
    "\n",
    "tokenizer = AutoTokenizer.from_pretrained(model_name_or_path, use_fast=True)\n",
    "\n",
    "model = exllama_set_max_input_length(model, max_input_length=5120)\n",
    "pipe = pipeline(\n",
    "    \"text-generation\",\n",
    "    model=model,\n",
    "    tokenizer=tokenizer,\n",
    "    max_new_tokens=200,\n",
    "    do_sample=True,\n",
    "    temperature=0.1,\n",
    "    top_k=40,\n",
    "    top_p=0.95,\n",
    "    repetition_penalty=1.15,\n",
    "    # streamer=streamer,\n",
    ")\n",
    "\n",
    "\n",
    "system_prompt = \"### System: You are a good JSON Interpreter who always answers \\\n",
    "the question based on the context only.\"\n",
    "\n",
    "prompt_template = \"\"\"\n",
    "### User:\n",
    "{query_str}\n",
    "\n",
    "### Assistant:\n",
    "\"\"\"\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": [
    "# Sample Question 2: Count the number of medically non-invasive assesments."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 3,
   "metadata": {},
   "outputs": [
    {
     "ename": "OutOfMemoryError",
     "evalue": "CUDA out of memory. Tried to allocate 6.47 GiB. GPU 0 has a total capacty of 22.19 GiB of which 6.29 GiB is free. Including non-PyTorch memory, this process has 15.89 GiB memory in use. Of the allocated memory 12.57 GiB is allocated by PyTorch, and 3.02 GiB is reserved by PyTorch but unallocated. If reserved but unallocated memory is large try setting max_split_size_mb to avoid fragmentation.  See documentation for Memory Management and PYTORCH_CUDA_ALLOC_CONF",
     "output_type": "error",
     "traceback": [
      "\u001b[0;31m---------------------------------------------------------------------------\u001b[0m",
      "\u001b[0;31mOutOfMemoryError\u001b[0m                          Traceback (most recent call last)",
      "Cell \u001b[0;32mIn[3], line 1\u001b[0m\n\u001b[0;32m----> 1\u001b[0m output \u001b[38;5;241m=\u001b[39m \u001b[43mpipe\u001b[49m\u001b[43m(\u001b[49m\u001b[38;5;124;43m\"\"\"\u001b[39;49m\u001b[38;5;124;43m### System: You are a good JSON Interpreter who always answers \u001b[39;49m\u001b[38;5;130;43;01m\\\u001b[39;49;00m\n\u001b[1;32m      2\u001b[0m \u001b[38;5;124;43mthe question based on the context only.\u001b[39;49m\n\u001b[1;32m      3\u001b[0m \n\u001b[1;32m      4\u001b[0m \u001b[38;5;124;43m### User: In the Given JSON,How many unique Selected_X are present for all the SOA_table_rows?\u001b[39;49m\n\u001b[1;32m      5\u001b[0m \u001b[38;5;124;43mJSON : \u001b[39;49m\u001b[38;5;124;43m{\u001b[39;49m\n\u001b[1;32m      6\u001b[0m \u001b[38;5;124;43m\t\u001b[39;49m\u001b[38;5;124;43m\"\u001b[39;49m\u001b[38;5;124;43mSOA_table_rows\u001b[39;49m\u001b[38;5;124;43m\"\u001b[39;49m\u001b[38;5;124;43m: [\u001b[39;49m\n\u001b[1;32m      7\u001b[0m \u001b[38;5;124;43m\t\t\u001b[39;49m\u001b[38;5;124;43m{\u001b[39;49m\n\u001b[1;32m      8\u001b[0m \u001b[38;5;124;43m\t\t\t\u001b[39;49m\u001b[38;5;124;43m\"\u001b[39;49m\u001b[38;5;124;43mAssessments\u001b[39;49m\u001b[38;5;124;43m\"\u001b[39;49m\u001b[38;5;124;43m: \u001b[39;49m\u001b[38;5;124;43m\"\u001b[39;49m\u001b[38;5;124;43mInformed consent/assent\u001b[39;49m\u001b[38;5;124;43m\"\u001b[39;49m\u001b[38;5;124;43m,\u001b[39;49m\n\u001b[1;32m      9\u001b[0m \u001b[38;5;124;43m\t\t\t\u001b[39;49m\u001b[38;5;124;43m\"\u001b[39;49m\u001b[38;5;124;43mSelected_X\u001b[39;49m\u001b[38;5;124;43m\"\u001b[39;49m\u001b[38;5;124;43m: [\u001b[39;49m\n\u001b[1;32m     10\u001b[0m \u001b[38;5;124;43m\t\t\t\t\u001b[39;49m\u001b[38;5;124;43m\"\u001b[39;49m\u001b[38;5;124;43mScreening  (-30 to -1)\u001b[39;49m\u001b[38;5;124;43m\"\u001b[39;49m\n\u001b[1;32m     11\u001b[0m \u001b[38;5;124;43m\t\t\t]\u001b[39;49m\n\u001b[1;32m     12\u001b[0m \u001b[38;5;124;43m\t\t},\u001b[39;49m\n\u001b[1;32m     13\u001b[0m \u001b[38;5;124;43m\t\t\u001b[39;49m\u001b[38;5;124;43m{\u001b[39;49m\n\u001b[1;32m     14\u001b[0m \u001b[38;5;124;43m\t\t\t\u001b[39;49m\u001b[38;5;124;43m\"\u001b[39;49m\u001b[38;5;124;43mAssessments\u001b[39;49m\u001b[38;5;124;43m\"\u001b[39;49m\u001b[38;5;124;43m: \u001b[39;49m\u001b[38;5;124;43m\"\u001b[39;49m\u001b[38;5;124;43mInclusion/exclusion\u001b[39;49m\u001b[38;5;124;43m\"\u001b[39;49m\u001b[38;5;124;43m,\u001b[39;49m\n\u001b[1;32m     15\u001b[0m \u001b[38;5;124;43m\t\t\t\u001b[39;49m\u001b[38;5;124;43m\"\u001b[39;49m\u001b[38;5;124;43mSelected_X\u001b[39;49m\u001b[38;5;124;43m\"\u001b[39;49m\u001b[38;5;124;43m: [\u001b[39;49m\n\u001b[1;32m     16\u001b[0m \u001b[38;5;124;43m\t\t\t\t\u001b[39;49m\u001b[38;5;124;43m\"\u001b[39;49m\u001b[38;5;124;43mScreening  (-30 to -1)\u001b[39;49m\u001b[38;5;124;43m\"\u001b[39;49m\u001b[38;5;124;43m,\u001b[39;49m\n\u001b[1;32m     17\u001b[0m \u001b[38;5;124;43m\t\t\t\t\u001b[39;49m\u001b[38;5;124;43m\"\u001b[39;49m\u001b[38;5;124;43mBaseline (D 1)\u001b[39;49m\u001b[38;5;124;43m\"\u001b[39;49m\n\u001b[1;32m     18\u001b[0m \u001b[38;5;124;43m\t\t\t]\u001b[39;49m\n\u001b[1;32m     19\u001b[0m \u001b[38;5;124;43m\t\t},\u001b[39;49m\n\u001b[1;32m     20\u001b[0m \u001b[38;5;124;43m\t\t\u001b[39;49m\u001b[38;5;124;43m{\u001b[39;49m\n\u001b[1;32m     21\u001b[0m \u001b[38;5;124;43m\t\t\t\u001b[39;49m\u001b[38;5;124;43m\"\u001b[39;49m\u001b[38;5;124;43mAssessments\u001b[39;49m\u001b[38;5;124;43m\"\u001b[39;49m\u001b[38;5;124;43m: \u001b[39;49m\u001b[38;5;124;43m\"\u001b[39;49m\u001b[38;5;124;43mUroflowmetry  Assessment\u001b[39;49m\u001b[38;5;124;43m\"\u001b[39;49m\u001b[38;5;124;43m,\u001b[39;49m\n\u001b[1;32m     22\u001b[0m \u001b[38;5;124;43m\t\t\t\u001b[39;49m\u001b[38;5;124;43m\"\u001b[39;49m\u001b[38;5;124;43mSelected_X\u001b[39;49m\u001b[38;5;124;43m\"\u001b[39;49m\u001b[38;5;124;43m: [\u001b[39;49m\n\u001b[1;32m     23\u001b[0m \u001b[38;5;124;43m\t\t\t\t\u001b[39;49m\u001b[38;5;124;43m\"\u001b[39;49m\u001b[38;5;124;43mScreening  (-30 to -1)\u001b[39;49m\u001b[38;5;124;43m\"\u001b[39;49m\n\u001b[1;32m     24\u001b[0m \u001b[38;5;124;43m\t\t\t]\u001b[39;49m\n\u001b[1;32m     25\u001b[0m \u001b[38;5;124;43m\t\t},\u001b[39;49m\n\u001b[1;32m     26\u001b[0m \u001b[38;5;124;43m\t\t\u001b[39;49m\u001b[38;5;124;43m{\u001b[39;49m\n\u001b[1;32m     27\u001b[0m \u001b[38;5;124;43m\t\t\t\u001b[39;49m\u001b[38;5;124;43m\"\u001b[39;49m\u001b[38;5;124;43mAssessments\u001b[39;49m\u001b[38;5;124;43m\"\u001b[39;49m\u001b[38;5;124;43m: \u001b[39;49m\u001b[38;5;124;43m\"\u001b[39;49m\u001b[38;5;124;43mDemographics,  medical/ADPKD history [\u001b[39;49m\u001b[38;5;124;43m{\u001b[39;49m\u001b[38;5;124;43mSuperscript \u001b[39;49m\u001b[38;5;124;43m'\u001b[39;49m\u001b[38;5;124;43me\u001b[39;49m\u001b[38;5;124;43m'\u001b[39;49m\u001b[38;5;124;43m : ADPKD genetic history to be collected if available, although it is not specifically required.}] \u001b[39;49m\u001b[38;5;124;43m\"\u001b[39;49m\u001b[38;5;124;43m,\u001b[39;49m\n\u001b[1;32m     28\u001b[0m \u001b[38;5;124;43m\t\t\t\u001b[39;49m\u001b[38;5;124;43m\"\u001b[39;49m\u001b[38;5;124;43mSelected_X\u001b[39;49m\u001b[38;5;124;43m\"\u001b[39;49m\u001b[38;5;124;43m: [\u001b[39;49m\n\u001b[1;32m     29\u001b[0m \u001b[38;5;124;43m\t\t\t\t\u001b[39;49m\u001b[38;5;124;43m\"\u001b[39;49m\u001b[38;5;124;43mScreening  (-30 to -1)\u001b[39;49m\u001b[38;5;124;43m\"\u001b[39;49m\n\u001b[1;32m     30\u001b[0m \u001b[38;5;124;43m\t\t\t]\u001b[39;49m\n\u001b[1;32m     31\u001b[0m \u001b[38;5;124;43m\t\t},\u001b[39;49m\n\u001b[1;32m     32\u001b[0m \u001b[38;5;124;43m\t\t\u001b[39;49m\u001b[38;5;124;43m{\u001b[39;49m\n\u001b[1;32m     33\u001b[0m \u001b[38;5;124;43m\t\t\t\u001b[39;49m\u001b[38;5;124;43m\"\u001b[39;49m\u001b[38;5;124;43mAssessments\u001b[39;49m\u001b[38;5;124;43m\"\u001b[39;49m\u001b[38;5;124;43m: \u001b[39;49m\u001b[38;5;124;43m\"\u001b[39;49m\u001b[38;5;124;43mTanner staging [\u001b[39;49m\u001b[38;5;124;43m{\u001b[39;49m\u001b[38;5;124;43mSuperscript \u001b[39;49m\u001b[38;5;124;43m'\u001b[39;49m\u001b[38;5;124;43mf\u001b[39;49m\u001b[38;5;124;43m'\u001b[39;49m\u001b[38;5;124;43m : A subject who reaches Stage 5 (both in pubic hair and genitalia) does not need to continue with Tanner Staging.}] \u001b[39;49m\u001b[38;5;124;43m\"\u001b[39;49m\u001b[38;5;124;43m,\u001b[39;49m\n\u001b[1;32m     34\u001b[0m \u001b[38;5;124;43m\t\t\t\u001b[39;49m\u001b[38;5;124;43m\"\u001b[39;49m\u001b[38;5;124;43mSelected_X\u001b[39;49m\u001b[38;5;124;43m\"\u001b[39;49m\u001b[38;5;124;43m: [\u001b[39;49m\n\u001b[1;32m     35\u001b[0m \u001b[38;5;124;43m\t\t\t\t\u001b[39;49m\u001b[38;5;124;43m\"\u001b[39;49m\u001b[38;5;124;43mBaseline (D 1)\u001b[39;49m\u001b[38;5;124;43m\"\u001b[39;49m\u001b[38;5;124;43m,\u001b[39;49m\n\u001b[1;32m     36\u001b[0m \u001b[38;5;124;43m\t\t\t\t\u001b[39;49m\u001b[38;5;124;43m\"\u001b[39;49m\u001b[38;5;124;43mM6 (±14 D)\u001b[39;49m\u001b[38;5;124;43m\"\u001b[39;49m\u001b[38;5;124;43m,\u001b[39;49m\n\u001b[1;32m     37\u001b[0m \u001b[38;5;124;43m\t\t\t\t\u001b[39;49m\u001b[38;5;124;43m\"\u001b[39;49m\u001b[38;5;124;43mM12 [\u001b[39;49m\u001b[38;5;124;43m{\u001b[39;49m\u001b[38;5;124;43mSuperscript \u001b[39;49m\u001b[38;5;124;43m'\u001b[39;49m\u001b[38;5;124;43mb\u001b[39;49m\u001b[38;5;124;43m'\u001b[39;49m\u001b[38;5;124;43m : The Month 12 visit will serve as the Baseline visit for Phase B. The subject’s body weight at this visit will be used to determine the starting dose in Phase B.}] (D365)  (+14 D)/ End of  Treatment  (EoTx)c [\u001b[39;49m\u001b[38;5;124;43m{\u001b[39;49m\u001b[38;5;124;43mSuperscript \u001b[39;49m\u001b[38;5;124;43m'\u001b[39;49m\u001b[38;5;124;43m'\u001b[39;49m\u001b[38;5;124;43m : Unknown}, \u001b[39;49m\u001b[38;5;124;43m{\u001b[39;49m\u001b[38;5;124;43mSuperscript \u001b[39;49m\u001b[38;5;124;43m'\u001b[39;49m\u001b[38;5;124;43m'\u001b[39;49m\u001b[38;5;124;43m : Unknown}] d\u001b[39;49m\u001b[38;5;124;43m\"\u001b[39;49m\n\u001b[1;32m     38\u001b[0m \u001b[38;5;124;43m\t\t\t]\u001b[39;49m\n\u001b[1;32m     39\u001b[0m \u001b[38;5;124;43m\t\t},\u001b[39;49m\n\u001b[1;32m     40\u001b[0m \u001b[38;5;124;43m\t\t\u001b[39;49m\u001b[38;5;124;43m{\u001b[39;49m\n\u001b[1;32m     41\u001b[0m \u001b[38;5;124;43m\t\t\t\u001b[39;49m\u001b[38;5;124;43m\"\u001b[39;49m\u001b[38;5;124;43mAssessments\u001b[39;49m\u001b[38;5;124;43m\"\u001b[39;49m\u001b[38;5;124;43m: \u001b[39;49m\u001b[38;5;124;43m\"\u001b[39;49m\u001b[38;5;124;43mMRI/ultrasound [\u001b[39;49m\u001b[38;5;124;43m{\u001b[39;49m\u001b[38;5;124;43mSuperscript \u001b[39;49m\u001b[38;5;124;43m'\u001b[39;49m\u001b[38;5;124;43mg\u001b[39;49m\u001b[38;5;124;43m'\u001b[39;49m\u001b[38;5;124;43m : MRI/ultrasound imaging: The baseline imaging used must be the same imaging used throughout the trial (Phase A and Phase B). It is recommended that subjects have their imaging done on the same day as the clinic visit; however imaging can be performed up to 30 days prior to the scheduled visit. The subject should be on IMP for 30 consecutive days prior to imaging (except screening). MRI/ultrasound is not required at the EoTx visit.}] \u001b[39;49m\u001b[38;5;124;43m\"\u001b[39;49m\u001b[38;5;124;43m,\u001b[39;49m\n\u001b[1;32m     42\u001b[0m \u001b[38;5;124;43m\t\t\t\u001b[39;49m\u001b[38;5;124;43m\"\u001b[39;49m\u001b[38;5;124;43mSelected_X\u001b[39;49m\u001b[38;5;124;43m\"\u001b[39;49m\u001b[38;5;124;43m: [\u001b[39;49m\n\u001b[1;32m     43\u001b[0m \u001b[38;5;124;43m\t\t\t\t\u001b[39;49m\u001b[38;5;124;43m\"\u001b[39;49m\u001b[38;5;124;43mScreening  (-30 to -1)\u001b[39;49m\u001b[38;5;124;43m\"\u001b[39;49m\u001b[38;5;124;43m,\u001b[39;49m\n\u001b[1;32m     44\u001b[0m \u001b[38;5;124;43m\t\t\t\t\u001b[39;49m\u001b[38;5;124;43m\"\u001b[39;49m\u001b[38;5;124;43mM12 [\u001b[39;49m\u001b[38;5;124;43m{\u001b[39;49m\u001b[38;5;124;43mSuperscript \u001b[39;49m\u001b[38;5;124;43m'\u001b[39;49m\u001b[38;5;124;43mb\u001b[39;49m\u001b[38;5;124;43m'\u001b[39;49m\u001b[38;5;124;43m : The Month 12 visit will serve as the Baseline visit for Phase B. The subject’s body weight at this visit will be used to determine the starting dose in Phase B.}] (D365)  (+14 D)/ End of  Treatment  (EoTx)c [\u001b[39;49m\u001b[38;5;124;43m{\u001b[39;49m\u001b[38;5;124;43mSuperscript \u001b[39;49m\u001b[38;5;124;43m'\u001b[39;49m\u001b[38;5;124;43m'\u001b[39;49m\u001b[38;5;124;43m : Unknown}, \u001b[39;49m\u001b[38;5;124;43m{\u001b[39;49m\u001b[38;5;124;43mSuperscript \u001b[39;49m\u001b[38;5;124;43m'\u001b[39;49m\u001b[38;5;124;43m'\u001b[39;49m\u001b[38;5;124;43m : Unknown}] d\u001b[39;49m\u001b[38;5;124;43m\"\u001b[39;49m\n\u001b[1;32m     45\u001b[0m \u001b[38;5;124;43m\t\t\t]\u001b[39;49m\n\u001b[1;32m     46\u001b[0m \u001b[38;5;124;43m\t\t},\u001b[39;49m\n\u001b[1;32m     47\u001b[0m \u001b[38;5;124;43m\t\t\u001b[39;49m\u001b[38;5;124;43m{\u001b[39;49m\n\u001b[1;32m     48\u001b[0m \u001b[38;5;124;43m\t\t\t\u001b[39;49m\u001b[38;5;124;43m\"\u001b[39;49m\u001b[38;5;124;43mAssessments\u001b[39;49m\u001b[38;5;124;43m\"\u001b[39;49m\u001b[38;5;124;43m: \u001b[39;49m\u001b[38;5;124;43m\"\u001b[39;49m\u001b[38;5;124;43mRenal pelvic  measurement [\u001b[39;49m\u001b[38;5;124;43m{\u001b[39;49m\u001b[38;5;124;43mSuperscript \u001b[39;49m\u001b[38;5;124;43m'\u001b[39;49m\u001b[38;5;124;43mh\u001b[39;49m\u001b[38;5;124;43m'\u001b[39;49m\u001b[38;5;124;43m : Renal pelvic assessments will be done using ultrasound. The Month 1 assessment can be performed at any scheduled visit between Month 1 and Month 3 but cannot be conducted until 30 days after the subject has started IMP, see Section 3.7.4.5.}] \u001b[39;49m\u001b[38;5;124;43m\"\u001b[39;49m\u001b[38;5;124;43m,\u001b[39;49m\n\u001b[1;32m     49\u001b[0m \u001b[38;5;124;43m\t\t\t\u001b[39;49m\u001b[38;5;124;43m\"\u001b[39;49m\u001b[38;5;124;43mSelected_X\u001b[39;49m\u001b[38;5;124;43m\"\u001b[39;49m\u001b[38;5;124;43m: [\u001b[39;49m\n\u001b[1;32m     50\u001b[0m \u001b[38;5;124;43m\t\t\t\t\u001b[39;49m\u001b[38;5;124;43m\"\u001b[39;49m\u001b[38;5;124;43mScreening  (-30 to -1)\u001b[39;49m\u001b[38;5;124;43m\"\u001b[39;49m\u001b[38;5;124;43m,\u001b[39;49m\n\u001b[1;32m     51\u001b[0m \u001b[38;5;124;43m\t\t\t\t\u001b[39;49m\u001b[38;5;124;43m\"\u001b[39;49m\u001b[38;5;124;43mM1 (Wk  4) (7 D)\u001b[39;49m\u001b[38;5;124;43m\"\u001b[39;49m\u001b[38;5;124;43m,\u001b[39;49m\n\u001b[1;32m     52\u001b[0m \u001b[38;5;124;43m\t\t\t\t\u001b[39;49m\u001b[38;5;124;43m\"\u001b[39;49m\u001b[38;5;124;43mM12 [\u001b[39;49m\u001b[38;5;124;43m{\u001b[39;49m\u001b[38;5;124;43mSuperscript \u001b[39;49m\u001b[38;5;124;43m'\u001b[39;49m\u001b[38;5;124;43mb\u001b[39;49m\u001b[38;5;124;43m'\u001b[39;49m\u001b[38;5;124;43m : The Month 12 visit will serve as the Baseline visit for Phase B. The subject’s body weight at this visit will be used to determine the starting dose in Phase B.}] (D365)  (+14 D)/ End of  Treatment  (EoTx)c [\u001b[39;49m\u001b[38;5;124;43m{\u001b[39;49m\u001b[38;5;124;43mSuperscript \u001b[39;49m\u001b[38;5;124;43m'\u001b[39;49m\u001b[38;5;124;43m'\u001b[39;49m\u001b[38;5;124;43m : Unknown}, \u001b[39;49m\u001b[38;5;124;43m{\u001b[39;49m\u001b[38;5;124;43mSuperscript \u001b[39;49m\u001b[38;5;124;43m'\u001b[39;49m\u001b[38;5;124;43m'\u001b[39;49m\u001b[38;5;124;43m : Unknown}] d\u001b[39;49m\u001b[38;5;124;43m\"\u001b[39;49m\n\u001b[1;32m     53\u001b[0m \u001b[38;5;124;43m\t\t\t]\u001b[39;49m\n\u001b[1;32m     54\u001b[0m \u001b[38;5;124;43m\t\t},\u001b[39;49m\n\u001b[1;32m     55\u001b[0m \u001b[38;5;124;43m\t\t\u001b[39;49m\u001b[38;5;124;43m{\u001b[39;49m\n\u001b[1;32m     56\u001b[0m \u001b[38;5;124;43m\t\t\t\u001b[39;49m\u001b[38;5;124;43m\"\u001b[39;49m\u001b[38;5;124;43mAssessments\u001b[39;49m\u001b[38;5;124;43m\"\u001b[39;49m\u001b[38;5;124;43m: \u001b[39;49m\u001b[38;5;124;43m\"\u001b[39;49m\u001b[38;5;124;43mVital signs [\u001b[39;49m\u001b[38;5;124;43m{\u001b[39;49m\u001b[38;5;124;43mSuperscript \u001b[39;49m\u001b[38;5;124;43m'\u001b[39;49m\u001b[38;5;124;43mi\u001b[39;49m\u001b[38;5;124;43m'\u001b[39;49m\u001b[38;5;124;43m : Vital signs at each visit include seated heart rate and blood pressure (systolic and diastolic). Temperature will be collected only at the Phase A baseline visit.}] \u001b[39;49m\u001b[38;5;124;43m\"\u001b[39;49m\u001b[38;5;124;43m,\u001b[39;49m\n\u001b[1;32m     57\u001b[0m \u001b[38;5;124;43m\t\t\t\u001b[39;49m\u001b[38;5;124;43m\"\u001b[39;49m\u001b[38;5;124;43mSelected_X\u001b[39;49m\u001b[38;5;124;43m\"\u001b[39;49m\u001b[38;5;124;43m: [\u001b[39;49m\n\u001b[1;32m     58\u001b[0m \u001b[38;5;124;43m\t\t\t\t\u001b[39;49m\u001b[38;5;124;43m\"\u001b[39;49m\u001b[38;5;124;43mScreening  (-30 to -1)\u001b[39;49m\u001b[38;5;124;43m\"\u001b[39;49m\u001b[38;5;124;43m,\u001b[39;49m\n\u001b[1;32m     59\u001b[0m \u001b[38;5;124;43m\t\t\t\t\u001b[39;49m\u001b[38;5;124;43m\"\u001b[39;49m\u001b[38;5;124;43mBaseline (D 1)\u001b[39;49m\u001b[38;5;124;43m\"\u001b[39;49m\u001b[38;5;124;43m,\u001b[39;49m\n\u001b[1;32m     60\u001b[0m \u001b[38;5;124;43m\t\t\t\t\u001b[39;49m\u001b[38;5;124;43m\"\u001b[39;49m\u001b[38;5;124;43mWk 1  (-1/+3 D)\u001b[39;49m\u001b[38;5;124;43m\"\u001b[39;49m\u001b[38;5;124;43m,\u001b[39;49m\n\u001b[1;32m     61\u001b[0m \u001b[38;5;124;43m\t\t\t\t\u001b[39;49m\u001b[38;5;124;43m\"\u001b[39;49m\u001b[38;5;124;43mM1 (Wk  4) (7 D)\u001b[39;49m\u001b[38;5;124;43m\"\u001b[39;49m\u001b[38;5;124;43m,\u001b[39;49m\n\u001b[1;32m     62\u001b[0m \u001b[38;5;124;43m\t\t\t\t\u001b[39;49m\u001b[38;5;124;43m\"\u001b[39;49m\u001b[38;5;124;43mM6 (±14 D)\u001b[39;49m\u001b[38;5;124;43m\"\u001b[39;49m\u001b[38;5;124;43m,\u001b[39;49m\n\u001b[1;32m     63\u001b[0m \u001b[38;5;124;43m\t\t\t\t\u001b[39;49m\u001b[38;5;124;43m\"\u001b[39;49m\u001b[38;5;124;43mM12 [\u001b[39;49m\u001b[38;5;124;43m{\u001b[39;49m\u001b[38;5;124;43mSuperscript \u001b[39;49m\u001b[38;5;124;43m'\u001b[39;49m\u001b[38;5;124;43mb\u001b[39;49m\u001b[38;5;124;43m'\u001b[39;49m\u001b[38;5;124;43m : The Month 12 visit will serve as the Baseline visit for Phase B. The subject’s body weight at this visit will be used to determine the starting dose in Phase B.}] (D365)  (+14 D)/ End of  Treatment  (EoTx)c [\u001b[39;49m\u001b[38;5;124;43m{\u001b[39;49m\u001b[38;5;124;43mSuperscript \u001b[39;49m\u001b[38;5;124;43m'\u001b[39;49m\u001b[38;5;124;43m'\u001b[39;49m\u001b[38;5;124;43m : Unknown}, \u001b[39;49m\u001b[38;5;124;43m{\u001b[39;49m\u001b[38;5;124;43mSuperscript \u001b[39;49m\u001b[38;5;124;43m'\u001b[39;49m\u001b[38;5;124;43m'\u001b[39;49m\u001b[38;5;124;43m : Unknown}] d\u001b[39;49m\u001b[38;5;124;43m\"\u001b[39;49m\n\u001b[1;32m     64\u001b[0m \u001b[38;5;124;43m\t\t\t]\u001b[39;49m\n\u001b[1;32m     65\u001b[0m \u001b[38;5;124;43m\t\t},\u001b[39;49m\n\u001b[1;32m     66\u001b[0m \u001b[38;5;124;43m\t\t\u001b[39;49m\u001b[38;5;124;43m{\u001b[39;49m\n\u001b[1;32m     67\u001b[0m \u001b[38;5;124;43m\t\t\t\u001b[39;49m\u001b[38;5;124;43m\"\u001b[39;49m\u001b[38;5;124;43mAssessments\u001b[39;49m\u001b[38;5;124;43m\"\u001b[39;49m\u001b[38;5;124;43m: \u001b[39;49m\u001b[38;5;124;43m\"\u001b[39;49m\u001b[38;5;124;43m12-lead electrocardiogram\u001b[39;49m\u001b[38;5;124;43m\"\u001b[39;49m\u001b[38;5;124;43m,\u001b[39;49m\n\u001b[1;32m     68\u001b[0m \u001b[38;5;124;43m\t\t\t\u001b[39;49m\u001b[38;5;124;43m\"\u001b[39;49m\u001b[38;5;124;43mSelected_X\u001b[39;49m\u001b[38;5;124;43m\"\u001b[39;49m\u001b[38;5;124;43m: [\u001b[39;49m\n\u001b[1;32m     69\u001b[0m \u001b[38;5;124;43m\t\t\t\t\u001b[39;49m\u001b[38;5;124;43m\"\u001b[39;49m\u001b[38;5;124;43mScreening  (-30 to -1)\u001b[39;49m\u001b[38;5;124;43m\"\u001b[39;49m\n\u001b[1;32m     70\u001b[0m \u001b[38;5;124;43m\t\t\t]\u001b[39;49m\n\u001b[1;32m     71\u001b[0m \u001b[38;5;124;43m\t\t},\u001b[39;49m\n\u001b[1;32m     72\u001b[0m \u001b[38;5;124;43m\t\t\u001b[39;49m\u001b[38;5;124;43m{\u001b[39;49m\n\u001b[1;32m     73\u001b[0m \u001b[38;5;124;43m\t\t\t\u001b[39;49m\u001b[38;5;124;43m\"\u001b[39;49m\u001b[38;5;124;43mAssessments\u001b[39;49m\u001b[38;5;124;43m\"\u001b[39;49m\u001b[38;5;124;43m: \u001b[39;49m\u001b[38;5;124;43m\"\u001b[39;49m\u001b[38;5;124;43mBody height and  weight/growth  percentiles [\u001b[39;49m\u001b[38;5;124;43m{\u001b[39;49m\u001b[38;5;124;43mSuperscript \u001b[39;49m\u001b[38;5;124;43m'\u001b[39;49m\u001b[38;5;124;43mj\u001b[39;49m\u001b[38;5;124;43m'\u001b[39;49m\u001b[38;5;124;43m : Body weight should be measured post-void. Growth percentile is not required at the baseline, Wk 1 and M1 visits. Body weight is not required at the Wk 1 and M1 visits. .}] \u001b[39;49m\u001b[38;5;124;43m\"\u001b[39;49m\u001b[38;5;124;43m,\u001b[39;49m\n\u001b[1;32m     74\u001b[0m \u001b[38;5;124;43m\t\t\t\u001b[39;49m\u001b[38;5;124;43m\"\u001b[39;49m\u001b[38;5;124;43mSelected_X\u001b[39;49m\u001b[38;5;124;43m\"\u001b[39;49m\u001b[38;5;124;43m: [\u001b[39;49m\n\u001b[1;32m     75\u001b[0m \u001b[38;5;124;43m\t\t\t\t\u001b[39;49m\u001b[38;5;124;43m\"\u001b[39;49m\u001b[38;5;124;43mScreening  (-30 to -1)\u001b[39;49m\u001b[38;5;124;43m\"\u001b[39;49m\u001b[38;5;124;43m,\u001b[39;49m\n\u001b[1;32m     76\u001b[0m \u001b[38;5;124;43m\t\t\t\t\u001b[39;49m\u001b[38;5;124;43m\"\u001b[39;49m\u001b[38;5;124;43mBaseline (D 1)\u001b[39;49m\u001b[38;5;124;43m\"\u001b[39;49m\u001b[38;5;124;43m,\u001b[39;49m\n\u001b[1;32m     77\u001b[0m \u001b[38;5;124;43m\t\t\t\t\u001b[39;49m\u001b[38;5;124;43m\"\u001b[39;49m\u001b[38;5;124;43mWk 1  (-1/+3 D)\u001b[39;49m\u001b[38;5;124;43m\"\u001b[39;49m\u001b[38;5;124;43m,\u001b[39;49m\n\u001b[1;32m     78\u001b[0m \u001b[38;5;124;43m\t\t\t\t\u001b[39;49m\u001b[38;5;124;43m\"\u001b[39;49m\u001b[38;5;124;43mM1 (Wk  4) (7 D)\u001b[39;49m\u001b[38;5;124;43m\"\u001b[39;49m\u001b[38;5;124;43m,\u001b[39;49m\n\u001b[1;32m     79\u001b[0m \u001b[38;5;124;43m\t\t\t\t\u001b[39;49m\u001b[38;5;124;43m\"\u001b[39;49m\u001b[38;5;124;43mM6 (±14 D)\u001b[39;49m\u001b[38;5;124;43m\"\u001b[39;49m\u001b[38;5;124;43m,\u001b[39;49m\n\u001b[1;32m     80\u001b[0m \u001b[38;5;124;43m\t\t\t\t\u001b[39;49m\u001b[38;5;124;43m\"\u001b[39;49m\u001b[38;5;124;43mM12 [\u001b[39;49m\u001b[38;5;124;43m{\u001b[39;49m\u001b[38;5;124;43mSuperscript \u001b[39;49m\u001b[38;5;124;43m'\u001b[39;49m\u001b[38;5;124;43mb\u001b[39;49m\u001b[38;5;124;43m'\u001b[39;49m\u001b[38;5;124;43m : The Month 12 visit will serve as the Baseline visit for Phase B. The subject’s body weight at this visit will be used to determine the starting dose in Phase B.}] (D365)  (+14 D)/ End of  Treatment  (EoTx)c [\u001b[39;49m\u001b[38;5;124;43m{\u001b[39;49m\u001b[38;5;124;43mSuperscript \u001b[39;49m\u001b[38;5;124;43m'\u001b[39;49m\u001b[38;5;124;43m'\u001b[39;49m\u001b[38;5;124;43m : Unknown}, \u001b[39;49m\u001b[38;5;124;43m{\u001b[39;49m\u001b[38;5;124;43mSuperscript \u001b[39;49m\u001b[38;5;124;43m'\u001b[39;49m\u001b[38;5;124;43m'\u001b[39;49m\u001b[38;5;124;43m : Unknown}] d\u001b[39;49m\u001b[38;5;124;43m\"\u001b[39;49m\n\u001b[1;32m     81\u001b[0m \u001b[38;5;124;43m\t\t\t]\u001b[39;49m\n\u001b[1;32m     82\u001b[0m \u001b[38;5;124;43m\t\t},\u001b[39;49m\n\u001b[1;32m     83\u001b[0m \u001b[38;5;124;43m\t\t\u001b[39;49m\u001b[38;5;124;43m{\u001b[39;49m\n\u001b[1;32m     84\u001b[0m \u001b[38;5;124;43m\t\t\t\u001b[39;49m\u001b[38;5;124;43m\"\u001b[39;49m\u001b[38;5;124;43mAssessments\u001b[39;49m\u001b[38;5;124;43m\"\u001b[39;49m\u001b[38;5;124;43m: \u001b[39;49m\u001b[38;5;124;43m\"\u001b[39;49m\u001b[38;5;124;43mSerum  chemistry/hematology/ urinalysis [\u001b[39;49m\u001b[38;5;124;43m{\u001b[39;49m\u001b[38;5;124;43mSuperscript \u001b[39;49m\u001b[38;5;124;43m'\u001b[39;49m\u001b[38;5;124;43mk\u001b[39;49m\u001b[38;5;124;43m'\u001b[39;49m\u001b[38;5;124;43m : Central laboratory serum laboratory tests will be performed for all visits (only monthly safety labs may be collected at a local laboratory). Fasting is required at the screening visit. Fasting is recommended for all other visits, but is not required. Upon request, if clinically indicated and approved by the medical monitor, subjects may have the following evaluations in addition to the protocol-specified chemistry panel: serum calcium, phosphorus, parathyroid hormone, vitamin D, and bicarbonate levels.}] \u001b[39;49m\u001b[38;5;124;43m\"\u001b[39;49m\u001b[38;5;124;43m,\u001b[39;49m\n\u001b[1;32m     85\u001b[0m \u001b[38;5;124;43m\t\t\t\u001b[39;49m\u001b[38;5;124;43m\"\u001b[39;49m\u001b[38;5;124;43mSelected_X\u001b[39;49m\u001b[38;5;124;43m\"\u001b[39;49m\u001b[38;5;124;43m: [\u001b[39;49m\n\u001b[1;32m     86\u001b[0m \u001b[38;5;124;43m\t\t\t\t\u001b[39;49m\u001b[38;5;124;43m\"\u001b[39;49m\u001b[38;5;124;43mScreening  (-30 to -1)\u001b[39;49m\u001b[38;5;124;43m\"\u001b[39;49m\u001b[38;5;124;43m,\u001b[39;49m\n\u001b[1;32m     87\u001b[0m \u001b[38;5;124;43m\t\t\t\t\u001b[39;49m\u001b[38;5;124;43m\"\u001b[39;49m\u001b[38;5;124;43mM6 (±14 D)\u001b[39;49m\u001b[38;5;124;43m\"\u001b[39;49m\u001b[38;5;124;43m,\u001b[39;49m\n\u001b[1;32m     88\u001b[0m \u001b[38;5;124;43m\t\t\t\t\u001b[39;49m\u001b[38;5;124;43m\"\u001b[39;49m\u001b[38;5;124;43mM12 [\u001b[39;49m\u001b[38;5;124;43m{\u001b[39;49m\u001b[38;5;124;43mSuperscript \u001b[39;49m\u001b[38;5;124;43m'\u001b[39;49m\u001b[38;5;124;43mb\u001b[39;49m\u001b[38;5;124;43m'\u001b[39;49m\u001b[38;5;124;43m : The Month 12 visit will serve as the Baseline visit for Phase B. The subject’s body weight at this visit will be used to determine the starting dose in Phase B.}] (D365)  (+14 D)/ End of  Treatment  (EoTx)c [\u001b[39;49m\u001b[38;5;124;43m{\u001b[39;49m\u001b[38;5;124;43mSuperscript \u001b[39;49m\u001b[38;5;124;43m'\u001b[39;49m\u001b[38;5;124;43m'\u001b[39;49m\u001b[38;5;124;43m : Unknown}, \u001b[39;49m\u001b[38;5;124;43m{\u001b[39;49m\u001b[38;5;124;43mSuperscript \u001b[39;49m\u001b[38;5;124;43m'\u001b[39;49m\u001b[38;5;124;43m'\u001b[39;49m\u001b[38;5;124;43m : Unknown}] d\u001b[39;49m\u001b[38;5;124;43m\"\u001b[39;49m\n\u001b[1;32m     89\u001b[0m \u001b[38;5;124;43m\t\t\t]\u001b[39;49m\n\u001b[1;32m     90\u001b[0m \u001b[38;5;124;43m\t\t},\u001b[39;49m\n\u001b[1;32m     91\u001b[0m \u001b[38;5;124;43m\t\t\u001b[39;49m\u001b[38;5;124;43m{\u001b[39;49m\n\u001b[1;32m     92\u001b[0m \u001b[38;5;124;43m\t\t\t\u001b[39;49m\u001b[38;5;124;43m\"\u001b[39;49m\u001b[38;5;124;43mAssessments\u001b[39;49m\u001b[38;5;124;43m\"\u001b[39;49m\u001b[38;5;124;43m: \u001b[39;49m\u001b[38;5;124;43m\"\u001b[39;49m\u001b[38;5;124;43mLiver function  tests/creatinine [\u001b[39;49m\u001b[38;5;124;43m{\u001b[39;49m\u001b[38;5;124;43mSuperscript \u001b[39;49m\u001b[38;5;124;43m'\u001b[39;49m\u001b[38;5;124;43mk\u001b[39;49m\u001b[38;5;124;43m'\u001b[39;49m\u001b[38;5;124;43m : Central laboratory serum laboratory tests will be performed for all visits (only monthly safety labs may be collected at a local laboratory). Fasting is required at the screening visit. Fasting is recommended for all other visits, but is not required. Upon request, if clinically indicated and approved by the medical monitor, subjects may have the following evaluations in addition to the protocol-specified chemistry panel: serum calcium, phosphorus, parathyroid hormone, vitamin D, and bicarbonate levels.}, \u001b[39;49m\u001b[38;5;124;43m{\u001b[39;49m\u001b[38;5;124;43mSuperscript \u001b[39;49m\u001b[38;5;124;43m'\u001b[39;49m\u001b[38;5;124;43ml\u001b[39;49m\u001b[38;5;124;43m'\u001b[39;49m\u001b[38;5;124;43m : A full liver function panel (AST, ALT, alkaline phosphatase [ALP], bilirubin, total [BT]) will be done at screening. At subsequent visits, LFTs include AST and ALT only, unless otherwise clinically indicated. Laboratory samples for LFTs, serum sodium, and serum creatinine will be collected at baseline only if the baseline visit occurs > 7 days after the Screening visit. Monthly visits include LFTs, serum creatinine and pregnancy test. See Section 5.4 for handling abnormal LFTs.}] \u001b[39;49m\u001b[38;5;124;43m\"\u001b[39;49m\u001b[38;5;124;43m,\u001b[39;49m\n\u001b[1;32m     93\u001b[0m \u001b[38;5;124;43m\t\t\t\u001b[39;49m\u001b[38;5;124;43m\"\u001b[39;49m\u001b[38;5;124;43mSelected_X\u001b[39;49m\u001b[38;5;124;43m\"\u001b[39;49m\u001b[38;5;124;43m: [\u001b[39;49m\n\u001b[1;32m     94\u001b[0m \u001b[38;5;124;43m\t\t\t\t\u001b[39;49m\u001b[38;5;124;43m\"\u001b[39;49m\u001b[38;5;124;43mScreening  (-30 to -1)\u001b[39;49m\u001b[38;5;124;43m\"\u001b[39;49m\u001b[38;5;124;43m,\u001b[39;49m\n\u001b[1;32m     95\u001b[0m \u001b[38;5;124;43m\t\t\t\t\u001b[39;49m\u001b[38;5;124;43m\"\u001b[39;49m\u001b[38;5;124;43mBaseline (D 1)\u001b[39;49m\u001b[38;5;124;43m\"\u001b[39;49m\u001b[38;5;124;43m,\u001b[39;49m\n\u001b[1;32m     96\u001b[0m \u001b[38;5;124;43m\t\t\t\t\u001b[39;49m\u001b[38;5;124;43m\"\u001b[39;49m\u001b[38;5;124;43mWk 1  (-1/+3 D)\u001b[39;49m\u001b[38;5;124;43m\"\u001b[39;49m\u001b[38;5;124;43m,\u001b[39;49m\n\u001b[1;32m     97\u001b[0m \u001b[38;5;124;43m\t\t\t\t\u001b[39;49m\u001b[38;5;124;43m\"\u001b[39;49m\u001b[38;5;124;43mM1 (Wk  4) (7 D)\u001b[39;49m\u001b[38;5;124;43m\"\u001b[39;49m\u001b[38;5;124;43m,\u001b[39;49m\n\u001b[1;32m     98\u001b[0m \u001b[38;5;124;43m\t\t\t\t\u001b[39;49m\u001b[38;5;124;43m\"\u001b[39;49m\u001b[38;5;124;43mM6 (±14 D)\u001b[39;49m\u001b[38;5;124;43m\"\u001b[39;49m\u001b[38;5;124;43m,\u001b[39;49m\n\u001b[1;32m     99\u001b[0m \u001b[38;5;124;43m\t\t\t\t\u001b[39;49m\u001b[38;5;124;43m\"\u001b[39;49m\u001b[38;5;124;43mMonthly Safety  Visits:  M2, 3, 4,  5, 7, 8, 9,  10, 11  (±4D) [\u001b[39;49m\u001b[38;5;124;43m{\u001b[39;49m\u001b[38;5;124;43mSuperscript \u001b[39;49m\u001b[38;5;124;43m'\u001b[39;49m\u001b[38;5;124;43ma\u001b[39;49m\u001b[38;5;124;43m'\u001b[39;49m\u001b[38;5;124;43m : Monthly safety visits: If it is more convenient for the subject, laboratory tests may be collected at a local laboratory; a clinic visit is not required. The PI is required to review monthly safety labs and record them in the electronic case report form (eCRF). Protocol 156-12-298 Confidential - Proprietary Information 40 Amendment 1, 08 Aug 2016}]\u001b[39;49m\u001b[38;5;124;43m\"\u001b[39;49m\u001b[38;5;124;43m,\u001b[39;49m\n\u001b[1;32m    100\u001b[0m \u001b[38;5;124;43m\t\t\t\t\u001b[39;49m\u001b[38;5;124;43m\"\u001b[39;49m\u001b[38;5;124;43mM12 [\u001b[39;49m\u001b[38;5;124;43m{\u001b[39;49m\u001b[38;5;124;43mSuperscript \u001b[39;49m\u001b[38;5;124;43m'\u001b[39;49m\u001b[38;5;124;43mb\u001b[39;49m\u001b[38;5;124;43m'\u001b[39;49m\u001b[38;5;124;43m : The Month 12 visit will serve as the Baseline visit for Phase B. The subject’s body weight at this visit will be used to determine the starting dose in Phase B.}] (D365)  (+14 D)/ End of  Treatment  (EoTx)c [\u001b[39;49m\u001b[38;5;124;43m{\u001b[39;49m\u001b[38;5;124;43mSuperscript \u001b[39;49m\u001b[38;5;124;43m'\u001b[39;49m\u001b[38;5;124;43m'\u001b[39;49m\u001b[38;5;124;43m : Unknown}, \u001b[39;49m\u001b[38;5;124;43m{\u001b[39;49m\u001b[38;5;124;43mSuperscript \u001b[39;49m\u001b[38;5;124;43m'\u001b[39;49m\u001b[38;5;124;43m'\u001b[39;49m\u001b[38;5;124;43m : Unknown}] d\u001b[39;49m\u001b[38;5;124;43m\"\u001b[39;49m\u001b[38;5;124;43m,\u001b[39;49m\n\u001b[1;32m    101\u001b[0m \u001b[38;5;124;43m\t\t\t\t\u001b[39;49m\u001b[38;5;124;43m\"\u001b[39;49m\u001b[38;5;124;43mFollow-Up [\u001b[39;49m\u001b[38;5;124;43m{\u001b[39;49m\u001b[38;5;124;43mSuperscript \u001b[39;49m\u001b[38;5;124;43m'\u001b[39;49m\u001b[38;5;124;43mc\u001b[39;49m\u001b[38;5;124;43m'\u001b[39;49m\u001b[38;5;124;43m : Any subject who discontinues IMP during Phase A will enter the Follow-up period and then be followed every 6 months through Phase A. The 14 day follow-up visit is a telephone contct only, a clinic visit is not required. Subjects who do not complete Phase A on treatment are not eligible to enter Phase B.}, \u001b[39;49m\u001b[38;5;124;43m{\u001b[39;49m\u001b[38;5;124;43mSuperscript \u001b[39;49m\u001b[38;5;124;43m'\u001b[39;49m\u001b[38;5;124;43md\u001b[39;49m\u001b[38;5;124;43m'\u001b[39;49m\u001b[38;5;124;43m : An assessment of vital status will be conducted on subjects who terminate IMP prior to the Phase A Month 12 visit and do not agree to additional safety follow-up but do not withdraw consent for continued telephone contact. See Section 3.7.4.8.}] || 7 D Post  Last Dose  (+2 D)\u001b[39;49m\u001b[38;5;124;43m\"\u001b[39;49m\n\u001b[1;32m    102\u001b[0m \u001b[38;5;124;43m\t\t\t]\u001b[39;49m\n\u001b[1;32m    103\u001b[0m \u001b[38;5;124;43m\t\t},\u001b[39;49m\n\u001b[1;32m    104\u001b[0m \u001b[38;5;124;43m\t\t\u001b[39;49m\u001b[38;5;124;43m{\u001b[39;49m\n\u001b[1;32m    105\u001b[0m \u001b[38;5;124;43m\t\t\t\u001b[39;49m\u001b[38;5;124;43m\"\u001b[39;49m\u001b[38;5;124;43mAssessments\u001b[39;49m\u001b[38;5;124;43m\"\u001b[39;49m\u001b[38;5;124;43m: \u001b[39;49m\u001b[38;5;124;43m\"\u001b[39;49m\u001b[38;5;124;43mSerum sodium [\u001b[39;49m\u001b[38;5;124;43m{\u001b[39;49m\u001b[38;5;124;43mSuperscript \u001b[39;49m\u001b[38;5;124;43m'\u001b[39;49m\u001b[38;5;124;43mk\u001b[39;49m\u001b[38;5;124;43m'\u001b[39;49m\u001b[38;5;124;43m : Central laboratory serum laboratory tests will be performed for all visits (only monthly safety labs may be collected at a local laboratory). Fasting is required at the screening visit. Fasting is recommended for all other visits, but is not required. Upon request, if clinically indicated and approved by the medical monitor, subjects may have the following evaluations in addition to the protocol-specified chemistry panel: serum calcium, phosphorus, parathyroid hormone, vitamin D, and bicarbonate levels.}] \u001b[39;49m\u001b[38;5;124;43m\"\u001b[39;49m\u001b[38;5;124;43m,\u001b[39;49m\n\u001b[1;32m    106\u001b[0m \u001b[38;5;124;43m\t\t\t\u001b[39;49m\u001b[38;5;124;43m\"\u001b[39;49m\u001b[38;5;124;43mSelected_X\u001b[39;49m\u001b[38;5;124;43m\"\u001b[39;49m\u001b[38;5;124;43m: [\u001b[39;49m\n\u001b[1;32m    107\u001b[0m \u001b[38;5;124;43m\t\t\t\t\u001b[39;49m\u001b[38;5;124;43m\"\u001b[39;49m\u001b[38;5;124;43mScreening  (-30 to -1)\u001b[39;49m\u001b[38;5;124;43m\"\u001b[39;49m\u001b[38;5;124;43m,\u001b[39;49m\n\u001b[1;32m    108\u001b[0m \u001b[38;5;124;43m\t\t\t\t\u001b[39;49m\u001b[38;5;124;43m\"\u001b[39;49m\u001b[38;5;124;43mBaseline (D 1)\u001b[39;49m\u001b[38;5;124;43m\"\u001b[39;49m\u001b[38;5;124;43m,\u001b[39;49m\n\u001b[1;32m    109\u001b[0m \u001b[38;5;124;43m\t\t\t\t\u001b[39;49m\u001b[38;5;124;43m\"\u001b[39;49m\u001b[38;5;124;43mWk 1  (-1/+3 D)\u001b[39;49m\u001b[38;5;124;43m\"\u001b[39;49m\u001b[38;5;124;43m,\u001b[39;49m\n\u001b[1;32m    110\u001b[0m \u001b[38;5;124;43m\t\t\t\t\u001b[39;49m\u001b[38;5;124;43m\"\u001b[39;49m\u001b[38;5;124;43mM1 (Wk  4) (7 D)\u001b[39;49m\u001b[38;5;124;43m\"\u001b[39;49m\u001b[38;5;124;43m,\u001b[39;49m\n\u001b[1;32m    111\u001b[0m \u001b[38;5;124;43m\t\t\t\t\u001b[39;49m\u001b[38;5;124;43m\"\u001b[39;49m\u001b[38;5;124;43mM6 (±14 D)\u001b[39;49m\u001b[38;5;124;43m\"\u001b[39;49m\u001b[38;5;124;43m,\u001b[39;49m\n\u001b[1;32m    112\u001b[0m \u001b[38;5;124;43m\t\t\t\t\u001b[39;49m\u001b[38;5;124;43m\"\u001b[39;49m\u001b[38;5;124;43mMonthly Safety  Visits:  M2, 3, 4,  5, 7, 8, 9,  10, 11  (±4D) [\u001b[39;49m\u001b[38;5;124;43m{\u001b[39;49m\u001b[38;5;124;43mSuperscript \u001b[39;49m\u001b[38;5;124;43m'\u001b[39;49m\u001b[38;5;124;43ma\u001b[39;49m\u001b[38;5;124;43m'\u001b[39;49m\u001b[38;5;124;43m : Monthly safety visits: If it is more convenient for the subject, laboratory tests may be collected at a local laboratory; a clinic visit is not required. The PI is required to review monthly safety labs and record them in the electronic case report form (eCRF). Protocol 156-12-298 Confidential - Proprietary Information 40 Amendment 1, 08 Aug 2016}]\u001b[39;49m\u001b[38;5;124;43m\"\u001b[39;49m\n\u001b[1;32m    113\u001b[0m \u001b[38;5;124;43m\t\t\t]\u001b[39;49m\n\u001b[1;32m    114\u001b[0m \u001b[38;5;124;43m\t\t},\u001b[39;49m\n\u001b[1;32m    115\u001b[0m \u001b[38;5;124;43m\t\t\u001b[39;49m\u001b[38;5;124;43m{\u001b[39;49m\n\u001b[1;32m    116\u001b[0m \u001b[38;5;124;43m\t\t\t\u001b[39;49m\u001b[38;5;124;43m\"\u001b[39;49m\u001b[38;5;124;43mAssessments\u001b[39;49m\u001b[38;5;124;43m\"\u001b[39;49m\u001b[38;5;124;43m: \u001b[39;49m\u001b[38;5;124;43m\"\u001b[39;49m\u001b[38;5;124;43mUrine osmolality [\u001b[39;49m\u001b[38;5;124;43m{\u001b[39;49m\u001b[38;5;124;43mSuperscript \u001b[39;49m\u001b[38;5;124;43m'\u001b[39;49m\u001b[38;5;124;43mn\u001b[39;49m\u001b[38;5;124;43m'\u001b[39;49m\u001b[38;5;124;43m : Spot urine sample collected predose on the morning of Day 1, prior to the morning dose on Week 1, and prior to the morning dose on Month 1. See Section 3.7.5.2 for sample collection details. Protocol 156-12-298 Confidential - Proprietary Information 41 Amendment 1, 08 Aug 2016}] \u001b[39;49m\u001b[38;5;124;43m\"\u001b[39;49m\u001b[38;5;124;43m,\u001b[39;49m\n\u001b[1;32m    117\u001b[0m \u001b[38;5;124;43m\t\t\t\u001b[39;49m\u001b[38;5;124;43m\"\u001b[39;49m\u001b[38;5;124;43mSelected_X\u001b[39;49m\u001b[38;5;124;43m\"\u001b[39;49m\u001b[38;5;124;43m: [\u001b[39;49m\n\u001b[1;32m    118\u001b[0m \u001b[38;5;124;43m\t\t\t\t\u001b[39;49m\u001b[38;5;124;43m\"\u001b[39;49m\u001b[38;5;124;43mBaseline (D 1)\u001b[39;49m\u001b[38;5;124;43m\"\u001b[39;49m\u001b[38;5;124;43m,\u001b[39;49m\n\u001b[1;32m    119\u001b[0m \u001b[38;5;124;43m\t\t\t\t\u001b[39;49m\u001b[38;5;124;43m\"\u001b[39;49m\u001b[38;5;124;43mWk 1  (-1/+3 D)\u001b[39;49m\u001b[38;5;124;43m\"\u001b[39;49m\u001b[38;5;124;43m,\u001b[39;49m\n\u001b[1;32m    120\u001b[0m \u001b[38;5;124;43m\t\t\t\t\u001b[39;49m\u001b[38;5;124;43m\"\u001b[39;49m\u001b[38;5;124;43mM1 (Wk  4) (7 D)\u001b[39;49m\u001b[38;5;124;43m\"\u001b[39;49m\n\u001b[1;32m    121\u001b[0m \u001b[38;5;124;43m\t\t\t]\u001b[39;49m\n\u001b[1;32m    122\u001b[0m \u001b[38;5;124;43m\t\t},\u001b[39;49m\n\u001b[1;32m    123\u001b[0m \u001b[38;5;124;43m\t\t\u001b[39;49m\u001b[38;5;124;43m{\u001b[39;49m\n\u001b[1;32m    124\u001b[0m \u001b[38;5;124;43m\t\t\t\u001b[39;49m\u001b[38;5;124;43m\"\u001b[39;49m\u001b[38;5;124;43mAssessments\u001b[39;49m\u001b[38;5;124;43m\"\u001b[39;49m\u001b[38;5;124;43m: \u001b[39;49m\u001b[38;5;124;43m\"\u001b[39;49m\u001b[38;5;124;43mUrine specific gravity\u001b[39;49m\u001b[38;5;124;43m\"\u001b[39;49m\u001b[38;5;124;43m,\u001b[39;49m\n\u001b[1;32m    125\u001b[0m \u001b[38;5;124;43m\t\t\t\u001b[39;49m\u001b[38;5;124;43m\"\u001b[39;49m\u001b[38;5;124;43mSelected_X\u001b[39;49m\u001b[38;5;124;43m\"\u001b[39;49m\u001b[38;5;124;43m: [\u001b[39;49m\n\u001b[1;32m    126\u001b[0m \u001b[38;5;124;43m\t\t\t\t\u001b[39;49m\u001b[38;5;124;43m\"\u001b[39;49m\u001b[38;5;124;43mBaseline (D 1)\u001b[39;49m\u001b[38;5;124;43m\"\u001b[39;49m\u001b[38;5;124;43m,\u001b[39;49m\n\u001b[1;32m    127\u001b[0m \u001b[38;5;124;43m\t\t\t\t\u001b[39;49m\u001b[38;5;124;43m\"\u001b[39;49m\u001b[38;5;124;43mWk 1  (-1/+3 D)\u001b[39;49m\u001b[38;5;124;43m\"\u001b[39;49m\u001b[38;5;124;43m,\u001b[39;49m\n\u001b[1;32m    128\u001b[0m \u001b[38;5;124;43m\t\t\t\t\u001b[39;49m\u001b[38;5;124;43m\"\u001b[39;49m\u001b[38;5;124;43mM1 (Wk  4) (7 D)\u001b[39;49m\u001b[38;5;124;43m\"\u001b[39;49m\n\u001b[1;32m    129\u001b[0m \u001b[38;5;124;43m\t\t\t]\u001b[39;49m\n\u001b[1;32m    130\u001b[0m \u001b[38;5;124;43m\t\t},\u001b[39;49m\n\u001b[1;32m    131\u001b[0m \u001b[38;5;124;43m\t\t\u001b[39;49m\u001b[38;5;124;43m{\u001b[39;49m\n\u001b[1;32m    132\u001b[0m \u001b[38;5;124;43m\t\t\t\u001b[39;49m\u001b[38;5;124;43m\"\u001b[39;49m\u001b[38;5;124;43mAssessments\u001b[39;49m\u001b[38;5;124;43m\"\u001b[39;49m\u001b[38;5;124;43m: \u001b[39;49m\u001b[38;5;124;43m\"\u001b[39;49m\u001b[38;5;124;43mUrine or serum pregnancy  test [\u001b[39;49m\u001b[38;5;124;43m{\u001b[39;49m\u001b[38;5;124;43mSuperscript \u001b[39;49m\u001b[38;5;124;43m'\u001b[39;49m\u001b[38;5;124;43mo\u001b[39;49m\u001b[38;5;124;43m'\u001b[39;49m\u001b[38;5;124;43m : A urine or serum pregnancy test for females of childbearing potential (all females ≥ 12 years of age and females < 12 years of age who have started menstruating) will be performed during the study. On suspicion of pregnancy, an unscheduled urine or serum pregnancy testing will be performed. Positive urine pregnancy tests must be confirmed with a serum pregnancy test. Investigator (or appropriate site staff) is advised to counsel participants on the risk of pregnancy while participating in a clinical trial as well as ensuring the child understands how pregnancies occur and can be avoided. This should be documented in source records.}] \u001b[39;49m\u001b[38;5;124;43m\"\u001b[39;49m\u001b[38;5;124;43m,\u001b[39;49m\n\u001b[1;32m    133\u001b[0m \u001b[38;5;124;43m\t\t\t\u001b[39;49m\u001b[38;5;124;43m\"\u001b[39;49m\u001b[38;5;124;43mSelected_X\u001b[39;49m\u001b[38;5;124;43m\"\u001b[39;49m\u001b[38;5;124;43m: [\u001b[39;49m\n\u001b[1;32m    134\u001b[0m \u001b[38;5;124;43m\t\t\t\t\u001b[39;49m\u001b[38;5;124;43m\"\u001b[39;49m\u001b[38;5;124;43mScreening  (-30 to -1)\u001b[39;49m\u001b[38;5;124;43m\"\u001b[39;49m\u001b[38;5;124;43m,\u001b[39;49m\n\u001b[1;32m    135\u001b[0m \u001b[38;5;124;43m\t\t\t\t\u001b[39;49m\u001b[38;5;124;43m\"\u001b[39;49m\u001b[38;5;124;43mBaseline (D 1)\u001b[39;49m\u001b[38;5;124;43m\"\u001b[39;49m\u001b[38;5;124;43m,\u001b[39;49m\n\u001b[1;32m    136\u001b[0m \u001b[38;5;124;43m\t\t\t\t\u001b[39;49m\u001b[38;5;124;43m\"\u001b[39;49m\u001b[38;5;124;43mM1 (Wk  4) (7 D)\u001b[39;49m\u001b[38;5;124;43m\"\u001b[39;49m\u001b[38;5;124;43m,\u001b[39;49m\n\u001b[1;32m    137\u001b[0m \u001b[38;5;124;43m\t\t\t\t\u001b[39;49m\u001b[38;5;124;43m\"\u001b[39;49m\u001b[38;5;124;43mM6 (±14 D)\u001b[39;49m\u001b[38;5;124;43m\"\u001b[39;49m\u001b[38;5;124;43m,\u001b[39;49m\n\u001b[1;32m    138\u001b[0m \u001b[38;5;124;43m\t\t\t\t\u001b[39;49m\u001b[38;5;124;43m\"\u001b[39;49m\u001b[38;5;124;43mMonthly Safety  Visits:  M2, 3, 4,  5, 7, 8, 9,  10, 11  (±4D) [\u001b[39;49m\u001b[38;5;124;43m{\u001b[39;49m\u001b[38;5;124;43mSuperscript \u001b[39;49m\u001b[38;5;124;43m'\u001b[39;49m\u001b[38;5;124;43ma\u001b[39;49m\u001b[38;5;124;43m'\u001b[39;49m\u001b[38;5;124;43m : Monthly safety visits: If it is more convenient for the subject, laboratory tests may be collected at a local laboratory; a clinic visit is not required. The PI is required to review monthly safety labs and record them in the electronic case report form (eCRF). Protocol 156-12-298 Confidential - Proprietary Information 40 Amendment 1, 08 Aug 2016}]\u001b[39;49m\u001b[38;5;124;43m\"\u001b[39;49m\u001b[38;5;124;43m,\u001b[39;49m\n\u001b[1;32m    139\u001b[0m \u001b[38;5;124;43m\t\t\t\t\u001b[39;49m\u001b[38;5;124;43m\"\u001b[39;49m\u001b[38;5;124;43mM12 [\u001b[39;49m\u001b[38;5;124;43m{\u001b[39;49m\u001b[38;5;124;43mSuperscript \u001b[39;49m\u001b[38;5;124;43m'\u001b[39;49m\u001b[38;5;124;43mb\u001b[39;49m\u001b[38;5;124;43m'\u001b[39;49m\u001b[38;5;124;43m : The Month 12 visit will serve as the Baseline visit for Phase B. The subject’s body weight at this visit will be used to determine the starting dose in Phase B.}] (D365)  (+14 D)/ End of  Treatment  (EoTx)c [\u001b[39;49m\u001b[38;5;124;43m{\u001b[39;49m\u001b[38;5;124;43mSuperscript \u001b[39;49m\u001b[38;5;124;43m'\u001b[39;49m\u001b[38;5;124;43m'\u001b[39;49m\u001b[38;5;124;43m : Unknown}, \u001b[39;49m\u001b[38;5;124;43m{\u001b[39;49m\u001b[38;5;124;43mSuperscript \u001b[39;49m\u001b[38;5;124;43m'\u001b[39;49m\u001b[38;5;124;43m'\u001b[39;49m\u001b[38;5;124;43m : Unknown}] d\u001b[39;49m\u001b[38;5;124;43m\"\u001b[39;49m\n\u001b[1;32m    140\u001b[0m \u001b[38;5;124;43m\t\t\t]\u001b[39;49m\n\u001b[1;32m    141\u001b[0m \u001b[38;5;124;43m\t\t},\u001b[39;49m\n\u001b[1;32m    142\u001b[0m \u001b[38;5;124;43m\t\t\u001b[39;49m\u001b[38;5;124;43m{\u001b[39;49m\n\u001b[1;32m    143\u001b[0m \u001b[38;5;124;43m\t\t\t\u001b[39;49m\u001b[38;5;124;43m\"\u001b[39;49m\u001b[38;5;124;43mAssessments\u001b[39;49m\u001b[38;5;124;43m\"\u001b[39;49m\u001b[38;5;124;43m: \u001b[39;49m\u001b[38;5;124;43m\"\u001b[39;49m\u001b[38;5;124;43mAlcohol & drug screen [\u001b[39;49m\u001b[38;5;124;43m{\u001b[39;49m\u001b[38;5;124;43mSuperscript \u001b[39;49m\u001b[38;5;124;43m'\u001b[39;49m\u001b[38;5;124;43mp\u001b[39;49m\u001b[38;5;124;43m'\u001b[39;49m\u001b[38;5;124;43m : Alcohol/drug screen is performed per clinical judgment and institutional guidelines.}] \u001b[39;49m\u001b[38;5;124;43m\"\u001b[39;49m\u001b[38;5;124;43m,\u001b[39;49m\n\u001b[1;32m    144\u001b[0m \u001b[38;5;124;43m\t\t\t\u001b[39;49m\u001b[38;5;124;43m\"\u001b[39;49m\u001b[38;5;124;43mSelected_X\u001b[39;49m\u001b[38;5;124;43m\"\u001b[39;49m\u001b[38;5;124;43m: [\u001b[39;49m\n\u001b[1;32m    145\u001b[0m \u001b[38;5;124;43m\t\t\t\t\u001b[39;49m\u001b[38;5;124;43m\"\u001b[39;49m\u001b[38;5;124;43mScreening  (-30 to -1)\u001b[39;49m\u001b[38;5;124;43m\"\u001b[39;49m\u001b[38;5;124;43m,\u001b[39;49m\n\u001b[1;32m    146\u001b[0m \u001b[38;5;124;43m\t\t\t\t\u001b[39;49m\u001b[38;5;124;43m\"\u001b[39;49m\u001b[38;5;124;43mBaseline (D 1)\u001b[39;49m\u001b[38;5;124;43m\"\u001b[39;49m\n\u001b[1;32m    147\u001b[0m \u001b[38;5;124;43m\t\t\t]\u001b[39;49m\n\u001b[1;32m    148\u001b[0m \u001b[38;5;124;43m\t\t},\u001b[39;49m\n\u001b[1;32m    149\u001b[0m \u001b[38;5;124;43m\t\t\u001b[39;49m\u001b[38;5;124;43m{\u001b[39;49m\n\u001b[1;32m    150\u001b[0m \u001b[38;5;124;43m\t\t\t\u001b[39;49m\u001b[38;5;124;43m\"\u001b[39;49m\u001b[38;5;124;43mAssessments\u001b[39;49m\u001b[38;5;124;43m\"\u001b[39;49m\u001b[38;5;124;43m: \u001b[39;49m\u001b[38;5;124;43m\"\u001b[39;49m\u001b[38;5;124;43mPhysical examination [\u001b[39;49m\u001b[38;5;124;43m{\u001b[39;49m\u001b[38;5;124;43mSuperscript \u001b[39;49m\u001b[38;5;124;43m'\u001b[39;49m\u001b[38;5;124;43mq\u001b[39;49m\u001b[38;5;124;43m'\u001b[39;49m\u001b[38;5;124;43m : A full physical examination is required at screening for the purposes of inclusion into the trial. At all other visits, as needed, a “directed” physical examination may be performed to focus on PKD-related signs and symptoms.}] \u001b[39;49m\u001b[38;5;124;43m\"\u001b[39;49m\u001b[38;5;124;43m,\u001b[39;49m\n\u001b[1;32m    151\u001b[0m \u001b[38;5;124;43m\t\t\t\u001b[39;49m\u001b[38;5;124;43m\"\u001b[39;49m\u001b[38;5;124;43mSelected_X\u001b[39;49m\u001b[38;5;124;43m\"\u001b[39;49m\u001b[38;5;124;43m: [\u001b[39;49m\n\u001b[1;32m    152\u001b[0m \u001b[38;5;124;43m\t\t\t\t\u001b[39;49m\u001b[38;5;124;43m\"\u001b[39;49m\u001b[38;5;124;43mScreening  (-30 to -1)\u001b[39;49m\u001b[38;5;124;43m\"\u001b[39;49m\u001b[38;5;124;43m,\u001b[39;49m\n\u001b[1;32m    153\u001b[0m \u001b[38;5;124;43m\t\t\t\t\u001b[39;49m\u001b[38;5;124;43m\"\u001b[39;49m\u001b[38;5;124;43mBaseline (D 1)\u001b[39;49m\u001b[38;5;124;43m\"\u001b[39;49m\u001b[38;5;124;43m,\u001b[39;49m\n\u001b[1;32m    154\u001b[0m \u001b[38;5;124;43m\t\t\t\t\u001b[39;49m\u001b[38;5;124;43m\"\u001b[39;49m\u001b[38;5;124;43mWk 1  (-1/+3 D)\u001b[39;49m\u001b[38;5;124;43m\"\u001b[39;49m\u001b[38;5;124;43m,\u001b[39;49m\n\u001b[1;32m    155\u001b[0m \u001b[38;5;124;43m\t\t\t\t\u001b[39;49m\u001b[38;5;124;43m\"\u001b[39;49m\u001b[38;5;124;43mM1 (Wk  4) (7 D)\u001b[39;49m\u001b[38;5;124;43m\"\u001b[39;49m\u001b[38;5;124;43m,\u001b[39;49m\n\u001b[1;32m    156\u001b[0m \u001b[38;5;124;43m\t\t\t\t\u001b[39;49m\u001b[38;5;124;43m\"\u001b[39;49m\u001b[38;5;124;43mM6 (±14 D)\u001b[39;49m\u001b[38;5;124;43m\"\u001b[39;49m\u001b[38;5;124;43m,\u001b[39;49m\n\u001b[1;32m    157\u001b[0m \u001b[38;5;124;43m\t\t\t\t\u001b[39;49m\u001b[38;5;124;43m\"\u001b[39;49m\u001b[38;5;124;43mM12 [\u001b[39;49m\u001b[38;5;124;43m{\u001b[39;49m\u001b[38;5;124;43mSuperscript \u001b[39;49m\u001b[38;5;124;43m'\u001b[39;49m\u001b[38;5;124;43mb\u001b[39;49m\u001b[38;5;124;43m'\u001b[39;49m\u001b[38;5;124;43m : The Month 12 visit will serve as the Baseline visit for Phase B. The subject’s body weight at this visit will be used to determine the starting dose in Phase B.}] (D365)  (+14 D)/ End of  Treatment  (EoTx)c [\u001b[39;49m\u001b[38;5;124;43m{\u001b[39;49m\u001b[38;5;124;43mSuperscript \u001b[39;49m\u001b[38;5;124;43m'\u001b[39;49m\u001b[38;5;124;43m'\u001b[39;49m\u001b[38;5;124;43m : Unknown}, \u001b[39;49m\u001b[38;5;124;43m{\u001b[39;49m\u001b[38;5;124;43mSuperscript \u001b[39;49m\u001b[38;5;124;43m'\u001b[39;49m\u001b[38;5;124;43m'\u001b[39;49m\u001b[38;5;124;43m : Unknown}] d\u001b[39;49m\u001b[38;5;124;43m\"\u001b[39;49m\n\u001b[1;32m    158\u001b[0m \u001b[38;5;124;43m\t\t\t]\u001b[39;49m\n\u001b[1;32m    159\u001b[0m \u001b[38;5;124;43m\t\t},\u001b[39;49m\n\u001b[1;32m    160\u001b[0m \u001b[38;5;124;43m\t\t\u001b[39;49m\u001b[38;5;124;43m{\u001b[39;49m\n\u001b[1;32m    161\u001b[0m \u001b[38;5;124;43m\t\t\t\u001b[39;49m\u001b[38;5;124;43m\"\u001b[39;49m\u001b[38;5;124;43mAssessments\u001b[39;49m\u001b[38;5;124;43m\"\u001b[39;49m\u001b[38;5;124;43m: \u001b[39;49m\u001b[38;5;124;43m\"\u001b[39;49m\u001b[38;5;124;43mRandomization\u001b[39;49m\u001b[38;5;124;43m\"\u001b[39;49m\u001b[38;5;124;43m,\u001b[39;49m\n\u001b[1;32m    162\u001b[0m \u001b[38;5;124;43m\t\t\t\u001b[39;49m\u001b[38;5;124;43m\"\u001b[39;49m\u001b[38;5;124;43mSelected_X\u001b[39;49m\u001b[38;5;124;43m\"\u001b[39;49m\u001b[38;5;124;43m: [\u001b[39;49m\n\u001b[1;32m    163\u001b[0m \u001b[38;5;124;43m\t\t\t\t\u001b[39;49m\u001b[38;5;124;43m\"\u001b[39;49m\u001b[38;5;124;43mBaseline (D 1)\u001b[39;49m\u001b[38;5;124;43m\"\u001b[39;49m\n\u001b[1;32m    164\u001b[0m \u001b[38;5;124;43m\t\t\t]\u001b[39;49m\n\u001b[1;32m    165\u001b[0m \u001b[38;5;124;43m\t\t},\u001b[39;49m\n\u001b[1;32m    166\u001b[0m \u001b[38;5;124;43m\t\t\u001b[39;49m\u001b[38;5;124;43m{\u001b[39;49m\n\u001b[1;32m    167\u001b[0m \u001b[38;5;124;43m\t\t\t\u001b[39;49m\u001b[38;5;124;43m\"\u001b[39;49m\u001b[38;5;124;43mAssessments\u001b[39;49m\u001b[38;5;124;43m\"\u001b[39;49m\u001b[38;5;124;43m: \u001b[39;49m\u001b[38;5;124;43m\"\u001b[39;49m\u001b[38;5;124;43mIMP administration [\u001b[39;49m\u001b[38;5;124;43m{\u001b[39;49m\u001b[38;5;124;43mSuperscript \u001b[39;49m\u001b[38;5;124;43m'\u001b[39;49m\u001b[38;5;124;43mr\u001b[39;49m\u001b[38;5;124;43m'\u001b[39;49m\u001b[38;5;124;43m : The first dose of IMP will be administered to the subject in the clinic. If the visit occurs in the afternoon, the first dose will be the PM dose of IMP. The last dose of Phase A will be taken the evening prior to the Month 12 visit.}] \u001b[39;49m\u001b[38;5;124;43m\"\u001b[39;49m\u001b[38;5;124;43m,\u001b[39;49m\n\u001b[1;32m    168\u001b[0m \u001b[38;5;124;43m\t\t\t\u001b[39;49m\u001b[38;5;124;43m\"\u001b[39;49m\u001b[38;5;124;43mSelected_X\u001b[39;49m\u001b[38;5;124;43m\"\u001b[39;49m\u001b[38;5;124;43m: [\u001b[39;49m\n\u001b[1;32m    169\u001b[0m \u001b[38;5;124;43m\t\t\t\t\u001b[39;49m\u001b[38;5;124;43m\"\u001b[39;49m\u001b[38;5;124;43mBaseline (D 1)\u001b[39;49m\u001b[38;5;124;43m\"\u001b[39;49m\u001b[38;5;124;43m,\u001b[39;49m\n\u001b[1;32m    170\u001b[0m \u001b[38;5;124;43m\t\t\t\t\u001b[39;49m\u001b[38;5;124;43m\"\u001b[39;49m\u001b[38;5;124;43mWk 1  (-1/+3 D)\u001b[39;49m\u001b[38;5;124;43m\"\u001b[39;49m\u001b[38;5;124;43m,\u001b[39;49m\n\u001b[1;32m    171\u001b[0m \u001b[38;5;124;43m\t\t\t\t\u001b[39;49m\u001b[38;5;124;43m\"\u001b[39;49m\u001b[38;5;124;43mM1 (Wk  4) (7 D)\u001b[39;49m\u001b[38;5;124;43m\"\u001b[39;49m\u001b[38;5;124;43m,\u001b[39;49m\n\u001b[1;32m    172\u001b[0m \u001b[38;5;124;43m\t\t\t\t\u001b[39;49m\u001b[38;5;124;43m\"\u001b[39;49m\u001b[38;5;124;43mM6 (±14 D)\u001b[39;49m\u001b[38;5;124;43m\"\u001b[39;49m\n\u001b[1;32m    173\u001b[0m \u001b[38;5;124;43m\t\t\t]\u001b[39;49m\n\u001b[1;32m    174\u001b[0m \u001b[38;5;124;43m\t\t},\u001b[39;49m\n\u001b[1;32m    175\u001b[0m \u001b[38;5;124;43m\t\t\u001b[39;49m\u001b[38;5;124;43m{\u001b[39;49m\n\u001b[1;32m    176\u001b[0m \u001b[38;5;124;43m\t\t\t\u001b[39;49m\u001b[38;5;124;43m\"\u001b[39;49m\u001b[38;5;124;43mAssessments\u001b[39;49m\u001b[38;5;124;43m\"\u001b[39;49m\u001b[38;5;124;43m: \u001b[39;49m\u001b[38;5;124;43m\"\u001b[39;49m\u001b[38;5;124;43mIMPdispensation [\u001b[39;49m\u001b[38;5;124;43m{\u001b[39;49m\u001b[38;5;124;43mSuperscript \u001b[39;49m\u001b[38;5;124;43m'\u001b[39;49m\u001b[38;5;124;43ms\u001b[39;49m\u001b[38;5;124;43m'\u001b[39;49m\u001b[38;5;124;43m : If during the titration contact the determination is made to adjust the dose regimen, dose adjustments will be made using dispensed supply if possible, and dose instructions will be provided by the investigator. The subject’s current dose will be recorded at each visit.}] \u001b[39;49m\u001b[38;5;124;43m\"\u001b[39;49m\u001b[38;5;124;43m,\u001b[39;49m\n\u001b[1;32m    177\u001b[0m \u001b[38;5;124;43m\t\t\t\u001b[39;49m\u001b[38;5;124;43m\"\u001b[39;49m\u001b[38;5;124;43mSelected_X\u001b[39;49m\u001b[38;5;124;43m\"\u001b[39;49m\u001b[38;5;124;43m: [\u001b[39;49m\n\u001b[1;32m    178\u001b[0m \u001b[38;5;124;43m\t\t\t\t\u001b[39;49m\u001b[38;5;124;43m\"\u001b[39;49m\u001b[38;5;124;43mBaseline (D 1)\u001b[39;49m\u001b[38;5;124;43m\"\u001b[39;49m\u001b[38;5;124;43m,\u001b[39;49m\n\u001b[1;32m    179\u001b[0m \u001b[38;5;124;43m\t\t\t\t\u001b[39;49m\u001b[38;5;124;43m\"\u001b[39;49m\u001b[38;5;124;43mWk 1  (-1/+3 D)\u001b[39;49m\u001b[38;5;124;43m\"\u001b[39;49m\u001b[38;5;124;43m,\u001b[39;49m\n\u001b[1;32m    180\u001b[0m \u001b[38;5;124;43m\t\t\t\t\u001b[39;49m\u001b[38;5;124;43m\"\u001b[39;49m\u001b[38;5;124;43mM1 (Wk  4) (7 D)\u001b[39;49m\u001b[38;5;124;43m\"\u001b[39;49m\u001b[38;5;124;43m,\u001b[39;49m\n\u001b[1;32m    181\u001b[0m \u001b[38;5;124;43m\t\t\t\t\u001b[39;49m\u001b[38;5;124;43m\"\u001b[39;49m\u001b[38;5;124;43mM6 (±14 D)\u001b[39;49m\u001b[38;5;124;43m\"\u001b[39;49m\u001b[38;5;124;43m,\u001b[39;49m\n\u001b[1;32m    182\u001b[0m \u001b[38;5;124;43m\t\t\t\t\u001b[39;49m\u001b[38;5;124;43m\"\u001b[39;49m\u001b[38;5;124;43mMonthly Safety  Visits:  M2, 3, 4,  5, 7, 8, 9,  10, 11  (±4D) [\u001b[39;49m\u001b[38;5;124;43m{\u001b[39;49m\u001b[38;5;124;43mSuperscript \u001b[39;49m\u001b[38;5;124;43m'\u001b[39;49m\u001b[38;5;124;43ma\u001b[39;49m\u001b[38;5;124;43m'\u001b[39;49m\u001b[38;5;124;43m : Monthly safety visits: If it is more convenient for the subject, laboratory tests may be collected at a local laboratory; a clinic visit is not required. The PI is required to review monthly safety labs and record them in the electronic case report form (eCRF). Protocol 156-12-298 Confidential - Proprietary Information 40 Amendment 1, 08 Aug 2016}]\u001b[39;49m\u001b[38;5;124;43m\"\u001b[39;49m\u001b[38;5;124;43m,\u001b[39;49m\n\u001b[1;32m    183\u001b[0m \u001b[38;5;124;43m\t\t\t\t\u001b[39;49m\u001b[38;5;124;43m\"\u001b[39;49m\u001b[38;5;124;43mTitration  Contact  (phone  call or  visit)\u001b[39;49m\u001b[38;5;124;43m\"\u001b[39;49m\n\u001b[1;32m    184\u001b[0m \u001b[38;5;124;43m\t\t\t]\u001b[39;49m\n\u001b[1;32m    185\u001b[0m \u001b[38;5;124;43m\t\t},\u001b[39;49m\n\u001b[1;32m    186\u001b[0m \u001b[38;5;124;43m\t\t\u001b[39;49m\u001b[38;5;124;43m{\u001b[39;49m\n\u001b[1;32m    187\u001b[0m \u001b[38;5;124;43m\t\t\t\u001b[39;49m\u001b[38;5;124;43m\"\u001b[39;49m\u001b[38;5;124;43mAssessments\u001b[39;49m\u001b[38;5;124;43m\"\u001b[39;49m\u001b[38;5;124;43m: \u001b[39;49m\u001b[38;5;124;43m\"\u001b[39;49m\u001b[38;5;124;43mIMPreconciliation [\u001b[39;49m\u001b[38;5;124;43m{\u001b[39;49m\u001b[38;5;124;43mSuperscript \u001b[39;49m\u001b[38;5;124;43m'\u001b[39;49m\u001b[38;5;124;43mt\u001b[39;49m\u001b[38;5;124;43m'\u001b[39;49m\u001b[38;5;124;43m : Drug reconciliation will be conducted at every visit. If additional drug supply is required for titration purposes, the site will arrange a subject visit for dispensation.}] \u001b[39;49m\u001b[38;5;124;43m\"\u001b[39;49m\u001b[38;5;124;43m,\u001b[39;49m\n\u001b[1;32m    188\u001b[0m \u001b[38;5;124;43m\t\t\t\u001b[39;49m\u001b[38;5;124;43m\"\u001b[39;49m\u001b[38;5;124;43mSelected_X\u001b[39;49m\u001b[38;5;124;43m\"\u001b[39;49m\u001b[38;5;124;43m: [\u001b[39;49m\n\u001b[1;32m    189\u001b[0m \u001b[38;5;124;43m\t\t\t\t\u001b[39;49m\u001b[38;5;124;43m\"\u001b[39;49m\u001b[38;5;124;43mWk 1  (-1/+3 D)\u001b[39;49m\u001b[38;5;124;43m\"\u001b[39;49m\u001b[38;5;124;43m,\u001b[39;49m\n\u001b[1;32m    190\u001b[0m \u001b[38;5;124;43m\t\t\t\t\u001b[39;49m\u001b[38;5;124;43m\"\u001b[39;49m\u001b[38;5;124;43mM1 (Wk  4) (7 D)\u001b[39;49m\u001b[38;5;124;43m\"\u001b[39;49m\u001b[38;5;124;43m,\u001b[39;49m\n\u001b[1;32m    191\u001b[0m \u001b[38;5;124;43m\t\t\t\t\u001b[39;49m\u001b[38;5;124;43m\"\u001b[39;49m\u001b[38;5;124;43mM6 (±14 D)\u001b[39;49m\u001b[38;5;124;43m\"\u001b[39;49m\u001b[38;5;124;43m,\u001b[39;49m\n\u001b[1;32m    192\u001b[0m \u001b[38;5;124;43m\t\t\t\t\u001b[39;49m\u001b[38;5;124;43m\"\u001b[39;49m\u001b[38;5;124;43mMonthly Safety  Visits:  M2, 3, 4,  5, 7, 8, 9,  10, 11  (±4D) [\u001b[39;49m\u001b[38;5;124;43m{\u001b[39;49m\u001b[38;5;124;43mSuperscript \u001b[39;49m\u001b[38;5;124;43m'\u001b[39;49m\u001b[38;5;124;43ma\u001b[39;49m\u001b[38;5;124;43m'\u001b[39;49m\u001b[38;5;124;43m : Monthly safety visits: If it is more convenient for the subject, laboratory tests may be collected at a local laboratory; a clinic visit is not required. The PI is required to review monthly safety labs and record them in the electronic case report form (eCRF). Protocol 156-12-298 Confidential - Proprietary Information 40 Amendment 1, 08 Aug 2016}]\u001b[39;49m\u001b[38;5;124;43m\"\u001b[39;49m\u001b[38;5;124;43m,\u001b[39;49m\n\u001b[1;32m    193\u001b[0m \u001b[38;5;124;43m\t\t\t\t\u001b[39;49m\u001b[38;5;124;43m\"\u001b[39;49m\u001b[38;5;124;43mM12 [\u001b[39;49m\u001b[38;5;124;43m{\u001b[39;49m\u001b[38;5;124;43mSuperscript \u001b[39;49m\u001b[38;5;124;43m'\u001b[39;49m\u001b[38;5;124;43mb\u001b[39;49m\u001b[38;5;124;43m'\u001b[39;49m\u001b[38;5;124;43m : The Month 12 visit will serve as the Baseline visit for Phase B. The subject’s body weight at this visit will be used to determine the starting dose in Phase B.}] (D365)  (+14 D)/ End of  Treatment  (EoTx)c [\u001b[39;49m\u001b[38;5;124;43m{\u001b[39;49m\u001b[38;5;124;43mSuperscript \u001b[39;49m\u001b[38;5;124;43m'\u001b[39;49m\u001b[38;5;124;43m'\u001b[39;49m\u001b[38;5;124;43m : Unknown}, \u001b[39;49m\u001b[38;5;124;43m{\u001b[39;49m\u001b[38;5;124;43mSuperscript \u001b[39;49m\u001b[38;5;124;43m'\u001b[39;49m\u001b[38;5;124;43m'\u001b[39;49m\u001b[38;5;124;43m : Unknown}] d\u001b[39;49m\u001b[38;5;124;43m\"\u001b[39;49m\n\u001b[1;32m    194\u001b[0m \u001b[38;5;124;43m\t\t\t]\u001b[39;49m\n\u001b[1;32m    195\u001b[0m \u001b[38;5;124;43m\t\t},\u001b[39;49m\n\u001b[1;32m    196\u001b[0m \u001b[38;5;124;43m\t\t\u001b[39;49m\u001b[38;5;124;43m{\u001b[39;49m\n\u001b[1;32m    197\u001b[0m \u001b[38;5;124;43m\t\t\t\u001b[39;49m\u001b[38;5;124;43m\"\u001b[39;49m\u001b[38;5;124;43mAssessments\u001b[39;49m\u001b[38;5;124;43m\"\u001b[39;49m\u001b[38;5;124;43m: \u001b[39;49m\u001b[38;5;124;43m\"\u001b[39;49m\u001b[38;5;124;43mPalatability and  acceptability\u001b[39;49m\u001b[38;5;124;43m\"\u001b[39;49m\u001b[38;5;124;43m,\u001b[39;49m\n\u001b[1;32m    198\u001b[0m \u001b[38;5;124;43m\t\t\t\u001b[39;49m\u001b[38;5;124;43m\"\u001b[39;49m\u001b[38;5;124;43mSelected_X\u001b[39;49m\u001b[38;5;124;43m\"\u001b[39;49m\u001b[38;5;124;43m: [\u001b[39;49m\n\u001b[1;32m    199\u001b[0m \u001b[38;5;124;43m\t\t\t\t\u001b[39;49m\u001b[38;5;124;43m\"\u001b[39;49m\u001b[38;5;124;43mBaseline (D 1)\u001b[39;49m\u001b[38;5;124;43m\"\u001b[39;49m\n\u001b[1;32m    200\u001b[0m \u001b[38;5;124;43m\t\t\t]\u001b[39;49m\n\u001b[1;32m    201\u001b[0m \u001b[38;5;124;43m\t\t},\u001b[39;49m\n\u001b[1;32m    202\u001b[0m \u001b[38;5;124;43m\t\t\u001b[39;49m\u001b[38;5;124;43m{\u001b[39;49m\n\u001b[1;32m    203\u001b[0m \u001b[38;5;124;43m\t\t\t\u001b[39;49m\u001b[38;5;124;43m\"\u001b[39;49m\u001b[38;5;124;43mAssessments\u001b[39;49m\u001b[38;5;124;43m\"\u001b[39;49m\u001b[38;5;124;43m: \u001b[39;49m\u001b[38;5;124;43m\"\u001b[39;49m\u001b[38;5;124;43mQoL questionnaires [\u001b[39;49m\u001b[38;5;124;43m{\u001b[39;49m\u001b[38;5;124;43mSuperscript \u001b[39;49m\u001b[38;5;124;43m'\u001b[39;49m\u001b[38;5;124;43mu\u001b[39;49m\u001b[38;5;124;43m'\u001b[39;49m\u001b[38;5;124;43m : Generic pediatric QoL questionnaires, as available will be assessed in subjects 12 years and older at baseline (pre-dose), Week 1, Months 1, 3, 6, and 12/EoTx prior to any blood draws. The Month 12 assessment should be completed prior to administration of Phase B IMP.}] \u001b[39;49m\u001b[38;5;124;43m\"\u001b[39;49m\u001b[38;5;124;43m,\u001b[39;49m\n\u001b[1;32m    204\u001b[0m \u001b[38;5;124;43m\t\t\t\u001b[39;49m\u001b[38;5;124;43m\"\u001b[39;49m\u001b[38;5;124;43mSelected_X\u001b[39;49m\u001b[38;5;124;43m\"\u001b[39;49m\u001b[38;5;124;43m: [\u001b[39;49m\n\u001b[1;32m    205\u001b[0m \u001b[38;5;124;43m\t\t\t\t\u001b[39;49m\u001b[38;5;124;43m\"\u001b[39;49m\u001b[38;5;124;43mScreening  (-30 to -1)\u001b[39;49m\u001b[38;5;124;43m\"\u001b[39;49m\u001b[38;5;124;43m,\u001b[39;49m\n\u001b[1;32m    206\u001b[0m \u001b[38;5;124;43m\t\t\t\t\u001b[39;49m\u001b[38;5;124;43m\"\u001b[39;49m\u001b[38;5;124;43mWk 1  (-1/+3 D)\u001b[39;49m\u001b[38;5;124;43m\"\u001b[39;49m\u001b[38;5;124;43m,\u001b[39;49m\n\u001b[1;32m    207\u001b[0m \u001b[38;5;124;43m\t\t\t\t\u001b[39;49m\u001b[38;5;124;43m\"\u001b[39;49m\u001b[38;5;124;43mM1 (Wk  4) (7 D)\u001b[39;49m\u001b[38;5;124;43m\"\u001b[39;49m\u001b[38;5;124;43m,\u001b[39;49m\n\u001b[1;32m    208\u001b[0m \u001b[38;5;124;43m\t\t\t\t\u001b[39;49m\u001b[38;5;124;43m\"\u001b[39;49m\u001b[38;5;124;43mM6 (±14 D)\u001b[39;49m\u001b[38;5;124;43m\"\u001b[39;49m\u001b[38;5;124;43m,\u001b[39;49m\n\u001b[1;32m    209\u001b[0m \u001b[38;5;124;43m\t\t\t\t\u001b[39;49m\u001b[38;5;124;43m\"\u001b[39;49m\u001b[38;5;124;43mMonthly Safety  Visits:  M2, 3, 4,  5, 7, 8, 9,  10, 11  (±4D) [\u001b[39;49m\u001b[38;5;124;43m{\u001b[39;49m\u001b[38;5;124;43mSuperscript \u001b[39;49m\u001b[38;5;124;43m'\u001b[39;49m\u001b[38;5;124;43ma\u001b[39;49m\u001b[38;5;124;43m'\u001b[39;49m\u001b[38;5;124;43m : Monthly safety visits: If it is more convenient for the subject, laboratory tests may be collected at a local laboratory; a clinic visit is not required. The PI is required to review monthly safety labs and record them in the electronic case report form (eCRF). Protocol 156-12-298 Confidential - Proprietary Information 40 Amendment 1, 08 Aug 2016}]\u001b[39;49m\u001b[38;5;124;43m\"\u001b[39;49m\u001b[38;5;124;43m,\u001b[39;49m\n\u001b[1;32m    210\u001b[0m \u001b[38;5;124;43m\t\t\t\t\u001b[39;49m\u001b[38;5;124;43m\"\u001b[39;49m\u001b[38;5;124;43mM12 [\u001b[39;49m\u001b[38;5;124;43m{\u001b[39;49m\u001b[38;5;124;43mSuperscript \u001b[39;49m\u001b[38;5;124;43m'\u001b[39;49m\u001b[38;5;124;43mb\u001b[39;49m\u001b[38;5;124;43m'\u001b[39;49m\u001b[38;5;124;43m : The Month 12 visit will serve as the Baseline visit for Phase B. The subject’s body weight at this visit will be used to determine the starting dose in Phase B.}] (D365)  (+14 D)/ End of  Treatment  (EoTx)c [\u001b[39;49m\u001b[38;5;124;43m{\u001b[39;49m\u001b[38;5;124;43mSuperscript \u001b[39;49m\u001b[38;5;124;43m'\u001b[39;49m\u001b[38;5;124;43m'\u001b[39;49m\u001b[38;5;124;43m : Unknown}, \u001b[39;49m\u001b[38;5;124;43m{\u001b[39;49m\u001b[38;5;124;43mSuperscript \u001b[39;49m\u001b[38;5;124;43m'\u001b[39;49m\u001b[38;5;124;43m'\u001b[39;49m\u001b[38;5;124;43m : Unknown}] d\u001b[39;49m\u001b[38;5;124;43m\"\u001b[39;49m\n\u001b[1;32m    211\u001b[0m \u001b[38;5;124;43m\t\t\t]\u001b[39;49m\n\u001b[1;32m    212\u001b[0m \u001b[38;5;124;43m\t\t},\u001b[39;49m\n\u001b[1;32m    213\u001b[0m \u001b[38;5;124;43m\t\t\u001b[39;49m\u001b[38;5;124;43m{\u001b[39;49m\n\u001b[1;32m    214\u001b[0m \u001b[38;5;124;43m\t\t\t\u001b[39;49m\u001b[38;5;124;43m\"\u001b[39;49m\u001b[38;5;124;43mAssessments\u001b[39;49m\u001b[38;5;124;43m\"\u001b[39;49m\u001b[38;5;124;43m: \u001b[39;49m\u001b[38;5;124;43m\"\u001b[39;49m\u001b[38;5;124;43mADPKD outcomes\u001b[39;49m\u001b[38;5;124;43m\"\u001b[39;49m\u001b[38;5;124;43m,\u001b[39;49m\n\u001b[1;32m    215\u001b[0m \u001b[38;5;124;43m\t\t\t\u001b[39;49m\u001b[38;5;124;43m\"\u001b[39;49m\u001b[38;5;124;43mSelected_X\u001b[39;49m\u001b[38;5;124;43m\"\u001b[39;49m\u001b[38;5;124;43m: [\u001b[39;49m\n\u001b[1;32m    216\u001b[0m \u001b[38;5;124;43m\t\t\t\t\u001b[39;49m\u001b[38;5;124;43m\"\u001b[39;49m\u001b[38;5;124;43mBaseline (D 1)\u001b[39;49m\u001b[38;5;124;43m\"\u001b[39;49m\u001b[38;5;124;43m,\u001b[39;49m\n\u001b[1;32m    217\u001b[0m \u001b[38;5;124;43m\t\t\t\t\u001b[39;49m\u001b[38;5;124;43m\"\u001b[39;49m\u001b[38;5;124;43mWk 1  (-1/+3 D)\u001b[39;49m\u001b[38;5;124;43m\"\u001b[39;49m\u001b[38;5;124;43m,\u001b[39;49m\n\u001b[1;32m    218\u001b[0m \u001b[38;5;124;43m\t\t\t\t\u001b[39;49m\u001b[38;5;124;43m\"\u001b[39;49m\u001b[38;5;124;43mM1 (Wk  4) (7 D)\u001b[39;49m\u001b[38;5;124;43m\"\u001b[39;49m\u001b[38;5;124;43m,\u001b[39;49m\n\u001b[1;32m    219\u001b[0m \u001b[38;5;124;43m\t\t\t\t\u001b[39;49m\u001b[38;5;124;43m\"\u001b[39;49m\u001b[38;5;124;43mM6 (±14 D)\u001b[39;49m\u001b[38;5;124;43m\"\u001b[39;49m\u001b[38;5;124;43m,\u001b[39;49m\n\u001b[1;32m    220\u001b[0m \u001b[38;5;124;43m\t\t\t\t\u001b[39;49m\u001b[38;5;124;43m\"\u001b[39;49m\u001b[38;5;124;43mM12 [\u001b[39;49m\u001b[38;5;124;43m{\u001b[39;49m\u001b[38;5;124;43mSuperscript \u001b[39;49m\u001b[38;5;124;43m'\u001b[39;49m\u001b[38;5;124;43mb\u001b[39;49m\u001b[38;5;124;43m'\u001b[39;49m\u001b[38;5;124;43m : The Month 12 visit will serve as the Baseline visit for Phase B. The subject’s body weight at this visit will be used to determine the starting dose in Phase B.}] (D365)  (+14 D)/ End of  Treatment  (EoTx)c [\u001b[39;49m\u001b[38;5;124;43m{\u001b[39;49m\u001b[38;5;124;43mSuperscript \u001b[39;49m\u001b[38;5;124;43m'\u001b[39;49m\u001b[38;5;124;43m'\u001b[39;49m\u001b[38;5;124;43m : Unknown}, \u001b[39;49m\u001b[38;5;124;43m{\u001b[39;49m\u001b[38;5;124;43mSuperscript \u001b[39;49m\u001b[38;5;124;43m'\u001b[39;49m\u001b[38;5;124;43m'\u001b[39;49m\u001b[38;5;124;43m : Unknown}] d\u001b[39;49m\u001b[38;5;124;43m\"\u001b[39;49m\n\u001b[1;32m    221\u001b[0m \u001b[38;5;124;43m\t\t\t]\u001b[39;49m\n\u001b[1;32m    222\u001b[0m \u001b[38;5;124;43m\t\t},\u001b[39;49m\n\u001b[1;32m    223\u001b[0m \u001b[38;5;124;43m\t\t\u001b[39;49m\u001b[38;5;124;43m{\u001b[39;49m\n\u001b[1;32m    224\u001b[0m \u001b[38;5;124;43m\t\t\t\u001b[39;49m\u001b[38;5;124;43m\"\u001b[39;49m\u001b[38;5;124;43mAssessments\u001b[39;49m\u001b[38;5;124;43m\"\u001b[39;49m\u001b[38;5;124;43m: \u001b[39;49m\u001b[38;5;124;43m\"\u001b[39;49m\u001b[38;5;124;43mDaytime and nighttime  void collection [\u001b[39;49m\u001b[38;5;124;43m{\u001b[39;49m\u001b[38;5;124;43mSuperscript \u001b[39;49m\u001b[38;5;124;43m'\u001b[39;49m\u001b[38;5;124;43mv\u001b[39;49m\u001b[38;5;124;43m'\u001b[39;49m\u001b[38;5;124;43m : The number of daytime and nightime voids for all subjects 12 years and older will be collected during Phase A. Refer also to Section 3.7.6.1. Daytime and nighttime voids are not required for the EoTx visit and subsequent follow-up visits.}] \u001b[39;49m\u001b[38;5;124;43m\"\u001b[39;49m\u001b[38;5;124;43m,\u001b[39;49m\n\u001b[1;32m    225\u001b[0m \u001b[38;5;124;43m\t\t\t\u001b[39;49m\u001b[38;5;124;43m\"\u001b[39;49m\u001b[38;5;124;43mSelected_X\u001b[39;49m\u001b[38;5;124;43m\"\u001b[39;49m\u001b[38;5;124;43m: [\u001b[39;49m\n\u001b[1;32m    226\u001b[0m \u001b[38;5;124;43m\t\t\t\t\u001b[39;49m\u001b[38;5;124;43m\"\u001b[39;49m\u001b[38;5;124;43mBaseline (D 1)\u001b[39;49m\u001b[38;5;124;43m\"\u001b[39;49m\u001b[38;5;124;43m,\u001b[39;49m\n\u001b[1;32m    227\u001b[0m \u001b[38;5;124;43m\t\t\t\t\u001b[39;49m\u001b[38;5;124;43m\"\u001b[39;49m\u001b[38;5;124;43mWk 1  (-1/+3 D)\u001b[39;49m\u001b[38;5;124;43m\"\u001b[39;49m\u001b[38;5;124;43m,\u001b[39;49m\n\u001b[1;32m    228\u001b[0m \u001b[38;5;124;43m\t\t\t\t\u001b[39;49m\u001b[38;5;124;43m\"\u001b[39;49m\u001b[38;5;124;43mM1 (Wk  4) (7 D)\u001b[39;49m\u001b[38;5;124;43m\"\u001b[39;49m\u001b[38;5;124;43m,\u001b[39;49m\n\u001b[1;32m    229\u001b[0m \u001b[38;5;124;43m\t\t\t\t\u001b[39;49m\u001b[38;5;124;43m\"\u001b[39;49m\u001b[38;5;124;43mM6 (±14 D)\u001b[39;49m\u001b[38;5;124;43m\"\u001b[39;49m\u001b[38;5;124;43m,\u001b[39;49m\n\u001b[1;32m    230\u001b[0m \u001b[38;5;124;43m\t\t\t\t\u001b[39;49m\u001b[38;5;124;43m\"\u001b[39;49m\u001b[38;5;124;43mM12 [\u001b[39;49m\u001b[38;5;124;43m{\u001b[39;49m\u001b[38;5;124;43mSuperscript \u001b[39;49m\u001b[38;5;124;43m'\u001b[39;49m\u001b[38;5;124;43mb\u001b[39;49m\u001b[38;5;124;43m'\u001b[39;49m\u001b[38;5;124;43m : The Month 12 visit will serve as the Baseline visit for Phase B. The subject’s body weight at this visit will be used to determine the starting dose in Phase B.}] (D365)  (+14 D)/ End of  Treatment  (EoTx)c [\u001b[39;49m\u001b[38;5;124;43m{\u001b[39;49m\u001b[38;5;124;43mSuperscript \u001b[39;49m\u001b[38;5;124;43m'\u001b[39;49m\u001b[38;5;124;43m'\u001b[39;49m\u001b[38;5;124;43m : Unknown}, \u001b[39;49m\u001b[38;5;124;43m{\u001b[39;49m\u001b[38;5;124;43mSuperscript \u001b[39;49m\u001b[38;5;124;43m'\u001b[39;49m\u001b[38;5;124;43m'\u001b[39;49m\u001b[38;5;124;43m : Unknown}] d\u001b[39;49m\u001b[38;5;124;43m\"\u001b[39;49m\n\u001b[1;32m    231\u001b[0m \u001b[38;5;124;43m\t\t\t]\u001b[39;49m\n\u001b[1;32m    232\u001b[0m \u001b[38;5;124;43m\t\t},\u001b[39;49m\n\u001b[1;32m    233\u001b[0m \u001b[38;5;124;43m\t\t\u001b[39;49m\u001b[38;5;124;43m{\u001b[39;49m\n\u001b[1;32m    234\u001b[0m \u001b[38;5;124;43m\t\t\t\u001b[39;49m\u001b[38;5;124;43m\"\u001b[39;49m\u001b[38;5;124;43mAssessments\u001b[39;49m\u001b[38;5;124;43m\"\u001b[39;49m\u001b[38;5;124;43m: \u001b[39;49m\u001b[38;5;124;43m\"\u001b[39;49m\u001b[38;5;124;43mPK & PD sample  collection [\u001b[39;49m\u001b[38;5;124;43m{\u001b[39;49m\u001b[38;5;124;43mSuperscript \u001b[39;49m\u001b[38;5;124;43m'\u001b[39;49m\u001b[38;5;124;43mw\u001b[39;49m\u001b[38;5;124;43m'\u001b[39;49m\u001b[38;5;124;43m : Dense PK and PD sampling will occur in a subset of subjects (see Section 3.7.5.1) after at least 1 month of dosing. These subjects will be hospitalized the evening prior to the scheduled PK sampling (typically a Friday evening) and discharged after the 24 hour PK sample collection (typically Sunday morning). Sparse PK sampling will occur in all subjects at the Week 1, Month 1, Month 6, and Month 12 visits.}] \u001b[39;49m\u001b[38;5;124;43m\"\u001b[39;49m\u001b[38;5;124;43m,\u001b[39;49m\n\u001b[1;32m    235\u001b[0m \u001b[38;5;124;43m\t\t\t\u001b[39;49m\u001b[38;5;124;43m\"\u001b[39;49m\u001b[38;5;124;43mSelected_X\u001b[39;49m\u001b[38;5;124;43m\"\u001b[39;49m\u001b[38;5;124;43m: [\u001b[39;49m\n\u001b[1;32m    236\u001b[0m \u001b[38;5;124;43m\t\t\t\t\u001b[39;49m\u001b[38;5;124;43m\"\u001b[39;49m\u001b[38;5;124;43mWk 1  (-1/+3 D)\u001b[39;49m\u001b[38;5;124;43m\"\u001b[39;49m\u001b[38;5;124;43m,\u001b[39;49m\n\u001b[1;32m    237\u001b[0m \u001b[38;5;124;43m\t\t\t\t\u001b[39;49m\u001b[38;5;124;43m\"\u001b[39;49m\u001b[38;5;124;43mM1 (Wk  4) (7 D)\u001b[39;49m\u001b[38;5;124;43m\"\u001b[39;49m\u001b[38;5;124;43m,\u001b[39;49m\n\u001b[1;32m    238\u001b[0m \u001b[38;5;124;43m\t\t\t\t\u001b[39;49m\u001b[38;5;124;43m\"\u001b[39;49m\u001b[38;5;124;43mM6 (±14 D)\u001b[39;49m\u001b[38;5;124;43m\"\u001b[39;49m\u001b[38;5;124;43m,\u001b[39;49m\n\u001b[1;32m    239\u001b[0m \u001b[38;5;124;43m\t\t\t\t\u001b[39;49m\u001b[38;5;124;43m\"\u001b[39;49m\u001b[38;5;124;43mM12 [\u001b[39;49m\u001b[38;5;124;43m{\u001b[39;49m\u001b[38;5;124;43mSuperscript \u001b[39;49m\u001b[38;5;124;43m'\u001b[39;49m\u001b[38;5;124;43mb\u001b[39;49m\u001b[38;5;124;43m'\u001b[39;49m\u001b[38;5;124;43m : The Month 12 visit will serve as the Baseline visit for Phase B. The subject’s body weight at this visit will be used to determine the starting dose in Phase B.}] (D365)  (+14 D)/ End of  Treatment  (EoTx)c [\u001b[39;49m\u001b[38;5;124;43m{\u001b[39;49m\u001b[38;5;124;43mSuperscript \u001b[39;49m\u001b[38;5;124;43m'\u001b[39;49m\u001b[38;5;124;43m'\u001b[39;49m\u001b[38;5;124;43m : Unknown}, \u001b[39;49m\u001b[38;5;124;43m{\u001b[39;49m\u001b[38;5;124;43mSuperscript \u001b[39;49m\u001b[38;5;124;43m'\u001b[39;49m\u001b[38;5;124;43m'\u001b[39;49m\u001b[38;5;124;43m : Unknown}] d\u001b[39;49m\u001b[38;5;124;43m\"\u001b[39;49m\n\u001b[1;32m    240\u001b[0m \u001b[38;5;124;43m\t\t\t]\u001b[39;49m\n\u001b[1;32m    241\u001b[0m \u001b[38;5;124;43m\t\t},\u001b[39;49m\n\u001b[1;32m    242\u001b[0m \u001b[38;5;124;43m\t\t\u001b[39;49m\u001b[38;5;124;43m{\u001b[39;49m\n\u001b[1;32m    243\u001b[0m \u001b[38;5;124;43m\t\t\t\u001b[39;49m\u001b[38;5;124;43m\"\u001b[39;49m\u001b[38;5;124;43mAssessments\u001b[39;49m\u001b[38;5;124;43m\"\u001b[39;49m\u001b[38;5;124;43m: \u001b[39;49m\u001b[38;5;124;43m\"\u001b[39;49m\u001b[38;5;124;43m24-hour fluid balance\u001b[39;49m\u001b[38;5;124;43m\"\u001b[39;49m\u001b[38;5;124;43m,\u001b[39;49m\n\u001b[1;32m    244\u001b[0m \u001b[38;5;124;43m\t\t\t\u001b[39;49m\u001b[38;5;124;43m\"\u001b[39;49m\u001b[38;5;124;43mSelected_X\u001b[39;49m\u001b[38;5;124;43m\"\u001b[39;49m\u001b[38;5;124;43m: [\u001b[39;49m\n\u001b[1;32m    245\u001b[0m \u001b[38;5;124;43m\t\t\t\t\u001b[39;49m\u001b[38;5;124;43m\"\u001b[39;49m\u001b[38;5;124;43mWk 1  (-1/+3 D)\u001b[39;49m\u001b[38;5;124;43m\"\u001b[39;49m\n\u001b[1;32m    246\u001b[0m \u001b[38;5;124;43m\t\t\t]\u001b[39;49m\n\u001b[1;32m    247\u001b[0m \u001b[38;5;124;43m\t\t},\u001b[39;49m\n\u001b[1;32m    248\u001b[0m \u001b[38;5;124;43m\t\t\u001b[39;49m\u001b[38;5;124;43m{\u001b[39;49m\n\u001b[1;32m    249\u001b[0m \u001b[38;5;124;43m\t\t\t\u001b[39;49m\u001b[38;5;124;43m\"\u001b[39;49m\u001b[38;5;124;43mAssessments\u001b[39;49m\u001b[38;5;124;43m\"\u001b[39;49m\u001b[38;5;124;43m: \u001b[39;49m\u001b[38;5;124;43m\"\u001b[39;49m\u001b[38;5;124;43mConcomitant medications\u001b[39;49m\u001b[38;5;124;43m\"\u001b[39;49m\u001b[38;5;124;43m,\u001b[39;49m\n\u001b[1;32m    250\u001b[0m \u001b[38;5;124;43m\t\t\t\u001b[39;49m\u001b[38;5;124;43m\"\u001b[39;49m\u001b[38;5;124;43mSelected_X\u001b[39;49m\u001b[38;5;124;43m\"\u001b[39;49m\u001b[38;5;124;43m: [\u001b[39;49m\n\u001b[1;32m    251\u001b[0m \u001b[38;5;124;43m\t\t\t\t\u001b[39;49m\u001b[38;5;124;43m\"\u001b[39;49m\u001b[38;5;124;43mScreening  (-30 to -1)\u001b[39;49m\u001b[38;5;124;43m\"\u001b[39;49m\u001b[38;5;124;43m,\u001b[39;49m\n\u001b[1;32m    252\u001b[0m \u001b[38;5;124;43m\t\t\t\t\u001b[39;49m\u001b[38;5;124;43m\"\u001b[39;49m\u001b[38;5;124;43mFollow-Up [\u001b[39;49m\u001b[38;5;124;43m{\u001b[39;49m\u001b[38;5;124;43mSuperscript \u001b[39;49m\u001b[38;5;124;43m'\u001b[39;49m\u001b[38;5;124;43mc\u001b[39;49m\u001b[38;5;124;43m'\u001b[39;49m\u001b[38;5;124;43m : Any subject who discontinues IMP during Phase A will enter the Follow-up period and then be followed every 6 months through Phase A. The 14 day follow-up visit is a telephone contct only, a clinic visit is not required. Subjects who do not complete Phase A on treatment are not eligible to enter Phase B.}, \u001b[39;49m\u001b[38;5;124;43m{\u001b[39;49m\u001b[38;5;124;43mSuperscript \u001b[39;49m\u001b[38;5;124;43m'\u001b[39;49m\u001b[38;5;124;43md\u001b[39;49m\u001b[38;5;124;43m'\u001b[39;49m\u001b[38;5;124;43m : An assessment of vital status will be conducted on subjects who terminate IMP prior to the Phase A Month 12 visit and do not agree to additional safety follow-up but do not withdraw consent for continued telephone contact. See Section 3.7.4.8.}] || 7 D Post  Last Dose  (+2 D)\u001b[39;49m\u001b[38;5;124;43m\"\u001b[39;49m\u001b[38;5;124;43m,\u001b[39;49m\n\u001b[1;32m    253\u001b[0m \u001b[38;5;124;43m\t\t\t\t\u001b[39;49m\u001b[38;5;124;43m\"\u001b[39;49m\u001b[38;5;124;43mFollow-Up [\u001b[39;49m\u001b[38;5;124;43m{\u001b[39;49m\u001b[38;5;124;43mSuperscript \u001b[39;49m\u001b[38;5;124;43m'\u001b[39;49m\u001b[38;5;124;43mc\u001b[39;49m\u001b[38;5;124;43m'\u001b[39;49m\u001b[38;5;124;43m : Any subject who discontinues IMP during Phase A will enter the Follow-up period and then be followed every 6 months through Phase A. The 14 day follow-up visit is a telephone contct only, a clinic visit is not required. Subjects who do not complete Phase A on treatment are not eligible to enter Phase B.}, \u001b[39;49m\u001b[38;5;124;43m{\u001b[39;49m\u001b[38;5;124;43mSuperscript \u001b[39;49m\u001b[38;5;124;43m'\u001b[39;49m\u001b[38;5;124;43md\u001b[39;49m\u001b[38;5;124;43m'\u001b[39;49m\u001b[38;5;124;43m : An assessment of vital status will be conducted on subjects who terminate IMP prior to the Phase A Month 12 visit and do not agree to additional safety follow-up but do not withdraw consent for continued telephone contact. See Section 3.7.4.8.}] || 14 D Post  Last Dose  (+2 D)\u001b[39;49m\u001b[38;5;124;43m\"\u001b[39;49m\n\u001b[1;32m    254\u001b[0m \u001b[38;5;124;43m\t\t\t]\u001b[39;49m\n\u001b[1;32m    255\u001b[0m \u001b[38;5;124;43m\t\t},\u001b[39;49m\n\u001b[1;32m    256\u001b[0m \u001b[38;5;124;43m\t\t\u001b[39;49m\u001b[38;5;124;43m{\u001b[39;49m\n\u001b[1;32m    257\u001b[0m \u001b[38;5;124;43m\t\t\t\u001b[39;49m\u001b[38;5;124;43m\"\u001b[39;49m\u001b[38;5;124;43mAssessments\u001b[39;49m\u001b[38;5;124;43m\"\u001b[39;49m\u001b[38;5;124;43m: \u001b[39;49m\u001b[38;5;124;43m\"\u001b[39;49m\u001b[38;5;124;43mAdverse events\u001b[39;49m\u001b[38;5;124;43m\"\u001b[39;49m\u001b[38;5;124;43m,\u001b[39;49m\n\u001b[1;32m    258\u001b[0m \u001b[38;5;124;43m\t\t\t\u001b[39;49m\u001b[38;5;124;43m\"\u001b[39;49m\u001b[38;5;124;43mSelected_X\u001b[39;49m\u001b[38;5;124;43m\"\u001b[39;49m\u001b[38;5;124;43m: [\u001b[39;49m\n\u001b[1;32m    259\u001b[0m \u001b[38;5;124;43m\t\t\t\t\u001b[39;49m\u001b[38;5;124;43m\"\u001b[39;49m\u001b[38;5;124;43mScreening  (-30 to -1)\u001b[39;49m\u001b[38;5;124;43m\"\u001b[39;49m\u001b[38;5;124;43m,\u001b[39;49m\n\u001b[1;32m    260\u001b[0m \u001b[38;5;124;43m\t\t\t\t\u001b[39;49m\u001b[38;5;124;43m\"\u001b[39;49m\u001b[38;5;124;43mFollow-Up [\u001b[39;49m\u001b[38;5;124;43m{\u001b[39;49m\u001b[38;5;124;43mSuperscript \u001b[39;49m\u001b[38;5;124;43m'\u001b[39;49m\u001b[38;5;124;43mc\u001b[39;49m\u001b[38;5;124;43m'\u001b[39;49m\u001b[38;5;124;43m : Any subject who discontinues IMP during Phase A will enter the Follow-up period and then be followed every 6 months through Phase A. The 14 day follow-up visit is a telephone contct only, a clinic visit is not required. Subjects who do not complete Phase A on treatment are not eligible to enter Phase B.}, \u001b[39;49m\u001b[38;5;124;43m{\u001b[39;49m\u001b[38;5;124;43mSuperscript \u001b[39;49m\u001b[38;5;124;43m'\u001b[39;49m\u001b[38;5;124;43md\u001b[39;49m\u001b[38;5;124;43m'\u001b[39;49m\u001b[38;5;124;43m : An assessment of vital status will be conducted on subjects who terminate IMP prior to the Phase A Month 12 visit and do not agree to additional safety follow-up but do not withdraw consent for continued telephone contact. See Section 3.7.4.8.}] || 7 D Post  Last Dose  (+2 D)\u001b[39;49m\u001b[38;5;124;43m\"\u001b[39;49m\u001b[38;5;124;43m,\u001b[39;49m\n\u001b[1;32m    261\u001b[0m \u001b[38;5;124;43m\t\t\t\t\u001b[39;49m\u001b[38;5;124;43m\"\u001b[39;49m\u001b[38;5;124;43mFollow-Up [\u001b[39;49m\u001b[38;5;124;43m{\u001b[39;49m\u001b[38;5;124;43mSuperscript \u001b[39;49m\u001b[38;5;124;43m'\u001b[39;49m\u001b[38;5;124;43mc\u001b[39;49m\u001b[38;5;124;43m'\u001b[39;49m\u001b[38;5;124;43m : Any subject who discontinues IMP during Phase A will enter the Follow-up period and then be followed every 6 months through Phase A. The 14 day follow-up visit is a telephone contct only, a clinic visit is not required. Subjects who do not complete Phase A on treatment are not eligible to enter Phase B.}, \u001b[39;49m\u001b[38;5;124;43m{\u001b[39;49m\u001b[38;5;124;43mSuperscript \u001b[39;49m\u001b[38;5;124;43m'\u001b[39;49m\u001b[38;5;124;43md\u001b[39;49m\u001b[38;5;124;43m'\u001b[39;49m\u001b[38;5;124;43m : An assessment of vital status will be conducted on subjects who terminate IMP prior to the Phase A Month 12 visit and do not agree to additional safety follow-up but do not withdraw consent for continued telephone contact. See Section 3.7.4.8.}] || 14 D Post  Last Dose  (+2 D)\u001b[39;49m\u001b[38;5;124;43m\"\u001b[39;49m\n\u001b[1;32m    262\u001b[0m \u001b[38;5;124;43m\t\t\t]\u001b[39;49m\n\u001b[1;32m    263\u001b[0m \u001b[38;5;124;43m\t\t}\u001b[39;49m\n\u001b[1;32m    264\u001b[0m \u001b[38;5;124;43m\t]\u001b[39;49m\n\u001b[1;32m    265\u001b[0m \u001b[38;5;124;43m}\u001b[39;49m\n\u001b[1;32m    266\u001b[0m \u001b[38;5;124;43m### Assistant:\u001b[39;49m\n\u001b[1;32m    267\u001b[0m \u001b[38;5;124;43m\"\"\"\u001b[39;49m\u001b[43m)\u001b[49m\n",
      "File \u001b[0;32m~/venv/lib/python3.8/site-packages/transformers/pipelines/text_generation.py:208\u001b[0m, in \u001b[0;36mTextGenerationPipeline.__call__\u001b[0;34m(self, text_inputs, **kwargs)\u001b[0m\n\u001b[1;32m    167\u001b[0m \u001b[38;5;28;01mdef\u001b[39;00m \u001b[38;5;21m__call__\u001b[39m(\u001b[38;5;28mself\u001b[39m, text_inputs, \u001b[38;5;241m*\u001b[39m\u001b[38;5;241m*\u001b[39mkwargs):\n\u001b[1;32m    168\u001b[0m \u001b[38;5;250m    \u001b[39m\u001b[38;5;124;03m\"\"\"\u001b[39;00m\n\u001b[1;32m    169\u001b[0m \u001b[38;5;124;03m    Complete the prompt(s) given as inputs.\u001b[39;00m\n\u001b[1;32m    170\u001b[0m \n\u001b[0;32m   (...)\u001b[0m\n\u001b[1;32m    206\u001b[0m \u001b[38;5;124;03m          ids of the generated text.\u001b[39;00m\n\u001b[1;32m    207\u001b[0m \u001b[38;5;124;03m    \"\"\"\u001b[39;00m\n\u001b[0;32m--> 208\u001b[0m     \u001b[38;5;28;01mreturn\u001b[39;00m \u001b[38;5;28;43msuper\u001b[39;49m\u001b[43m(\u001b[49m\u001b[43m)\u001b[49m\u001b[38;5;241;43m.\u001b[39;49m\u001b[38;5;21;43m__call__\u001b[39;49m\u001b[43m(\u001b[49m\u001b[43mtext_inputs\u001b[49m\u001b[43m,\u001b[49m\u001b[43m \u001b[49m\u001b[38;5;241;43m*\u001b[39;49m\u001b[38;5;241;43m*\u001b[39;49m\u001b[43mkwargs\u001b[49m\u001b[43m)\u001b[49m\n",
      "File \u001b[0;32m~/venv/lib/python3.8/site-packages/transformers/pipelines/base.py:1140\u001b[0m, in \u001b[0;36mPipeline.__call__\u001b[0;34m(self, inputs, num_workers, batch_size, *args, **kwargs)\u001b[0m\n\u001b[1;32m   1132\u001b[0m     \u001b[38;5;28;01mreturn\u001b[39;00m \u001b[38;5;28mnext\u001b[39m(\n\u001b[1;32m   1133\u001b[0m         \u001b[38;5;28miter\u001b[39m(\n\u001b[1;32m   1134\u001b[0m             \u001b[38;5;28mself\u001b[39m\u001b[38;5;241m.\u001b[39mget_iterator(\n\u001b[0;32m   (...)\u001b[0m\n\u001b[1;32m   1137\u001b[0m         )\n\u001b[1;32m   1138\u001b[0m     )\n\u001b[1;32m   1139\u001b[0m \u001b[38;5;28;01melse\u001b[39;00m:\n\u001b[0;32m-> 1140\u001b[0m     \u001b[38;5;28;01mreturn\u001b[39;00m \u001b[38;5;28;43mself\u001b[39;49m\u001b[38;5;241;43m.\u001b[39;49m\u001b[43mrun_single\u001b[49m\u001b[43m(\u001b[49m\u001b[43minputs\u001b[49m\u001b[43m,\u001b[49m\u001b[43m \u001b[49m\u001b[43mpreprocess_params\u001b[49m\u001b[43m,\u001b[49m\u001b[43m \u001b[49m\u001b[43mforward_params\u001b[49m\u001b[43m,\u001b[49m\u001b[43m \u001b[49m\u001b[43mpostprocess_params\u001b[49m\u001b[43m)\u001b[49m\n",
      "File \u001b[0;32m~/venv/lib/python3.8/site-packages/transformers/pipelines/base.py:1147\u001b[0m, in \u001b[0;36mPipeline.run_single\u001b[0;34m(self, inputs, preprocess_params, forward_params, postprocess_params)\u001b[0m\n\u001b[1;32m   1145\u001b[0m \u001b[38;5;28;01mdef\u001b[39;00m \u001b[38;5;21mrun_single\u001b[39m(\u001b[38;5;28mself\u001b[39m, inputs, preprocess_params, forward_params, postprocess_params):\n\u001b[1;32m   1146\u001b[0m     model_inputs \u001b[38;5;241m=\u001b[39m \u001b[38;5;28mself\u001b[39m\u001b[38;5;241m.\u001b[39mpreprocess(inputs, \u001b[38;5;241m*\u001b[39m\u001b[38;5;241m*\u001b[39mpreprocess_params)\n\u001b[0;32m-> 1147\u001b[0m     model_outputs \u001b[38;5;241m=\u001b[39m \u001b[38;5;28;43mself\u001b[39;49m\u001b[38;5;241;43m.\u001b[39;49m\u001b[43mforward\u001b[49m\u001b[43m(\u001b[49m\u001b[43mmodel_inputs\u001b[49m\u001b[43m,\u001b[49m\u001b[43m \u001b[49m\u001b[38;5;241;43m*\u001b[39;49m\u001b[38;5;241;43m*\u001b[39;49m\u001b[43mforward_params\u001b[49m\u001b[43m)\u001b[49m\n\u001b[1;32m   1148\u001b[0m     outputs \u001b[38;5;241m=\u001b[39m \u001b[38;5;28mself\u001b[39m\u001b[38;5;241m.\u001b[39mpostprocess(model_outputs, \u001b[38;5;241m*\u001b[39m\u001b[38;5;241m*\u001b[39mpostprocess_params)\n\u001b[1;32m   1149\u001b[0m     \u001b[38;5;28;01mreturn\u001b[39;00m outputs\n",
      "File \u001b[0;32m~/venv/lib/python3.8/site-packages/transformers/pipelines/base.py:1046\u001b[0m, in \u001b[0;36mPipeline.forward\u001b[0;34m(self, model_inputs, **forward_params)\u001b[0m\n\u001b[1;32m   1044\u001b[0m     \u001b[38;5;28;01mwith\u001b[39;00m inference_context():\n\u001b[1;32m   1045\u001b[0m         model_inputs \u001b[38;5;241m=\u001b[39m \u001b[38;5;28mself\u001b[39m\u001b[38;5;241m.\u001b[39m_ensure_tensor_on_device(model_inputs, device\u001b[38;5;241m=\u001b[39m\u001b[38;5;28mself\u001b[39m\u001b[38;5;241m.\u001b[39mdevice)\n\u001b[0;32m-> 1046\u001b[0m         model_outputs \u001b[38;5;241m=\u001b[39m \u001b[38;5;28;43mself\u001b[39;49m\u001b[38;5;241;43m.\u001b[39;49m\u001b[43m_forward\u001b[49m\u001b[43m(\u001b[49m\u001b[43mmodel_inputs\u001b[49m\u001b[43m,\u001b[49m\u001b[43m \u001b[49m\u001b[38;5;241;43m*\u001b[39;49m\u001b[38;5;241;43m*\u001b[39;49m\u001b[43mforward_params\u001b[49m\u001b[43m)\u001b[49m\n\u001b[1;32m   1047\u001b[0m         model_outputs \u001b[38;5;241m=\u001b[39m \u001b[38;5;28mself\u001b[39m\u001b[38;5;241m.\u001b[39m_ensure_tensor_on_device(model_outputs, device\u001b[38;5;241m=\u001b[39mtorch\u001b[38;5;241m.\u001b[39mdevice(\u001b[38;5;124m\"\u001b[39m\u001b[38;5;124mcpu\u001b[39m\u001b[38;5;124m\"\u001b[39m))\n\u001b[1;32m   1048\u001b[0m \u001b[38;5;28;01melse\u001b[39;00m:\n",
      "File \u001b[0;32m~/venv/lib/python3.8/site-packages/transformers/pipelines/text_generation.py:271\u001b[0m, in \u001b[0;36mTextGenerationPipeline._forward\u001b[0;34m(self, model_inputs, **generate_kwargs)\u001b[0m\n\u001b[1;32m    268\u001b[0m         generate_kwargs[\u001b[38;5;124m\"\u001b[39m\u001b[38;5;124mmin_length\u001b[39m\u001b[38;5;124m\"\u001b[39m] \u001b[38;5;241m+\u001b[39m\u001b[38;5;241m=\u001b[39m prefix_length\n\u001b[1;32m    270\u001b[0m \u001b[38;5;66;03m# BS x SL\u001b[39;00m\n\u001b[0;32m--> 271\u001b[0m generated_sequence \u001b[38;5;241m=\u001b[39m \u001b[38;5;28;43mself\u001b[39;49m\u001b[38;5;241;43m.\u001b[39;49m\u001b[43mmodel\u001b[49m\u001b[38;5;241;43m.\u001b[39;49m\u001b[43mgenerate\u001b[49m\u001b[43m(\u001b[49m\u001b[43minput_ids\u001b[49m\u001b[38;5;241;43m=\u001b[39;49m\u001b[43minput_ids\u001b[49m\u001b[43m,\u001b[49m\u001b[43m \u001b[49m\u001b[43mattention_mask\u001b[49m\u001b[38;5;241;43m=\u001b[39;49m\u001b[43mattention_mask\u001b[49m\u001b[43m,\u001b[49m\u001b[43m \u001b[49m\u001b[38;5;241;43m*\u001b[39;49m\u001b[38;5;241;43m*\u001b[39;49m\u001b[43mgenerate_kwargs\u001b[49m\u001b[43m)\u001b[49m\n\u001b[1;32m    272\u001b[0m out_b \u001b[38;5;241m=\u001b[39m generated_sequence\u001b[38;5;241m.\u001b[39mshape[\u001b[38;5;241m0\u001b[39m]\n\u001b[1;32m    273\u001b[0m \u001b[38;5;28;01mif\u001b[39;00m \u001b[38;5;28mself\u001b[39m\u001b[38;5;241m.\u001b[39mframework \u001b[38;5;241m==\u001b[39m \u001b[38;5;124m\"\u001b[39m\u001b[38;5;124mpt\u001b[39m\u001b[38;5;124m\"\u001b[39m:\n",
      "File \u001b[0;32m~/venv/lib/python3.8/site-packages/torch/utils/_contextlib.py:115\u001b[0m, in \u001b[0;36mcontext_decorator.<locals>.decorate_context\u001b[0;34m(*args, **kwargs)\u001b[0m\n\u001b[1;32m    112\u001b[0m \u001b[38;5;129m@functools\u001b[39m\u001b[38;5;241m.\u001b[39mwraps(func)\n\u001b[1;32m    113\u001b[0m \u001b[38;5;28;01mdef\u001b[39;00m \u001b[38;5;21mdecorate_context\u001b[39m(\u001b[38;5;241m*\u001b[39margs, \u001b[38;5;241m*\u001b[39m\u001b[38;5;241m*\u001b[39mkwargs):\n\u001b[1;32m    114\u001b[0m     \u001b[38;5;28;01mwith\u001b[39;00m ctx_factory():\n\u001b[0;32m--> 115\u001b[0m         \u001b[38;5;28;01mreturn\u001b[39;00m \u001b[43mfunc\u001b[49m\u001b[43m(\u001b[49m\u001b[38;5;241;43m*\u001b[39;49m\u001b[43margs\u001b[49m\u001b[43m,\u001b[49m\u001b[43m \u001b[49m\u001b[38;5;241;43m*\u001b[39;49m\u001b[38;5;241;43m*\u001b[39;49m\u001b[43mkwargs\u001b[49m\u001b[43m)\u001b[49m\n",
      "File \u001b[0;32m~/venv/lib/python3.8/site-packages/transformers/generation/utils.py:1719\u001b[0m, in \u001b[0;36mGenerationMixin.generate\u001b[0;34m(self, inputs, generation_config, logits_processor, stopping_criteria, prefix_allowed_tokens_fn, synced_gpus, assistant_model, streamer, negative_prompt_ids, negative_prompt_attention_mask, **kwargs)\u001b[0m\n\u001b[1;32m   1711\u001b[0m     input_ids, model_kwargs \u001b[38;5;241m=\u001b[39m \u001b[38;5;28mself\u001b[39m\u001b[38;5;241m.\u001b[39m_expand_inputs_for_generation(\n\u001b[1;32m   1712\u001b[0m         input_ids\u001b[38;5;241m=\u001b[39minput_ids,\n\u001b[1;32m   1713\u001b[0m         expand_size\u001b[38;5;241m=\u001b[39mgeneration_config\u001b[38;5;241m.\u001b[39mnum_return_sequences,\n\u001b[1;32m   1714\u001b[0m         is_encoder_decoder\u001b[38;5;241m=\u001b[39m\u001b[38;5;28mself\u001b[39m\u001b[38;5;241m.\u001b[39mconfig\u001b[38;5;241m.\u001b[39mis_encoder_decoder,\n\u001b[1;32m   1715\u001b[0m         \u001b[38;5;241m*\u001b[39m\u001b[38;5;241m*\u001b[39mmodel_kwargs,\n\u001b[1;32m   1716\u001b[0m     )\n\u001b[1;32m   1718\u001b[0m     \u001b[38;5;66;03m# 13. run sample\u001b[39;00m\n\u001b[0;32m-> 1719\u001b[0m     \u001b[38;5;28;01mreturn\u001b[39;00m \u001b[38;5;28;43mself\u001b[39;49m\u001b[38;5;241;43m.\u001b[39;49m\u001b[43msample\u001b[49m\u001b[43m(\u001b[49m\n\u001b[1;32m   1720\u001b[0m \u001b[43m        \u001b[49m\u001b[43minput_ids\u001b[49m\u001b[43m,\u001b[49m\n\u001b[1;32m   1721\u001b[0m \u001b[43m        \u001b[49m\u001b[43mlogits_processor\u001b[49m\u001b[38;5;241;43m=\u001b[39;49m\u001b[43mlogits_processor\u001b[49m\u001b[43m,\u001b[49m\n\u001b[1;32m   1722\u001b[0m \u001b[43m        \u001b[49m\u001b[43mlogits_warper\u001b[49m\u001b[38;5;241;43m=\u001b[39;49m\u001b[43mlogits_warper\u001b[49m\u001b[43m,\u001b[49m\n\u001b[1;32m   1723\u001b[0m \u001b[43m        \u001b[49m\u001b[43mstopping_criteria\u001b[49m\u001b[38;5;241;43m=\u001b[39;49m\u001b[43mstopping_criteria\u001b[49m\u001b[43m,\u001b[49m\n\u001b[1;32m   1724\u001b[0m \u001b[43m        \u001b[49m\u001b[43mpad_token_id\u001b[49m\u001b[38;5;241;43m=\u001b[39;49m\u001b[43mgeneration_config\u001b[49m\u001b[38;5;241;43m.\u001b[39;49m\u001b[43mpad_token_id\u001b[49m\u001b[43m,\u001b[49m\n\u001b[1;32m   1725\u001b[0m \u001b[43m        \u001b[49m\u001b[43meos_token_id\u001b[49m\u001b[38;5;241;43m=\u001b[39;49m\u001b[43mgeneration_config\u001b[49m\u001b[38;5;241;43m.\u001b[39;49m\u001b[43meos_token_id\u001b[49m\u001b[43m,\u001b[49m\n\u001b[1;32m   1726\u001b[0m \u001b[43m        \u001b[49m\u001b[43moutput_scores\u001b[49m\u001b[38;5;241;43m=\u001b[39;49m\u001b[43mgeneration_config\u001b[49m\u001b[38;5;241;43m.\u001b[39;49m\u001b[43moutput_scores\u001b[49m\u001b[43m,\u001b[49m\n\u001b[1;32m   1727\u001b[0m \u001b[43m        \u001b[49m\u001b[43mreturn_dict_in_generate\u001b[49m\u001b[38;5;241;43m=\u001b[39;49m\u001b[43mgeneration_config\u001b[49m\u001b[38;5;241;43m.\u001b[39;49m\u001b[43mreturn_dict_in_generate\u001b[49m\u001b[43m,\u001b[49m\n\u001b[1;32m   1728\u001b[0m \u001b[43m        \u001b[49m\u001b[43msynced_gpus\u001b[49m\u001b[38;5;241;43m=\u001b[39;49m\u001b[43msynced_gpus\u001b[49m\u001b[43m,\u001b[49m\n\u001b[1;32m   1729\u001b[0m \u001b[43m        \u001b[49m\u001b[43mstreamer\u001b[49m\u001b[38;5;241;43m=\u001b[39;49m\u001b[43mstreamer\u001b[49m\u001b[43m,\u001b[49m\n\u001b[1;32m   1730\u001b[0m \u001b[43m        \u001b[49m\u001b[38;5;241;43m*\u001b[39;49m\u001b[38;5;241;43m*\u001b[39;49m\u001b[43mmodel_kwargs\u001b[49m\u001b[43m,\u001b[49m\n\u001b[1;32m   1731\u001b[0m \u001b[43m    \u001b[49m\u001b[43m)\u001b[49m\n\u001b[1;32m   1733\u001b[0m \u001b[38;5;28;01melif\u001b[39;00m generation_mode \u001b[38;5;241m==\u001b[39m GenerationMode\u001b[38;5;241m.\u001b[39mBEAM_SEARCH:\n\u001b[1;32m   1734\u001b[0m     \u001b[38;5;66;03m# 11. prepare beam search scorer\u001b[39;00m\n\u001b[1;32m   1735\u001b[0m     beam_scorer \u001b[38;5;241m=\u001b[39m BeamSearchScorer(\n\u001b[1;32m   1736\u001b[0m         batch_size\u001b[38;5;241m=\u001b[39mbatch_size,\n\u001b[1;32m   1737\u001b[0m         num_beams\u001b[38;5;241m=\u001b[39mgeneration_config\u001b[38;5;241m.\u001b[39mnum_beams,\n\u001b[0;32m   (...)\u001b[0m\n\u001b[1;32m   1742\u001b[0m         max_length\u001b[38;5;241m=\u001b[39mgeneration_config\u001b[38;5;241m.\u001b[39mmax_length,\n\u001b[1;32m   1743\u001b[0m     )\n",
      "File \u001b[0;32m~/venv/lib/python3.8/site-packages/transformers/generation/utils.py:2801\u001b[0m, in \u001b[0;36mGenerationMixin.sample\u001b[0;34m(self, input_ids, logits_processor, stopping_criteria, logits_warper, max_length, pad_token_id, eos_token_id, output_attentions, output_hidden_states, output_scores, return_dict_in_generate, synced_gpus, streamer, **model_kwargs)\u001b[0m\n\u001b[1;32m   2798\u001b[0m model_inputs \u001b[38;5;241m=\u001b[39m \u001b[38;5;28mself\u001b[39m\u001b[38;5;241m.\u001b[39mprepare_inputs_for_generation(input_ids, \u001b[38;5;241m*\u001b[39m\u001b[38;5;241m*\u001b[39mmodel_kwargs)\n\u001b[1;32m   2800\u001b[0m \u001b[38;5;66;03m# forward pass to get next token\u001b[39;00m\n\u001b[0;32m-> 2801\u001b[0m outputs \u001b[38;5;241m=\u001b[39m \u001b[38;5;28;43mself\u001b[39;49m\u001b[43m(\u001b[49m\n\u001b[1;32m   2802\u001b[0m \u001b[43m    \u001b[49m\u001b[38;5;241;43m*\u001b[39;49m\u001b[38;5;241;43m*\u001b[39;49m\u001b[43mmodel_inputs\u001b[49m\u001b[43m,\u001b[49m\n\u001b[1;32m   2803\u001b[0m \u001b[43m    \u001b[49m\u001b[43mreturn_dict\u001b[49m\u001b[38;5;241;43m=\u001b[39;49m\u001b[38;5;28;43;01mTrue\u001b[39;49;00m\u001b[43m,\u001b[49m\n\u001b[1;32m   2804\u001b[0m \u001b[43m    \u001b[49m\u001b[43moutput_attentions\u001b[49m\u001b[38;5;241;43m=\u001b[39;49m\u001b[43moutput_attentions\u001b[49m\u001b[43m,\u001b[49m\n\u001b[1;32m   2805\u001b[0m \u001b[43m    \u001b[49m\u001b[43moutput_hidden_states\u001b[49m\u001b[38;5;241;43m=\u001b[39;49m\u001b[43moutput_hidden_states\u001b[49m\u001b[43m,\u001b[49m\n\u001b[1;32m   2806\u001b[0m \u001b[43m\u001b[49m\u001b[43m)\u001b[49m\n\u001b[1;32m   2808\u001b[0m \u001b[38;5;28;01mif\u001b[39;00m synced_gpus \u001b[38;5;129;01mand\u001b[39;00m this_peer_finished:\n\u001b[1;32m   2809\u001b[0m     \u001b[38;5;28;01mcontinue\u001b[39;00m  \u001b[38;5;66;03m# don't waste resources running the code we don't need\u001b[39;00m\n",
      "File \u001b[0;32m~/venv/lib/python3.8/site-packages/torch/nn/modules/module.py:1518\u001b[0m, in \u001b[0;36mModule._wrapped_call_impl\u001b[0;34m(self, *args, **kwargs)\u001b[0m\n\u001b[1;32m   1516\u001b[0m     \u001b[38;5;28;01mreturn\u001b[39;00m \u001b[38;5;28mself\u001b[39m\u001b[38;5;241m.\u001b[39m_compiled_call_impl(\u001b[38;5;241m*\u001b[39margs, \u001b[38;5;241m*\u001b[39m\u001b[38;5;241m*\u001b[39mkwargs)  \u001b[38;5;66;03m# type: ignore[misc]\u001b[39;00m\n\u001b[1;32m   1517\u001b[0m \u001b[38;5;28;01melse\u001b[39;00m:\n\u001b[0;32m-> 1518\u001b[0m     \u001b[38;5;28;01mreturn\u001b[39;00m \u001b[38;5;28;43mself\u001b[39;49m\u001b[38;5;241;43m.\u001b[39;49m\u001b[43m_call_impl\u001b[49m\u001b[43m(\u001b[49m\u001b[38;5;241;43m*\u001b[39;49m\u001b[43margs\u001b[49m\u001b[43m,\u001b[49m\u001b[43m \u001b[49m\u001b[38;5;241;43m*\u001b[39;49m\u001b[38;5;241;43m*\u001b[39;49m\u001b[43mkwargs\u001b[49m\u001b[43m)\u001b[49m\n",
      "File \u001b[0;32m~/venv/lib/python3.8/site-packages/torch/nn/modules/module.py:1527\u001b[0m, in \u001b[0;36mModule._call_impl\u001b[0;34m(self, *args, **kwargs)\u001b[0m\n\u001b[1;32m   1522\u001b[0m \u001b[38;5;66;03m# If we don't have any hooks, we want to skip the rest of the logic in\u001b[39;00m\n\u001b[1;32m   1523\u001b[0m \u001b[38;5;66;03m# this function, and just call forward.\u001b[39;00m\n\u001b[1;32m   1524\u001b[0m \u001b[38;5;28;01mif\u001b[39;00m \u001b[38;5;129;01mnot\u001b[39;00m (\u001b[38;5;28mself\u001b[39m\u001b[38;5;241m.\u001b[39m_backward_hooks \u001b[38;5;129;01mor\u001b[39;00m \u001b[38;5;28mself\u001b[39m\u001b[38;5;241m.\u001b[39m_backward_pre_hooks \u001b[38;5;129;01mor\u001b[39;00m \u001b[38;5;28mself\u001b[39m\u001b[38;5;241m.\u001b[39m_forward_hooks \u001b[38;5;129;01mor\u001b[39;00m \u001b[38;5;28mself\u001b[39m\u001b[38;5;241m.\u001b[39m_forward_pre_hooks\n\u001b[1;32m   1525\u001b[0m         \u001b[38;5;129;01mor\u001b[39;00m _global_backward_pre_hooks \u001b[38;5;129;01mor\u001b[39;00m _global_backward_hooks\n\u001b[1;32m   1526\u001b[0m         \u001b[38;5;129;01mor\u001b[39;00m _global_forward_hooks \u001b[38;5;129;01mor\u001b[39;00m _global_forward_pre_hooks):\n\u001b[0;32m-> 1527\u001b[0m     \u001b[38;5;28;01mreturn\u001b[39;00m \u001b[43mforward_call\u001b[49m\u001b[43m(\u001b[49m\u001b[38;5;241;43m*\u001b[39;49m\u001b[43margs\u001b[49m\u001b[43m,\u001b[49m\u001b[43m \u001b[49m\u001b[38;5;241;43m*\u001b[39;49m\u001b[38;5;241;43m*\u001b[39;49m\u001b[43mkwargs\u001b[49m\u001b[43m)\u001b[49m\n\u001b[1;32m   1529\u001b[0m \u001b[38;5;28;01mtry\u001b[39;00m:\n\u001b[1;32m   1530\u001b[0m     result \u001b[38;5;241m=\u001b[39m \u001b[38;5;28;01mNone\u001b[39;00m\n",
      "File \u001b[0;32m~/venv/lib/python3.8/site-packages/transformers/models/mistral/modeling_mistral.py:1009\u001b[0m, in \u001b[0;36mMistralForCausalLM.forward\u001b[0;34m(self, input_ids, attention_mask, position_ids, past_key_values, inputs_embeds, labels, use_cache, output_attentions, output_hidden_states, return_dict)\u001b[0m\n\u001b[1;32m   1006\u001b[0m return_dict \u001b[38;5;241m=\u001b[39m return_dict \u001b[38;5;28;01mif\u001b[39;00m return_dict \u001b[38;5;129;01mis\u001b[39;00m \u001b[38;5;129;01mnot\u001b[39;00m \u001b[38;5;28;01mNone\u001b[39;00m \u001b[38;5;28;01melse\u001b[39;00m \u001b[38;5;28mself\u001b[39m\u001b[38;5;241m.\u001b[39mconfig\u001b[38;5;241m.\u001b[39muse_return_dict\n\u001b[1;32m   1008\u001b[0m \u001b[38;5;66;03m# decoder outputs consists of (dec_features, layer_state, dec_hidden, dec_attn)\u001b[39;00m\n\u001b[0;32m-> 1009\u001b[0m outputs \u001b[38;5;241m=\u001b[39m \u001b[38;5;28;43mself\u001b[39;49m\u001b[38;5;241;43m.\u001b[39;49m\u001b[43mmodel\u001b[49m\u001b[43m(\u001b[49m\n\u001b[1;32m   1010\u001b[0m \u001b[43m    \u001b[49m\u001b[43minput_ids\u001b[49m\u001b[38;5;241;43m=\u001b[39;49m\u001b[43minput_ids\u001b[49m\u001b[43m,\u001b[49m\n\u001b[1;32m   1011\u001b[0m \u001b[43m    \u001b[49m\u001b[43mattention_mask\u001b[49m\u001b[38;5;241;43m=\u001b[39;49m\u001b[43mattention_mask\u001b[49m\u001b[43m,\u001b[49m\n\u001b[1;32m   1012\u001b[0m \u001b[43m    \u001b[49m\u001b[43mposition_ids\u001b[49m\u001b[38;5;241;43m=\u001b[39;49m\u001b[43mposition_ids\u001b[49m\u001b[43m,\u001b[49m\n\u001b[1;32m   1013\u001b[0m \u001b[43m    \u001b[49m\u001b[43mpast_key_values\u001b[49m\u001b[38;5;241;43m=\u001b[39;49m\u001b[43mpast_key_values\u001b[49m\u001b[43m,\u001b[49m\n\u001b[1;32m   1014\u001b[0m \u001b[43m    \u001b[49m\u001b[43minputs_embeds\u001b[49m\u001b[38;5;241;43m=\u001b[39;49m\u001b[43minputs_embeds\u001b[49m\u001b[43m,\u001b[49m\n\u001b[1;32m   1015\u001b[0m \u001b[43m    \u001b[49m\u001b[43muse_cache\u001b[49m\u001b[38;5;241;43m=\u001b[39;49m\u001b[43muse_cache\u001b[49m\u001b[43m,\u001b[49m\n\u001b[1;32m   1016\u001b[0m \u001b[43m    \u001b[49m\u001b[43moutput_attentions\u001b[49m\u001b[38;5;241;43m=\u001b[39;49m\u001b[43moutput_attentions\u001b[49m\u001b[43m,\u001b[49m\n\u001b[1;32m   1017\u001b[0m \u001b[43m    \u001b[49m\u001b[43moutput_hidden_states\u001b[49m\u001b[38;5;241;43m=\u001b[39;49m\u001b[43moutput_hidden_states\u001b[49m\u001b[43m,\u001b[49m\n\u001b[1;32m   1018\u001b[0m \u001b[43m    \u001b[49m\u001b[43mreturn_dict\u001b[49m\u001b[38;5;241;43m=\u001b[39;49m\u001b[43mreturn_dict\u001b[49m\u001b[43m,\u001b[49m\n\u001b[1;32m   1019\u001b[0m \u001b[43m\u001b[49m\u001b[43m)\u001b[49m\n\u001b[1;32m   1021\u001b[0m hidden_states \u001b[38;5;241m=\u001b[39m outputs[\u001b[38;5;241m0\u001b[39m]\n\u001b[1;32m   1022\u001b[0m logits \u001b[38;5;241m=\u001b[39m \u001b[38;5;28mself\u001b[39m\u001b[38;5;241m.\u001b[39mlm_head(hidden_states)\n",
      "File \u001b[0;32m~/venv/lib/python3.8/site-packages/torch/nn/modules/module.py:1518\u001b[0m, in \u001b[0;36mModule._wrapped_call_impl\u001b[0;34m(self, *args, **kwargs)\u001b[0m\n\u001b[1;32m   1516\u001b[0m     \u001b[38;5;28;01mreturn\u001b[39;00m \u001b[38;5;28mself\u001b[39m\u001b[38;5;241m.\u001b[39m_compiled_call_impl(\u001b[38;5;241m*\u001b[39margs, \u001b[38;5;241m*\u001b[39m\u001b[38;5;241m*\u001b[39mkwargs)  \u001b[38;5;66;03m# type: ignore[misc]\u001b[39;00m\n\u001b[1;32m   1517\u001b[0m \u001b[38;5;28;01melse\u001b[39;00m:\n\u001b[0;32m-> 1518\u001b[0m     \u001b[38;5;28;01mreturn\u001b[39;00m \u001b[38;5;28;43mself\u001b[39;49m\u001b[38;5;241;43m.\u001b[39;49m\u001b[43m_call_impl\u001b[49m\u001b[43m(\u001b[49m\u001b[38;5;241;43m*\u001b[39;49m\u001b[43margs\u001b[49m\u001b[43m,\u001b[49m\u001b[43m \u001b[49m\u001b[38;5;241;43m*\u001b[39;49m\u001b[38;5;241;43m*\u001b[39;49m\u001b[43mkwargs\u001b[49m\u001b[43m)\u001b[49m\n",
      "File \u001b[0;32m~/venv/lib/python3.8/site-packages/torch/nn/modules/module.py:1527\u001b[0m, in \u001b[0;36mModule._call_impl\u001b[0;34m(self, *args, **kwargs)\u001b[0m\n\u001b[1;32m   1522\u001b[0m \u001b[38;5;66;03m# If we don't have any hooks, we want to skip the rest of the logic in\u001b[39;00m\n\u001b[1;32m   1523\u001b[0m \u001b[38;5;66;03m# this function, and just call forward.\u001b[39;00m\n\u001b[1;32m   1524\u001b[0m \u001b[38;5;28;01mif\u001b[39;00m \u001b[38;5;129;01mnot\u001b[39;00m (\u001b[38;5;28mself\u001b[39m\u001b[38;5;241m.\u001b[39m_backward_hooks \u001b[38;5;129;01mor\u001b[39;00m \u001b[38;5;28mself\u001b[39m\u001b[38;5;241m.\u001b[39m_backward_pre_hooks \u001b[38;5;129;01mor\u001b[39;00m \u001b[38;5;28mself\u001b[39m\u001b[38;5;241m.\u001b[39m_forward_hooks \u001b[38;5;129;01mor\u001b[39;00m \u001b[38;5;28mself\u001b[39m\u001b[38;5;241m.\u001b[39m_forward_pre_hooks\n\u001b[1;32m   1525\u001b[0m         \u001b[38;5;129;01mor\u001b[39;00m _global_backward_pre_hooks \u001b[38;5;129;01mor\u001b[39;00m _global_backward_hooks\n\u001b[1;32m   1526\u001b[0m         \u001b[38;5;129;01mor\u001b[39;00m _global_forward_hooks \u001b[38;5;129;01mor\u001b[39;00m _global_forward_pre_hooks):\n\u001b[0;32m-> 1527\u001b[0m     \u001b[38;5;28;01mreturn\u001b[39;00m \u001b[43mforward_call\u001b[49m\u001b[43m(\u001b[49m\u001b[38;5;241;43m*\u001b[39;49m\u001b[43margs\u001b[49m\u001b[43m,\u001b[49m\u001b[43m \u001b[49m\u001b[38;5;241;43m*\u001b[39;49m\u001b[38;5;241;43m*\u001b[39;49m\u001b[43mkwargs\u001b[49m\u001b[43m)\u001b[49m\n\u001b[1;32m   1529\u001b[0m \u001b[38;5;28;01mtry\u001b[39;00m:\n\u001b[1;32m   1530\u001b[0m     result \u001b[38;5;241m=\u001b[39m \u001b[38;5;28;01mNone\u001b[39;00m\n",
      "File \u001b[0;32m~/venv/lib/python3.8/site-packages/transformers/models/mistral/modeling_mistral.py:897\u001b[0m, in \u001b[0;36mMistralModel.forward\u001b[0;34m(self, input_ids, attention_mask, position_ids, past_key_values, inputs_embeds, use_cache, output_attentions, output_hidden_states, return_dict)\u001b[0m\n\u001b[1;32m    887\u001b[0m     layer_outputs \u001b[38;5;241m=\u001b[39m \u001b[38;5;28mself\u001b[39m\u001b[38;5;241m.\u001b[39m_gradient_checkpointing_func(\n\u001b[1;32m    888\u001b[0m         decoder_layer\u001b[38;5;241m.\u001b[39m\u001b[38;5;21m__call__\u001b[39m,\n\u001b[1;32m    889\u001b[0m         hidden_states,\n\u001b[0;32m   (...)\u001b[0m\n\u001b[1;32m    894\u001b[0m         use_cache,\n\u001b[1;32m    895\u001b[0m     )\n\u001b[1;32m    896\u001b[0m \u001b[38;5;28;01melse\u001b[39;00m:\n\u001b[0;32m--> 897\u001b[0m     layer_outputs \u001b[38;5;241m=\u001b[39m \u001b[43mdecoder_layer\u001b[49m\u001b[43m(\u001b[49m\n\u001b[1;32m    898\u001b[0m \u001b[43m        \u001b[49m\u001b[43mhidden_states\u001b[49m\u001b[43m,\u001b[49m\n\u001b[1;32m    899\u001b[0m \u001b[43m        \u001b[49m\u001b[43mattention_mask\u001b[49m\u001b[38;5;241;43m=\u001b[39;49m\u001b[43mattention_mask\u001b[49m\u001b[43m,\u001b[49m\n\u001b[1;32m    900\u001b[0m \u001b[43m        \u001b[49m\u001b[43mposition_ids\u001b[49m\u001b[38;5;241;43m=\u001b[39;49m\u001b[43mposition_ids\u001b[49m\u001b[43m,\u001b[49m\n\u001b[1;32m    901\u001b[0m \u001b[43m        \u001b[49m\u001b[43mpast_key_value\u001b[49m\u001b[38;5;241;43m=\u001b[39;49m\u001b[43mpast_key_value\u001b[49m\u001b[43m,\u001b[49m\n\u001b[1;32m    902\u001b[0m \u001b[43m        \u001b[49m\u001b[43moutput_attentions\u001b[49m\u001b[38;5;241;43m=\u001b[39;49m\u001b[43moutput_attentions\u001b[49m\u001b[43m,\u001b[49m\n\u001b[1;32m    903\u001b[0m \u001b[43m        \u001b[49m\u001b[43muse_cache\u001b[49m\u001b[38;5;241;43m=\u001b[39;49m\u001b[43muse_cache\u001b[49m\u001b[43m,\u001b[49m\n\u001b[1;32m    904\u001b[0m \u001b[43m    \u001b[49m\u001b[43m)\u001b[49m\n\u001b[1;32m    906\u001b[0m hidden_states \u001b[38;5;241m=\u001b[39m layer_outputs[\u001b[38;5;241m0\u001b[39m]\n\u001b[1;32m    908\u001b[0m \u001b[38;5;28;01mif\u001b[39;00m use_cache:\n",
      "File \u001b[0;32m~/venv/lib/python3.8/site-packages/torch/nn/modules/module.py:1518\u001b[0m, in \u001b[0;36mModule._wrapped_call_impl\u001b[0;34m(self, *args, **kwargs)\u001b[0m\n\u001b[1;32m   1516\u001b[0m     \u001b[38;5;28;01mreturn\u001b[39;00m \u001b[38;5;28mself\u001b[39m\u001b[38;5;241m.\u001b[39m_compiled_call_impl(\u001b[38;5;241m*\u001b[39margs, \u001b[38;5;241m*\u001b[39m\u001b[38;5;241m*\u001b[39mkwargs)  \u001b[38;5;66;03m# type: ignore[misc]\u001b[39;00m\n\u001b[1;32m   1517\u001b[0m \u001b[38;5;28;01melse\u001b[39;00m:\n\u001b[0;32m-> 1518\u001b[0m     \u001b[38;5;28;01mreturn\u001b[39;00m \u001b[38;5;28;43mself\u001b[39;49m\u001b[38;5;241;43m.\u001b[39;49m\u001b[43m_call_impl\u001b[49m\u001b[43m(\u001b[49m\u001b[38;5;241;43m*\u001b[39;49m\u001b[43margs\u001b[49m\u001b[43m,\u001b[49m\u001b[43m \u001b[49m\u001b[38;5;241;43m*\u001b[39;49m\u001b[38;5;241;43m*\u001b[39;49m\u001b[43mkwargs\u001b[49m\u001b[43m)\u001b[49m\n",
      "File \u001b[0;32m~/venv/lib/python3.8/site-packages/torch/nn/modules/module.py:1527\u001b[0m, in \u001b[0;36mModule._call_impl\u001b[0;34m(self, *args, **kwargs)\u001b[0m\n\u001b[1;32m   1522\u001b[0m \u001b[38;5;66;03m# If we don't have any hooks, we want to skip the rest of the logic in\u001b[39;00m\n\u001b[1;32m   1523\u001b[0m \u001b[38;5;66;03m# this function, and just call forward.\u001b[39;00m\n\u001b[1;32m   1524\u001b[0m \u001b[38;5;28;01mif\u001b[39;00m \u001b[38;5;129;01mnot\u001b[39;00m (\u001b[38;5;28mself\u001b[39m\u001b[38;5;241m.\u001b[39m_backward_hooks \u001b[38;5;129;01mor\u001b[39;00m \u001b[38;5;28mself\u001b[39m\u001b[38;5;241m.\u001b[39m_backward_pre_hooks \u001b[38;5;129;01mor\u001b[39;00m \u001b[38;5;28mself\u001b[39m\u001b[38;5;241m.\u001b[39m_forward_hooks \u001b[38;5;129;01mor\u001b[39;00m \u001b[38;5;28mself\u001b[39m\u001b[38;5;241m.\u001b[39m_forward_pre_hooks\n\u001b[1;32m   1525\u001b[0m         \u001b[38;5;129;01mor\u001b[39;00m _global_backward_pre_hooks \u001b[38;5;129;01mor\u001b[39;00m _global_backward_hooks\n\u001b[1;32m   1526\u001b[0m         \u001b[38;5;129;01mor\u001b[39;00m _global_forward_hooks \u001b[38;5;129;01mor\u001b[39;00m _global_forward_pre_hooks):\n\u001b[0;32m-> 1527\u001b[0m     \u001b[38;5;28;01mreturn\u001b[39;00m \u001b[43mforward_call\u001b[49m\u001b[43m(\u001b[49m\u001b[38;5;241;43m*\u001b[39;49m\u001b[43margs\u001b[49m\u001b[43m,\u001b[49m\u001b[43m \u001b[49m\u001b[38;5;241;43m*\u001b[39;49m\u001b[38;5;241;43m*\u001b[39;49m\u001b[43mkwargs\u001b[49m\u001b[43m)\u001b[49m\n\u001b[1;32m   1529\u001b[0m \u001b[38;5;28;01mtry\u001b[39;00m:\n\u001b[1;32m   1530\u001b[0m     result \u001b[38;5;241m=\u001b[39m \u001b[38;5;28;01mNone\u001b[39;00m\n",
      "File \u001b[0;32m~/venv/lib/python3.8/site-packages/transformers/models/mistral/modeling_mistral.py:626\u001b[0m, in \u001b[0;36mMistralDecoderLayer.forward\u001b[0;34m(self, hidden_states, attention_mask, position_ids, past_key_value, output_attentions, use_cache, **kwargs)\u001b[0m\n\u001b[1;32m    623\u001b[0m hidden_states \u001b[38;5;241m=\u001b[39m \u001b[38;5;28mself\u001b[39m\u001b[38;5;241m.\u001b[39minput_layernorm(hidden_states)\n\u001b[1;32m    625\u001b[0m \u001b[38;5;66;03m# Self Attention\u001b[39;00m\n\u001b[0;32m--> 626\u001b[0m hidden_states, self_attn_weights, present_key_value \u001b[38;5;241m=\u001b[39m \u001b[38;5;28;43mself\u001b[39;49m\u001b[38;5;241;43m.\u001b[39;49m\u001b[43mself_attn\u001b[49m\u001b[43m(\u001b[49m\n\u001b[1;32m    627\u001b[0m \u001b[43m    \u001b[49m\u001b[43mhidden_states\u001b[49m\u001b[38;5;241;43m=\u001b[39;49m\u001b[43mhidden_states\u001b[49m\u001b[43m,\u001b[49m\n\u001b[1;32m    628\u001b[0m \u001b[43m    \u001b[49m\u001b[43mattention_mask\u001b[49m\u001b[38;5;241;43m=\u001b[39;49m\u001b[43mattention_mask\u001b[49m\u001b[43m,\u001b[49m\n\u001b[1;32m    629\u001b[0m \u001b[43m    \u001b[49m\u001b[43mposition_ids\u001b[49m\u001b[38;5;241;43m=\u001b[39;49m\u001b[43mposition_ids\u001b[49m\u001b[43m,\u001b[49m\n\u001b[1;32m    630\u001b[0m \u001b[43m    \u001b[49m\u001b[43mpast_key_value\u001b[49m\u001b[38;5;241;43m=\u001b[39;49m\u001b[43mpast_key_value\u001b[49m\u001b[43m,\u001b[49m\n\u001b[1;32m    631\u001b[0m \u001b[43m    \u001b[49m\u001b[43moutput_attentions\u001b[49m\u001b[38;5;241;43m=\u001b[39;49m\u001b[43moutput_attentions\u001b[49m\u001b[43m,\u001b[49m\n\u001b[1;32m    632\u001b[0m \u001b[43m    \u001b[49m\u001b[43muse_cache\u001b[49m\u001b[38;5;241;43m=\u001b[39;49m\u001b[43muse_cache\u001b[49m\u001b[43m,\u001b[49m\n\u001b[1;32m    633\u001b[0m \u001b[43m\u001b[49m\u001b[43m)\u001b[49m\n\u001b[1;32m    634\u001b[0m hidden_states \u001b[38;5;241m=\u001b[39m residual \u001b[38;5;241m+\u001b[39m hidden_states\n\u001b[1;32m    636\u001b[0m \u001b[38;5;66;03m# Fully Connected\u001b[39;00m\n",
      "File \u001b[0;32m~/venv/lib/python3.8/site-packages/torch/nn/modules/module.py:1518\u001b[0m, in \u001b[0;36mModule._wrapped_call_impl\u001b[0;34m(self, *args, **kwargs)\u001b[0m\n\u001b[1;32m   1516\u001b[0m     \u001b[38;5;28;01mreturn\u001b[39;00m \u001b[38;5;28mself\u001b[39m\u001b[38;5;241m.\u001b[39m_compiled_call_impl(\u001b[38;5;241m*\u001b[39margs, \u001b[38;5;241m*\u001b[39m\u001b[38;5;241m*\u001b[39mkwargs)  \u001b[38;5;66;03m# type: ignore[misc]\u001b[39;00m\n\u001b[1;32m   1517\u001b[0m \u001b[38;5;28;01melse\u001b[39;00m:\n\u001b[0;32m-> 1518\u001b[0m     \u001b[38;5;28;01mreturn\u001b[39;00m \u001b[38;5;28;43mself\u001b[39;49m\u001b[38;5;241;43m.\u001b[39;49m\u001b[43m_call_impl\u001b[49m\u001b[43m(\u001b[49m\u001b[38;5;241;43m*\u001b[39;49m\u001b[43margs\u001b[49m\u001b[43m,\u001b[49m\u001b[43m \u001b[49m\u001b[38;5;241;43m*\u001b[39;49m\u001b[38;5;241;43m*\u001b[39;49m\u001b[43mkwargs\u001b[49m\u001b[43m)\u001b[49m\n",
      "File \u001b[0;32m~/venv/lib/python3.8/site-packages/torch/nn/modules/module.py:1527\u001b[0m, in \u001b[0;36mModule._call_impl\u001b[0;34m(self, *args, **kwargs)\u001b[0m\n\u001b[1;32m   1522\u001b[0m \u001b[38;5;66;03m# If we don't have any hooks, we want to skip the rest of the logic in\u001b[39;00m\n\u001b[1;32m   1523\u001b[0m \u001b[38;5;66;03m# this function, and just call forward.\u001b[39;00m\n\u001b[1;32m   1524\u001b[0m \u001b[38;5;28;01mif\u001b[39;00m \u001b[38;5;129;01mnot\u001b[39;00m (\u001b[38;5;28mself\u001b[39m\u001b[38;5;241m.\u001b[39m_backward_hooks \u001b[38;5;129;01mor\u001b[39;00m \u001b[38;5;28mself\u001b[39m\u001b[38;5;241m.\u001b[39m_backward_pre_hooks \u001b[38;5;129;01mor\u001b[39;00m \u001b[38;5;28mself\u001b[39m\u001b[38;5;241m.\u001b[39m_forward_hooks \u001b[38;5;129;01mor\u001b[39;00m \u001b[38;5;28mself\u001b[39m\u001b[38;5;241m.\u001b[39m_forward_pre_hooks\n\u001b[1;32m   1525\u001b[0m         \u001b[38;5;129;01mor\u001b[39;00m _global_backward_pre_hooks \u001b[38;5;129;01mor\u001b[39;00m _global_backward_hooks\n\u001b[1;32m   1526\u001b[0m         \u001b[38;5;129;01mor\u001b[39;00m _global_forward_hooks \u001b[38;5;129;01mor\u001b[39;00m _global_forward_pre_hooks):\n\u001b[0;32m-> 1527\u001b[0m     \u001b[38;5;28;01mreturn\u001b[39;00m \u001b[43mforward_call\u001b[49m\u001b[43m(\u001b[49m\u001b[38;5;241;43m*\u001b[39;49m\u001b[43margs\u001b[49m\u001b[43m,\u001b[49m\u001b[43m \u001b[49m\u001b[38;5;241;43m*\u001b[39;49m\u001b[38;5;241;43m*\u001b[39;49m\u001b[43mkwargs\u001b[49m\u001b[43m)\u001b[49m\n\u001b[1;32m   1529\u001b[0m \u001b[38;5;28;01mtry\u001b[39;00m:\n\u001b[1;32m   1530\u001b[0m     result \u001b[38;5;241m=\u001b[39m \u001b[38;5;28;01mNone\u001b[39;00m\n",
      "File \u001b[0;32m~/venv/lib/python3.8/site-packages/transformers/models/mistral/modeling_mistral.py:286\u001b[0m, in \u001b[0;36mMistralAttention.forward\u001b[0;34m(self, hidden_states, attention_mask, position_ids, past_key_value, output_attentions, use_cache, **kwargs)\u001b[0m\n\u001b[1;32m    283\u001b[0m     attn_weights \u001b[38;5;241m=\u001b[39m attn_weights \u001b[38;5;241m+\u001b[39m attention_mask\n\u001b[1;32m    285\u001b[0m \u001b[38;5;66;03m# upcast attention to fp32\u001b[39;00m\n\u001b[0;32m--> 286\u001b[0m attn_weights \u001b[38;5;241m=\u001b[39m \u001b[43mnn\u001b[49m\u001b[38;5;241;43m.\u001b[39;49m\u001b[43mfunctional\u001b[49m\u001b[38;5;241;43m.\u001b[39;49m\u001b[43msoftmax\u001b[49m\u001b[43m(\u001b[49m\u001b[43mattn_weights\u001b[49m\u001b[43m,\u001b[49m\u001b[43m \u001b[49m\u001b[43mdim\u001b[49m\u001b[38;5;241;43m=\u001b[39;49m\u001b[38;5;241;43m-\u001b[39;49m\u001b[38;5;241;43m1\u001b[39;49m\u001b[43m,\u001b[49m\u001b[43m \u001b[49m\u001b[43mdtype\u001b[49m\u001b[38;5;241;43m=\u001b[39;49m\u001b[43mtorch\u001b[49m\u001b[38;5;241;43m.\u001b[39;49m\u001b[43mfloat32\u001b[49m\u001b[43m)\u001b[49m\u001b[38;5;241m.\u001b[39mto(query_states\u001b[38;5;241m.\u001b[39mdtype)\n\u001b[1;32m    287\u001b[0m attn_output \u001b[38;5;241m=\u001b[39m torch\u001b[38;5;241m.\u001b[39mmatmul(attn_weights, value_states)\n\u001b[1;32m    289\u001b[0m \u001b[38;5;28;01mif\u001b[39;00m attn_output\u001b[38;5;241m.\u001b[39msize() \u001b[38;5;241m!=\u001b[39m (bsz, \u001b[38;5;28mself\u001b[39m\u001b[38;5;241m.\u001b[39mnum_heads, q_len, \u001b[38;5;28mself\u001b[39m\u001b[38;5;241m.\u001b[39mhead_dim):\n",
      "File \u001b[0;32m~/venv/lib/python3.8/site-packages/torch/nn/functional.py:1858\u001b[0m, in \u001b[0;36msoftmax\u001b[0;34m(input, dim, _stacklevel, dtype)\u001b[0m\n\u001b[1;32m   1856\u001b[0m     ret \u001b[38;5;241m=\u001b[39m \u001b[38;5;28minput\u001b[39m\u001b[38;5;241m.\u001b[39msoftmax(dim)\n\u001b[1;32m   1857\u001b[0m \u001b[38;5;28;01melse\u001b[39;00m:\n\u001b[0;32m-> 1858\u001b[0m     ret \u001b[38;5;241m=\u001b[39m \u001b[38;5;28;43minput\u001b[39;49m\u001b[38;5;241;43m.\u001b[39;49m\u001b[43msoftmax\u001b[49m\u001b[43m(\u001b[49m\u001b[43mdim\u001b[49m\u001b[43m,\u001b[49m\u001b[43m \u001b[49m\u001b[43mdtype\u001b[49m\u001b[38;5;241;43m=\u001b[39;49m\u001b[43mdtype\u001b[49m\u001b[43m)\u001b[49m\n\u001b[1;32m   1859\u001b[0m \u001b[38;5;28;01mreturn\u001b[39;00m ret\n",
      "\u001b[0;31mOutOfMemoryError\u001b[0m: CUDA out of memory. Tried to allocate 6.47 GiB. GPU 0 has a total capacty of 22.19 GiB of which 6.29 GiB is free. Including non-PyTorch memory, this process has 15.89 GiB memory in use. Of the allocated memory 12.57 GiB is allocated by PyTorch, and 3.02 GiB is reserved by PyTorch but unallocated. If reserved but unallocated memory is large try setting max_split_size_mb to avoid fragmentation.  See documentation for Memory Management and PYTORCH_CUDA_ALLOC_CONF"
     ]
    }
   ],
   "source": [
    "output = pipe(\"\"\"### System: You are a good JSON Interpreter who always answers \\\n",
    "the question based on the context only.\n",
    "\n",
    "### User: In the Given JSON,How many unique Selected_X are present for all the SOA_table_rows?\n",
    "JSON : {\n",
    "\t\"SOA_table_rows\": [\n",
    "\t\t{\n",
    "\t\t\t\"Assessments\": \"Informed consent/assent\",\n",
    "\t\t\t\"Selected_X\": [\n",
    "\t\t\t\t\"Screening  (-30 to -1)\"\n",
    "\t\t\t]\n",
    "\t\t},\n",
    "\t\t{\n",
    "\t\t\t\"Assessments\": \"Inclusion/exclusion\",\n",
    "\t\t\t\"Selected_X\": [\n",
    "\t\t\t\t\"Screening  (-30 to -1)\",\n",
    "\t\t\t\t\"Baseline (D 1)\"\n",
    "\t\t\t]\n",
    "\t\t},\n",
    "\t\t{\n",
    "\t\t\t\"Assessments\": \"Uroflowmetry  Assessment\",\n",
    "\t\t\t\"Selected_X\": [\n",
    "\t\t\t\t\"Screening  (-30 to -1)\"\n",
    "\t\t\t]\n",
    "\t\t},\n",
    "\t\t{\n",
    "\t\t\t\"Assessments\": \"Demographics,  medical/ADPKD history [{Superscript 'e' : ADPKD genetic history to be collected if available, although it is not specifically required.}] \",\n",
    "\t\t\t\"Selected_X\": [\n",
    "\t\t\t\t\"Screening  (-30 to -1)\"\n",
    "\t\t\t]\n",
    "\t\t},\n",
    "\t\t{\n",
    "\t\t\t\"Assessments\": \"Tanner staging [{Superscript 'f' : A subject who reaches Stage 5 (both in pubic hair and genitalia) does not need to continue with Tanner Staging.}] \",\n",
    "\t\t\t\"Selected_X\": [\n",
    "\t\t\t\t\"Baseline (D 1)\",\n",
    "\t\t\t\t\"M6 (±14 D)\",\n",
    "\t\t\t\t\"M12 [{Superscript 'b' : The Month 12 visit will serve as the Baseline visit for Phase B. The subject’s body weight at this visit will be used to determine the starting dose in Phase B.}] (D365)  (+14 D)/ End of  Treatment  (EoTx)c [{Superscript '' : Unknown}, {Superscript '' : Unknown}] d\"\n",
    "\t\t\t]\n",
    "\t\t},\n",
    "\t\t{\n",
    "\t\t\t\"Assessments\": \"MRI/ultrasound [{Superscript 'g' : MRI/ultrasound imaging: The baseline imaging used must be the same imaging used throughout the trial (Phase A and Phase B). It is recommended that subjects have their imaging done on the same day as the clinic visit; however imaging can be performed up to 30 days prior to the scheduled visit. The subject should be on IMP for 30 consecutive days prior to imaging (except screening). MRI/ultrasound is not required at the EoTx visit.}] \",\n",
    "\t\t\t\"Selected_X\": [\n",
    "\t\t\t\t\"Screening  (-30 to -1)\",\n",
    "\t\t\t\t\"M12 [{Superscript 'b' : The Month 12 visit will serve as the Baseline visit for Phase B. The subject’s body weight at this visit will be used to determine the starting dose in Phase B.}] (D365)  (+14 D)/ End of  Treatment  (EoTx)c [{Superscript '' : Unknown}, {Superscript '' : Unknown}] d\"\n",
    "\t\t\t]\n",
    "\t\t},\n",
    "\t\t{\n",
    "\t\t\t\"Assessments\": \"Renal pelvic  measurement [{Superscript 'h' : Renal pelvic assessments will be done using ultrasound. The Month 1 assessment can be performed at any scheduled visit between Month 1 and Month 3 but cannot be conducted until 30 days after the subject has started IMP, see Section 3.7.4.5.}] \",\n",
    "\t\t\t\"Selected_X\": [\n",
    "\t\t\t\t\"Screening  (-30 to -1)\",\n",
    "\t\t\t\t\"M1 (Wk  4) (7 D)\",\n",
    "\t\t\t\t\"M12 [{Superscript 'b' : The Month 12 visit will serve as the Baseline visit for Phase B. The subject’s body weight at this visit will be used to determine the starting dose in Phase B.}] (D365)  (+14 D)/ End of  Treatment  (EoTx)c [{Superscript '' : Unknown}, {Superscript '' : Unknown}] d\"\n",
    "\t\t\t]\n",
    "\t\t},\n",
    "\t\t{\n",
    "\t\t\t\"Assessments\": \"Vital signs [{Superscript 'i' : Vital signs at each visit include seated heart rate and blood pressure (systolic and diastolic). Temperature will be collected only at the Phase A baseline visit.}] \",\n",
    "\t\t\t\"Selected_X\": [\n",
    "\t\t\t\t\"Screening  (-30 to -1)\",\n",
    "\t\t\t\t\"Baseline (D 1)\",\n",
    "\t\t\t\t\"Wk 1  (-1/+3 D)\",\n",
    "\t\t\t\t\"M1 (Wk  4) (7 D)\",\n",
    "\t\t\t\t\"M6 (±14 D)\",\n",
    "\t\t\t\t\"M12 [{Superscript 'b' : The Month 12 visit will serve as the Baseline visit for Phase B. The subject’s body weight at this visit will be used to determine the starting dose in Phase B.}] (D365)  (+14 D)/ End of  Treatment  (EoTx)c [{Superscript '' : Unknown}, {Superscript '' : Unknown}] d\"\n",
    "\t\t\t]\n",
    "\t\t},\n",
    "\t\t{\n",
    "\t\t\t\"Assessments\": \"12-lead electrocardiogram\",\n",
    "\t\t\t\"Selected_X\": [\n",
    "\t\t\t\t\"Screening  (-30 to -1)\"\n",
    "\t\t\t]\n",
    "\t\t},\n",
    "\t\t{\n",
    "\t\t\t\"Assessments\": \"Body height and  weight/growth  percentiles [{Superscript 'j' : Body weight should be measured post-void. Growth percentile is not required at the baseline, Wk 1 and M1 visits. Body weight is not required at the Wk 1 and M1 visits. .}] \",\n",
    "\t\t\t\"Selected_X\": [\n",
    "\t\t\t\t\"Screening  (-30 to -1)\",\n",
    "\t\t\t\t\"Baseline (D 1)\",\n",
    "\t\t\t\t\"Wk 1  (-1/+3 D)\",\n",
    "\t\t\t\t\"M1 (Wk  4) (7 D)\",\n",
    "\t\t\t\t\"M6 (±14 D)\",\n",
    "\t\t\t\t\"M12 [{Superscript 'b' : The Month 12 visit will serve as the Baseline visit for Phase B. The subject’s body weight at this visit will be used to determine the starting dose in Phase B.}] (D365)  (+14 D)/ End of  Treatment  (EoTx)c [{Superscript '' : Unknown}, {Superscript '' : Unknown}] d\"\n",
    "\t\t\t]\n",
    "\t\t},\n",
    "\t\t{\n",
    "\t\t\t\"Assessments\": \"Serum  chemistry/hematology/ urinalysis [{Superscript 'k' : Central laboratory serum laboratory tests will be performed for all visits (only monthly safety labs may be collected at a local laboratory). Fasting is required at the screening visit. Fasting is recommended for all other visits, but is not required. Upon request, if clinically indicated and approved by the medical monitor, subjects may have the following evaluations in addition to the protocol-specified chemistry panel: serum calcium, phosphorus, parathyroid hormone, vitamin D, and bicarbonate levels.}] \",\n",
    "\t\t\t\"Selected_X\": [\n",
    "\t\t\t\t\"Screening  (-30 to -1)\",\n",
    "\t\t\t\t\"M6 (±14 D)\",\n",
    "\t\t\t\t\"M12 [{Superscript 'b' : The Month 12 visit will serve as the Baseline visit for Phase B. The subject’s body weight at this visit will be used to determine the starting dose in Phase B.}] (D365)  (+14 D)/ End of  Treatment  (EoTx)c [{Superscript '' : Unknown}, {Superscript '' : Unknown}] d\"\n",
    "\t\t\t]\n",
    "\t\t},\n",
    "\t\t{\n",
    "\t\t\t\"Assessments\": \"Liver function  tests/creatinine [{Superscript 'k' : Central laboratory serum laboratory tests will be performed for all visits (only monthly safety labs may be collected at a local laboratory). Fasting is required at the screening visit. Fasting is recommended for all other visits, but is not required. Upon request, if clinically indicated and approved by the medical monitor, subjects may have the following evaluations in addition to the protocol-specified chemistry panel: serum calcium, phosphorus, parathyroid hormone, vitamin D, and bicarbonate levels.}, {Superscript 'l' : A full liver function panel (AST, ALT, alkaline phosphatase [ALP], bilirubin, total [BT]) will be done at screening. At subsequent visits, LFTs include AST and ALT only, unless otherwise clinically indicated. Laboratory samples for LFTs, serum sodium, and serum creatinine will be collected at baseline only if the baseline visit occurs > 7 days after the Screening visit. Monthly visits include LFTs, serum creatinine and pregnancy test. See Section 5.4 for handling abnormal LFTs.}] \",\n",
    "\t\t\t\"Selected_X\": [\n",
    "\t\t\t\t\"Screening  (-30 to -1)\",\n",
    "\t\t\t\t\"Baseline (D 1)\",\n",
    "\t\t\t\t\"Wk 1  (-1/+3 D)\",\n",
    "\t\t\t\t\"M1 (Wk  4) (7 D)\",\n",
    "\t\t\t\t\"M6 (±14 D)\",\n",
    "\t\t\t\t\"Monthly Safety  Visits:  M2, 3, 4,  5, 7, 8, 9,  10, 11  (±4D) [{Superscript 'a' : Monthly safety visits: If it is more convenient for the subject, laboratory tests may be collected at a local laboratory; a clinic visit is not required. The PI is required to review monthly safety labs and record them in the electronic case report form (eCRF). Protocol 156-12-298 Confidential - Proprietary Information 40 Amendment 1, 08 Aug 2016}]\",\n",
    "\t\t\t\t\"M12 [{Superscript 'b' : The Month 12 visit will serve as the Baseline visit for Phase B. The subject’s body weight at this visit will be used to determine the starting dose in Phase B.}] (D365)  (+14 D)/ End of  Treatment  (EoTx)c [{Superscript '' : Unknown}, {Superscript '' : Unknown}] d\",\n",
    "\t\t\t\t\"Follow-Up [{Superscript 'c' : Any subject who discontinues IMP during Phase A will enter the Follow-up period and then be followed every 6 months through Phase A. The 14 day follow-up visit is a telephone contct only, a clinic visit is not required. Subjects who do not complete Phase A on treatment are not eligible to enter Phase B.}, {Superscript 'd' : An assessment of vital status will be conducted on subjects who terminate IMP prior to the Phase A Month 12 visit and do not agree to additional safety follow-up but do not withdraw consent for continued telephone contact. See Section 3.7.4.8.}] || 7 D Post  Last Dose  (+2 D)\"\n",
    "\t\t\t]\n",
    "\t\t},\n",
    "\t\t{\n",
    "\t\t\t\"Assessments\": \"Serum sodium [{Superscript 'k' : Central laboratory serum laboratory tests will be performed for all visits (only monthly safety labs may be collected at a local laboratory). Fasting is required at the screening visit. Fasting is recommended for all other visits, but is not required. Upon request, if clinically indicated and approved by the medical monitor, subjects may have the following evaluations in addition to the protocol-specified chemistry panel: serum calcium, phosphorus, parathyroid hormone, vitamin D, and bicarbonate levels.}] \",\n",
    "\t\t\t\"Selected_X\": [\n",
    "\t\t\t\t\"Screening  (-30 to -1)\",\n",
    "\t\t\t\t\"Baseline (D 1)\",\n",
    "\t\t\t\t\"Wk 1  (-1/+3 D)\",\n",
    "\t\t\t\t\"M1 (Wk  4) (7 D)\",\n",
    "\t\t\t\t\"M6 (±14 D)\",\n",
    "\t\t\t\t\"Monthly Safety  Visits:  M2, 3, 4,  5, 7, 8, 9,  10, 11  (±4D) [{Superscript 'a' : Monthly safety visits: If it is more convenient for the subject, laboratory tests may be collected at a local laboratory; a clinic visit is not required. The PI is required to review monthly safety labs and record them in the electronic case report form (eCRF). Protocol 156-12-298 Confidential - Proprietary Information 40 Amendment 1, 08 Aug 2016}]\"\n",
    "\t\t\t]\n",
    "\t\t},\n",
    "\t\t{\n",
    "\t\t\t\"Assessments\": \"Urine osmolality [{Superscript 'n' : Spot urine sample collected predose on the morning of Day 1, prior to the morning dose on Week 1, and prior to the morning dose on Month 1. See Section 3.7.5.2 for sample collection details. Protocol 156-12-298 Confidential - Proprietary Information 41 Amendment 1, 08 Aug 2016}] \",\n",
    "\t\t\t\"Selected_X\": [\n",
    "\t\t\t\t\"Baseline (D 1)\",\n",
    "\t\t\t\t\"Wk 1  (-1/+3 D)\",\n",
    "\t\t\t\t\"M1 (Wk  4) (7 D)\"\n",
    "\t\t\t]\n",
    "\t\t},\n",
    "\t\t{\n",
    "\t\t\t\"Assessments\": \"Urine specific gravity\",\n",
    "\t\t\t\"Selected_X\": [\n",
    "\t\t\t\t\"Baseline (D 1)\",\n",
    "\t\t\t\t\"Wk 1  (-1/+3 D)\",\n",
    "\t\t\t\t\"M1 (Wk  4) (7 D)\"\n",
    "\t\t\t]\n",
    "\t\t},\n",
    "\t\t{\n",
    "\t\t\t\"Assessments\": \"Urine or serum pregnancy  test [{Superscript 'o' : A urine or serum pregnancy test for females of childbearing potential (all females ≥ 12 years of age and females < 12 years of age who have started menstruating) will be performed during the study. On suspicion of pregnancy, an unscheduled urine or serum pregnancy testing will be performed. Positive urine pregnancy tests must be confirmed with a serum pregnancy test. Investigator (or appropriate site staff) is advised to counsel participants on the risk of pregnancy while participating in a clinical trial as well as ensuring the child understands how pregnancies occur and can be avoided. This should be documented in source records.}] \",\n",
    "\t\t\t\"Selected_X\": [\n",
    "\t\t\t\t\"Screening  (-30 to -1)\",\n",
    "\t\t\t\t\"Baseline (D 1)\",\n",
    "\t\t\t\t\"M1 (Wk  4) (7 D)\",\n",
    "\t\t\t\t\"M6 (±14 D)\",\n",
    "\t\t\t\t\"Monthly Safety  Visits:  M2, 3, 4,  5, 7, 8, 9,  10, 11  (±4D) [{Superscript 'a' : Monthly safety visits: If it is more convenient for the subject, laboratory tests may be collected at a local laboratory; a clinic visit is not required. The PI is required to review monthly safety labs and record them in the electronic case report form (eCRF). Protocol 156-12-298 Confidential - Proprietary Information 40 Amendment 1, 08 Aug 2016}]\",\n",
    "\t\t\t\t\"M12 [{Superscript 'b' : The Month 12 visit will serve as the Baseline visit for Phase B. The subject’s body weight at this visit will be used to determine the starting dose in Phase B.}] (D365)  (+14 D)/ End of  Treatment  (EoTx)c [{Superscript '' : Unknown}, {Superscript '' : Unknown}] d\"\n",
    "\t\t\t]\n",
    "\t\t},\n",
    "\t\t{\n",
    "\t\t\t\"Assessments\": \"Alcohol & drug screen [{Superscript 'p' : Alcohol/drug screen is performed per clinical judgment and institutional guidelines.}] \",\n",
    "\t\t\t\"Selected_X\": [\n",
    "\t\t\t\t\"Screening  (-30 to -1)\",\n",
    "\t\t\t\t\"Baseline (D 1)\"\n",
    "\t\t\t]\n",
    "\t\t},\n",
    "\t\t{\n",
    "\t\t\t\"Assessments\": \"Physical examination [{Superscript 'q' : A full physical examination is required at screening for the purposes of inclusion into the trial. At all other visits, as needed, a “directed” physical examination may be performed to focus on PKD-related signs and symptoms.}] \",\n",
    "\t\t\t\"Selected_X\": [\n",
    "\t\t\t\t\"Screening  (-30 to -1)\",\n",
    "\t\t\t\t\"Baseline (D 1)\",\n",
    "\t\t\t\t\"Wk 1  (-1/+3 D)\",\n",
    "\t\t\t\t\"M1 (Wk  4) (7 D)\",\n",
    "\t\t\t\t\"M6 (±14 D)\",\n",
    "\t\t\t\t\"M12 [{Superscript 'b' : The Month 12 visit will serve as the Baseline visit for Phase B. The subject’s body weight at this visit will be used to determine the starting dose in Phase B.}] (D365)  (+14 D)/ End of  Treatment  (EoTx)c [{Superscript '' : Unknown}, {Superscript '' : Unknown}] d\"\n",
    "\t\t\t]\n",
    "\t\t},\n",
    "\t\t{\n",
    "\t\t\t\"Assessments\": \"Randomization\",\n",
    "\t\t\t\"Selected_X\": [\n",
    "\t\t\t\t\"Baseline (D 1)\"\n",
    "\t\t\t]\n",
    "\t\t},\n",
    "\t\t{\n",
    "\t\t\t\"Assessments\": \"IMP administration [{Superscript 'r' : The first dose of IMP will be administered to the subject in the clinic. If the visit occurs in the afternoon, the first dose will be the PM dose of IMP. The last dose of Phase A will be taken the evening prior to the Month 12 visit.}] \",\n",
    "\t\t\t\"Selected_X\": [\n",
    "\t\t\t\t\"Baseline (D 1)\",\n",
    "\t\t\t\t\"Wk 1  (-1/+3 D)\",\n",
    "\t\t\t\t\"M1 (Wk  4) (7 D)\",\n",
    "\t\t\t\t\"M6 (±14 D)\"\n",
    "\t\t\t]\n",
    "\t\t},\n",
    "\t\t{\n",
    "\t\t\t\"Assessments\": \"IMPdispensation [{Superscript 's' : If during the titration contact the determination is made to adjust the dose regimen, dose adjustments will be made using dispensed supply if possible, and dose instructions will be provided by the investigator. The subject’s current dose will be recorded at each visit.}] \",\n",
    "\t\t\t\"Selected_X\": [\n",
    "\t\t\t\t\"Baseline (D 1)\",\n",
    "\t\t\t\t\"Wk 1  (-1/+3 D)\",\n",
    "\t\t\t\t\"M1 (Wk  4) (7 D)\",\n",
    "\t\t\t\t\"M6 (±14 D)\",\n",
    "\t\t\t\t\"Monthly Safety  Visits:  M2, 3, 4,  5, 7, 8, 9,  10, 11  (±4D) [{Superscript 'a' : Monthly safety visits: If it is more convenient for the subject, laboratory tests may be collected at a local laboratory; a clinic visit is not required. The PI is required to review monthly safety labs and record them in the electronic case report form (eCRF). Protocol 156-12-298 Confidential - Proprietary Information 40 Amendment 1, 08 Aug 2016}]\",\n",
    "\t\t\t\t\"Titration  Contact  (phone  call or  visit)\"\n",
    "\t\t\t]\n",
    "\t\t},\n",
    "\t\t{\n",
    "\t\t\t\"Assessments\": \"IMPreconciliation [{Superscript 't' : Drug reconciliation will be conducted at every visit. If additional drug supply is required for titration purposes, the site will arrange a subject visit for dispensation.}] \",\n",
    "\t\t\t\"Selected_X\": [\n",
    "\t\t\t\t\"Wk 1  (-1/+3 D)\",\n",
    "\t\t\t\t\"M1 (Wk  4) (7 D)\",\n",
    "\t\t\t\t\"M6 (±14 D)\",\n",
    "\t\t\t\t\"Monthly Safety  Visits:  M2, 3, 4,  5, 7, 8, 9,  10, 11  (±4D) [{Superscript 'a' : Monthly safety visits: If it is more convenient for the subject, laboratory tests may be collected at a local laboratory; a clinic visit is not required. The PI is required to review monthly safety labs and record them in the electronic case report form (eCRF). Protocol 156-12-298 Confidential - Proprietary Information 40 Amendment 1, 08 Aug 2016}]\",\n",
    "\t\t\t\t\"M12 [{Superscript 'b' : The Month 12 visit will serve as the Baseline visit for Phase B. The subject’s body weight at this visit will be used to determine the starting dose in Phase B.}] (D365)  (+14 D)/ End of  Treatment  (EoTx)c [{Superscript '' : Unknown}, {Superscript '' : Unknown}] d\"\n",
    "\t\t\t]\n",
    "\t\t},\n",
    "\t\t{\n",
    "\t\t\t\"Assessments\": \"Palatability and  acceptability\",\n",
    "\t\t\t\"Selected_X\": [\n",
    "\t\t\t\t\"Baseline (D 1)\"\n",
    "\t\t\t]\n",
    "\t\t},\n",
    "\t\t{\n",
    "\t\t\t\"Assessments\": \"QoL questionnaires [{Superscript 'u' : Generic pediatric QoL questionnaires, as available will be assessed in subjects 12 years and older at baseline (pre-dose), Week 1, Months 1, 3, 6, and 12/EoTx prior to any blood draws. The Month 12 assessment should be completed prior to administration of Phase B IMP.}] \",\n",
    "\t\t\t\"Selected_X\": [\n",
    "\t\t\t\t\"Screening  (-30 to -1)\",\n",
    "\t\t\t\t\"Wk 1  (-1/+3 D)\",\n",
    "\t\t\t\t\"M1 (Wk  4) (7 D)\",\n",
    "\t\t\t\t\"M6 (±14 D)\",\n",
    "\t\t\t\t\"Monthly Safety  Visits:  M2, 3, 4,  5, 7, 8, 9,  10, 11  (±4D) [{Superscript 'a' : Monthly safety visits: If it is more convenient for the subject, laboratory tests may be collected at a local laboratory; a clinic visit is not required. The PI is required to review monthly safety labs and record them in the electronic case report form (eCRF). Protocol 156-12-298 Confidential - Proprietary Information 40 Amendment 1, 08 Aug 2016}]\",\n",
    "\t\t\t\t\"M12 [{Superscript 'b' : The Month 12 visit will serve as the Baseline visit for Phase B. The subject’s body weight at this visit will be used to determine the starting dose in Phase B.}] (D365)  (+14 D)/ End of  Treatment  (EoTx)c [{Superscript '' : Unknown}, {Superscript '' : Unknown}] d\"\n",
    "\t\t\t]\n",
    "\t\t},\n",
    "\t\t{\n",
    "\t\t\t\"Assessments\": \"ADPKD outcomes\",\n",
    "\t\t\t\"Selected_X\": [\n",
    "\t\t\t\t\"Baseline (D 1)\",\n",
    "\t\t\t\t\"Wk 1  (-1/+3 D)\",\n",
    "\t\t\t\t\"M1 (Wk  4) (7 D)\",\n",
    "\t\t\t\t\"M6 (±14 D)\",\n",
    "\t\t\t\t\"M12 [{Superscript 'b' : The Month 12 visit will serve as the Baseline visit for Phase B. The subject’s body weight at this visit will be used to determine the starting dose in Phase B.}] (D365)  (+14 D)/ End of  Treatment  (EoTx)c [{Superscript '' : Unknown}, {Superscript '' : Unknown}] d\"\n",
    "\t\t\t]\n",
    "\t\t},\n",
    "\t\t{\n",
    "\t\t\t\"Assessments\": \"Daytime and nighttime  void collection [{Superscript 'v' : The number of daytime and nightime voids for all subjects 12 years and older will be collected during Phase A. Refer also to Section 3.7.6.1. Daytime and nighttime voids are not required for the EoTx visit and subsequent follow-up visits.}] \",\n",
    "\t\t\t\"Selected_X\": [\n",
    "\t\t\t\t\"Baseline (D 1)\",\n",
    "\t\t\t\t\"Wk 1  (-1/+3 D)\",\n",
    "\t\t\t\t\"M1 (Wk  4) (7 D)\",\n",
    "\t\t\t\t\"M6 (±14 D)\",\n",
    "\t\t\t\t\"M12 [{Superscript 'b' : The Month 12 visit will serve as the Baseline visit for Phase B. The subject’s body weight at this visit will be used to determine the starting dose in Phase B.}] (D365)  (+14 D)/ End of  Treatment  (EoTx)c [{Superscript '' : Unknown}, {Superscript '' : Unknown}] d\"\n",
    "\t\t\t]\n",
    "\t\t},\n",
    "\t\t{\n",
    "\t\t\t\"Assessments\": \"PK & PD sample  collection [{Superscript 'w' : Dense PK and PD sampling will occur in a subset of subjects (see Section 3.7.5.1) after at least 1 month of dosing. These subjects will be hospitalized the evening prior to the scheduled PK sampling (typically a Friday evening) and discharged after the 24 hour PK sample collection (typically Sunday morning). Sparse PK sampling will occur in all subjects at the Week 1, Month 1, Month 6, and Month 12 visits.}] \",\n",
    "\t\t\t\"Selected_X\": [\n",
    "\t\t\t\t\"Wk 1  (-1/+3 D)\",\n",
    "\t\t\t\t\"M1 (Wk  4) (7 D)\",\n",
    "\t\t\t\t\"M6 (±14 D)\",\n",
    "\t\t\t\t\"M12 [{Superscript 'b' : The Month 12 visit will serve as the Baseline visit for Phase B. The subject’s body weight at this visit will be used to determine the starting dose in Phase B.}] (D365)  (+14 D)/ End of  Treatment  (EoTx)c [{Superscript '' : Unknown}, {Superscript '' : Unknown}] d\"\n",
    "\t\t\t]\n",
    "\t\t},\n",
    "\t\t{\n",
    "\t\t\t\"Assessments\": \"24-hour fluid balance\",\n",
    "\t\t\t\"Selected_X\": [\n",
    "\t\t\t\t\"Wk 1  (-1/+3 D)\"\n",
    "\t\t\t]\n",
    "\t\t},\n",
    "\t\t{\n",
    "\t\t\t\"Assessments\": \"Concomitant medications\",\n",
    "\t\t\t\"Selected_X\": [\n",
    "\t\t\t\t\"Screening  (-30 to -1)\",\n",
    "\t\t\t\t\"Follow-Up [{Superscript 'c' : Any subject who discontinues IMP during Phase A will enter the Follow-up period and then be followed every 6 months through Phase A. The 14 day follow-up visit is a telephone contct only, a clinic visit is not required. Subjects who do not complete Phase A on treatment are not eligible to enter Phase B.}, {Superscript 'd' : An assessment of vital status will be conducted on subjects who terminate IMP prior to the Phase A Month 12 visit and do not agree to additional safety follow-up but do not withdraw consent for continued telephone contact. See Section 3.7.4.8.}] || 7 D Post  Last Dose  (+2 D)\",\n",
    "\t\t\t\t\"Follow-Up [{Superscript 'c' : Any subject who discontinues IMP during Phase A will enter the Follow-up period and then be followed every 6 months through Phase A. The 14 day follow-up visit is a telephone contct only, a clinic visit is not required. Subjects who do not complete Phase A on treatment are not eligible to enter Phase B.}, {Superscript 'd' : An assessment of vital status will be conducted on subjects who terminate IMP prior to the Phase A Month 12 visit and do not agree to additional safety follow-up but do not withdraw consent for continued telephone contact. See Section 3.7.4.8.}] || 14 D Post  Last Dose  (+2 D)\"\n",
    "\t\t\t]\n",
    "\t\t},\n",
    "\t\t{\n",
    "\t\t\t\"Assessments\": \"Adverse events\",\n",
    "\t\t\t\"Selected_X\": [\n",
    "\t\t\t\t\"Screening  (-30 to -1)\",\n",
    "\t\t\t\t\"Follow-Up [{Superscript 'c' : Any subject who discontinues IMP during Phase A will enter the Follow-up period and then be followed every 6 months through Phase A. The 14 day follow-up visit is a telephone contct only, a clinic visit is not required. Subjects who do not complete Phase A on treatment are not eligible to enter Phase B.}, {Superscript 'd' : An assessment of vital status will be conducted on subjects who terminate IMP prior to the Phase A Month 12 visit and do not agree to additional safety follow-up but do not withdraw consent for continued telephone contact. See Section 3.7.4.8.}] || 7 D Post  Last Dose  (+2 D)\",\n",
    "\t\t\t\t\"Follow-Up [{Superscript 'c' : Any subject who discontinues IMP during Phase A will enter the Follow-up period and then be followed every 6 months through Phase A. The 14 day follow-up visit is a telephone contct only, a clinic visit is not required. Subjects who do not complete Phase A on treatment are not eligible to enter Phase B.}, {Superscript 'd' : An assessment of vital status will be conducted on subjects who terminate IMP prior to the Phase A Month 12 visit and do not agree to additional safety follow-up but do not withdraw consent for continued telephone contact. See Section 3.7.4.8.}] || 14 D Post  Last Dose  (+2 D)\"\n",
    "\t\t\t]\n",
    "\t\t}\n",
    "\t]\n",
    "}\n",
    "### Assistant:\n",
    "\"\"\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": 5,
   "metadata": {},
   "outputs": [],
   "source": [
    "from llama_index import SimpleDirectoryReader\n",
    "from llama_index.node_parser import SimpleNodeParser\n",
    "from llama_index.schema import MetadataMode\n",
    "\n",
    "\n",
    "reader = SimpleDirectoryReader(input_files = [\"/home/ubuntu/open-llm/pdfs/X06-201-00001_Protocol_Amendment_4.pdf\"])"
   ]
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "venv",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.8.10"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 2
}
